
<html lang="en"     class="pb-page"  data-request-id="e6b29426-6a60-4383-92f6-f53dca8d19bd"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b01108;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2018.61.issue-19;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS" /></meta><meta name="dc.Creator" content="Timothy&#xA;R.  Hodges" /></meta><meta name="dc.Creator" content="Jason R.  Abbott" /></meta><meta name="dc.Creator" content="Andrew J.  Little" /></meta><meta name="dc.Creator" content="Dhruba  Sarkar" /></meta><meta name="dc.Creator" content="James M.  Salovich" /></meta><meta name="dc.Creator" content="Jennifer E.  Howes" /></meta><meta name="dc.Creator" content="Denis T.  Akan" /></meta><meta name="dc.Creator" content="Jiqing  Sai" /></meta><meta name="dc.Creator" content="Allison L.  Arnold" /></meta><meta name="dc.Creator" content="Carrie  Browning" /></meta><meta name="dc.Creator" content="Michael C.  Burns" /></meta><meta name="dc.Creator" content="Tammy  Sobolik" /></meta><meta name="dc.Creator" content="Qi  Sun" /></meta><meta name="dc.Creator" content="Yugandhar  Beesetty" /></meta><meta name="dc.Creator" content="Jesse A.  Coker" /></meta><meta name="dc.Creator" content="Dirk  Scharn" /></meta><meta name="dc.Creator" content="Heinz  Stadtmueller" /></meta><meta name="dc.Creator" content="Olivia W.  Rossanese" /></meta><meta name="dc.Creator" content="Jason  Phan" /></meta><meta name="dc.Creator" content="Alex G.  Waterson" /></meta><meta name="dc.Creator" content="Darryl B.  McConnell" /></meta><meta name="dc.Creator" content="Stephen W.  Fesik" /></meta><meta name="dc.Description" content="Son of sevenless homologue 1 (SOS1) is a guanine nucleotide exchange factor that catalyzes the exchange of GDP for GTP on RAS. In its active form, GTP-bound RAS is responsible for numerous critical..." /></meta><meta name="Description" content="Son of sevenless homologue 1 (SOS1) is a guanine nucleotide exchange factor that catalyzes the exchange of GDP for GTP on RAS. In its active form, GTP-bound RAS is responsible for numerous critical..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 11, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01108" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01108" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01108" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01108" /></link>
        
    
    

<title>Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01108" /></meta><meta property="og:title" content="Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0021.jpeg" /></meta><meta property="og:description" content="Son of sevenless homologue 1 (SOS1) is a guanine nucleotide exchange factor that catalyzes the exchange of GDP for GTP on RAS. In its active form, GTP-bound RAS is responsible for numerous critical cellular processes. Aberrant RAS activity is involved in ∼30% of all human cancers; hence, SOS1 is an attractive therapeutic target for its role in modulating RAS activation. Here, we describe a new series of benzimidazole-derived SOS1 agonists. Using structure-guided design, we discovered small molecules that increase nucleotide exchange on RAS in vitro at submicromolar concentrations, bind to SOS1 with low double-digit nanomolar affinity, rapidly enhance cellular RAS-GTP levels, and invoke biphasic signaling changes in phosphorylation of ERK 1/2. These compounds represent the most potent series of SOS1 agonists reported to date." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01108"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01108">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01108&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01108&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01108&amp;href=/doi/10.1021/acs.jmedchem.8b01108" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 8875-8894</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01106" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01136" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Timothy R. Hodges</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Timothy R. Hodges</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Timothy%0AR.++Hodges">Timothy R. Hodges</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1216-9551" title="Orcid link">http://orcid.org/0000-0003-1216-9551</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jason R. Abbott</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jason R. Abbott</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jason+R.++Abbott">Jason R. Abbott</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2291-2903" title="Orcid link">http://orcid.org/0000-0002-2291-2903</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrew J. Little</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew J. Little</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+J.++Little">Andrew J. Little</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dhruba Sarkar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dhruba Sarkar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dhruba++Sarkar">Dhruba Sarkar</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0597-3066" title="Orcid link">http://orcid.org/0000-0003-0597-3066</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James M. Salovich</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James M. Salovich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James+M.++Salovich">James M. Salovich</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jennifer E. Howes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jennifer E. Howes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+E.++Howes">Jennifer E. Howes</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1138-6183" title="Orcid link">http://orcid.org/0000-0003-1138-6183</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Denis T. Akan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Denis T. Akan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Denis+T.++Akan">Denis T. Akan</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1476-4883" title="Orcid link">http://orcid.org/0000-0002-1476-4883</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jiqing Sai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiqing Sai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiqing++Sai">Jiqing Sai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Allison L. Arnold</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Allison L. Arnold</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Allison+L.++Arnold">Allison L. Arnold</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carrie Browning</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carrie Browning</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carrie++Browning">Carrie Browning</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael C. Burns</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael C. Burns</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+C.++Burns">Michael C. Burns</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tammy Sobolik</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tammy Sobolik</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tammy++Sobolik">Tammy Sobolik</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qi Sun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qi Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Sun">Qi Sun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yugandhar Beesetty</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yugandhar Beesetty</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yugandhar++Beesetty">Yugandhar Beesetty</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jesse A. Coker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jesse A. Coker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jesse+A.++Coker">Jesse A. Coker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dirk Scharn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dirk Scharn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co. KG, Doktor-Boehringer-Gasse 5-11, 1120 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dirk++Scharn">Dirk Scharn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Heinz Stadtmueller</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Heinz Stadtmueller</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co. KG, Doktor-Boehringer-Gasse 5-11, 1120 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Heinz++Stadtmueller">Heinz Stadtmueller</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Olivia W. Rossanese</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Olivia W. Rossanese</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Olivia+W.++Rossanese">Olivia W. Rossanese</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jason Phan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jason Phan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Phan">Jason Phan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alex G. Waterson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alex G. Waterson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div><div class="loa-info-affiliations-info">Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37232-0146, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alex+G.++Waterson">Alex G. Waterson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Darryl B. McConnell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Darryl B. McConnell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Boehringer Ingelheim RCV GmbH & Co. KG, Doktor-Boehringer-Gasse 5-11, 1120 Vienna, Austria</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Darryl+B.++McConnell">Darryl B. McConnell</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Stephen W. Fesik</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen W. Fesik</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry,  Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States</div><div class="loa-info-affiliations-info">Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37232-0146, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (615)322-6303. Fax: (615)875-3236. E-mail: <a href="/cdn-cgi/l/email-protection#6c1f18091c040902420a091f05072c1a0d0208091e0e05001842090819"><span class="__cf_email__" data-cfemail="780b0c1d08101d16561e1d0b1113380e19161c1d0a1a11140c561d1c0d">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+W.++Fesik">Stephen W. Fesik</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5957-6192" title="Orcid link">http://orcid.org/0000-0001-5957-6192</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01108&amp;href=/doi/10.1021%2Facs.jmedchem.8b01108" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 8875–8894</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 11, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 July 2018</li><li><span class="item_label"><b>Published</b> online</span>11 September 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 October 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01108" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01108</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8875%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTimothy%250AR.%2BHodges%252C%2BJason%2BR.%2BAbbott%252C%2BAndrew%2BJ.%2BLittle%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D19%26contentID%3Dacs.jmedchem.8b01108%26title%3DDiscovery%2Band%2BStructure-Based%2BOptimization%2Bof%2BBenzimidazole-Derived%2BActivators%2Bof%2BSOS1-Mediated%2BNucleotide%2BExchange%2Bon%2BRAS%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8894%26publicationDate%3DOctober%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01108"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3380</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01108" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RAS&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Timothy\nR.&quot;,&quot;last_name&quot;:&quot;Hodges&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;R. Abbott&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;J. Little&quot;},{&quot;first_name&quot;:&quot;Dhruba&quot;,&quot;last_name&quot;:&quot;Sarkar&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;M. Salovich&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;E. Howes&quot;},{&quot;first_name&quot;:&quot;Denis&quot;,&quot;last_name&quot;:&quot;T. Akan&quot;},{&quot;first_name&quot;:&quot;Jiqing&quot;,&quot;last_name&quot;:&quot;Sai&quot;},{&quot;first_name&quot;:&quot;Allison&quot;,&quot;last_name&quot;:&quot;L. Arnold&quot;},{&quot;first_name&quot;:&quot;Carrie&quot;,&quot;last_name&quot;:&quot;Browning&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;C. Burns&quot;},{&quot;first_name&quot;:&quot;Tammy&quot;,&quot;last_name&quot;:&quot;Sobolik&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Yugandhar&quot;,&quot;last_name&quot;:&quot;Beesetty&quot;},{&quot;first_name&quot;:&quot;Jesse&quot;,&quot;last_name&quot;:&quot;A. Coker&quot;},{&quot;first_name&quot;:&quot;Dirk&quot;,&quot;last_name&quot;:&quot;Scharn&quot;},{&quot;first_name&quot;:&quot;Heinz&quot;,&quot;last_name&quot;:&quot;Stadtmueller&quot;},{&quot;first_name&quot;:&quot;Olivia&quot;,&quot;last_name&quot;:&quot;W. Rossanese&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Phan&quot;},{&quot;first_name&quot;:&quot;Alex&quot;,&quot;last_name&quot;:&quot;G. Waterson&quot;},{&quot;first_name&quot;:&quot;Darryl&quot;,&quot;last_name&quot;:&quot;B. McConnell&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;W. Fesik&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;8875-8894&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01108&quot;},&quot;abstract&quot;:&quot;Son of sevenless homologue 1 (SOS1) is a guanine nucleotide exchange factor that catalyzes the exchange of GDP for GTP on RAS. In its active form, GTP-bound RAS is responsible for numerous critical cellular processes. Aberrant RAS activity is involved in ∼30% of all human cancers; hence, SOS1 is an attractive therapeutic target for its role in modulating RAS activation. Here, we describe a new series of benzimidazole-derived SOS1 agonists. Using structure-guided design, we discovered small molecules that increase nucleotide exchange on RAS in vitro at submicromolar concentrations, bind to SOS1 with low double-digit nanomolar affinity, rapidly enhance cellular RAS-GTP levels, and invoke biphasic signaling changes in phosphorylation of ERK 1/2. These compounds represent the most potent series of SOS1 agonists reported to date.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01108&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01108" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01108&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01108" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01108&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01108" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01108&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01108&amp;href=/doi/10.1021/acs.jmedchem.8b01108" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01108" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01108" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (11 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01108%26sid%3Dliteratum%253Aachs%26pmid%3D30205005%26genre%3Darticle%26aulast%3DHodges%26date%3D2018%26atitle%3DDiscovery%2Band%2BStructure-Based%2BOptimization%2Bof%2BBenzimidazole-Derived%2BActivators%2Bof%2BSOS1-Mediated%2BNucleotide%2BExchange%2Bon%2BRAS%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D19%26spage%3D8875%26epage%3D8894%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291301" title="Salts">Salts</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/jmcmar.2018.61.issue-19/20181011/jmcmar.2018.61.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Son of sevenless homologue 1 (SOS1) is a guanine nucleotide exchange factor that catalyzes the exchange of GDP for GTP on RAS. In its active form, GTP-bound RAS is responsible for numerous critical cellular processes. Aberrant RAS activity is involved in ∼30% of all human cancers; hence, SOS1 is an attractive therapeutic target for its role in modulating RAS activation. Here, we describe a new series of benzimidazole-derived SOS1 agonists. Using structure-guided design, we discovered small molecules that increase nucleotide exchange on RAS in vitro at submicromolar concentrations, bind to SOS1 with low double-digit nanomolar affinity, rapidly enhance cellular RAS-GTP levels, and invoke biphasic signaling changes in phosphorylation of ERK 1/2. These compounds represent the most potent series of SOS1 agonists reported to date.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61513" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61513" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">RAS proteins act as molecular switches, cycling between active (GTP-bound) and inactive (GDP-bound) states in order to regulate multiple intracellular signaling pathways that control cell proliferation, growth, differentiation, and survival.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Deregulation of these pathways via oncogenic RAS mutations can result in cells displaying many of the hallmarks of cancer and is implicated in the oncogenesis and progression of ∼30% of all malignant tumors.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7">(3−7)</a> Therefore, therapeutic targeting of oncogenic RAS has been an important and long-standing goal in modern drug discovery. Unfortunately, only limited success has been realized when directly targeting RAS due to the lack of chemically tractable pockets on the protein surface.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a> The recalcitrant nature of these proteins toward traditional drug discovery strategies has inspired the pursuit of alternative approaches to inhibit RAS signaling.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19">(11−19)</a> One strategy is to indirectly target RAS through therapeutic modulation of the regulatory proteins that control its activity. The conversion of RAS-GDP to RAS-GTP is the rate-limiting step in the activation of RAS signaling and is controlled by guanine nucleotide exchange factors (GEFs) such as son of sevenless homologue 1 (SOS1).<a onclick="showRef(event, 'ref7 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref7 ref20 ref21">(7,20,21)</a> Because of its importance in RAS signaling, SOS1 has emerged as an attractive therapeutic target for the treatment of RAS-driven cancers.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a></div><div class="NLM_p last">Our group recently reported two unrelated chemical series that bind to the same hydrophobic pocket on SOS1 as part of a RAS:SOS1:RAS complex.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24−26)</a> We have previously shown that these compounds activate nucleotide exchange on RAS, resulting in increased levels of cellular RAS-GTP and, at low concentrations, enhance phosphorylation of extracellular regulared kinase (ERK) 1/2 via the RAS-MAPK signaling pathway.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> At higher doses of compound, phosphorylated ERK (pERK) phosphorylates SOS1 leading to disruption of the SOS1-GRB2 complex and dissociation of RAS from SOS1, thereby achieving a compound-mediated negative feedback loop that results in reduced ERK phosphorylation. Although seemingly counterintuitive, a growing body of evidence suggests that activation of RAS may be a viable therapeutic strategy.<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28−30)</a> The “Goldilocks principle” suggests that cells can only tolerate changes in signaling that stay within certain parameters, which do not go either above, or below a certain cellular threshold.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> For example, enhancement of RAS-GTP levels in the cell by ectopic overexpression of mutant RAS can lead to pronounced antitumoral responses.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Furthermore, naturally occurring concomitant expression of mutant RAS with either mutant BRAF or mutant EGFR is very rare, and overexpression of RAS is synthetically lethal in the context of an EGFR or BRAF mutation.<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33−35)</a> Thus, the RAS activation that we observe with SOS1 agonists may represent a promising approach for targeting cells with underlying oncogenic RAS, BRAF, or EGFR mutations. Here, we describe the structure-guided design, synthesis, and structure–activity relationships (SAR) of a new benzimidazole-derived series of SOS1 ligands. These efforts led to the discovery of molecules that robustly activate SOS1-mediated nucleotide exchange in vitro, bind with high affinity to SOS1, rapidly increase cellular RAS-GTP levels, and modulate ERK phosphorylation in cells, resulting in the most potent SOS1 agonists yet reported.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23136" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23136" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Discovery of Benzimidazole-Derived SOS1 Compounds</h3><div class="NLM_p">To identify compounds that bind to SOS1 and affect SOS1-mediated nucleotide exchange in vitro, we conducted a high throughput screen (HTS) of the Vanderbilt Compound Collection.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> This screen revealed multiple molecules in different chemical series that elicited robust and reproducible SOS1-mediated activation of nucleotide exchange on RAS. Similar to our previously reported work,<a onclick="showRef(event, 'ref24 ref25 ref26 ref36'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref36">(24−26,36)</a> compound efficacy is described by relative percent activation (Act.), which is the rate of nucleotide exchange at the maximum compound dose of 100 μM, relative to the previously reported indole-derived control compound at the same concentration in the same run of the assay.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The corresponding potency is described as the half maximal effective concentration (EC<sub>50</sub>) determined from the dose response curve (0–100 μM of compound) generated from the nucleotide exchange assay. From the HTS hits, several benzimidazole-containing molecules emerged as potentially useful starting points. For example, compounds <b>1</b> and <b>2</b> were found to activate nucleotide exchange with EC<sub>50</sub> values of 63.0 and 23.2 μM, respectively (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). An early follow-up analogue, <b>3</b>, was synthesized that removed the ring constraints from the 2-position nitrogen atom and introduced a substitution pattern on the benzyl group similar to that of an aniline ring system in a previously reported anilinoquinazoline series.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> These structural modifications afforded a 3-fold improvement in nucleotide exchange activation EC<sub>50</sub> when comparing derivative <b>3</b> to <b>2</b>. Furthermore, an X-ray co-crystal structure obtained of <b>3</b> bound to the RAS:SOS1:RAS ternary complex confirmed that it binds in the same hydrophobic pocket of the CDC25 domain of SOS1, adjacent to the Switch II region of RAS, that is utilized by previously reported series of SOS1 ligands (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B).<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref36'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref36">(23−26,36)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Early hit benzimidazole-derived activators of SOS1-mediated nucleotide exchange. (B) X-ray co-crystal structure of <b>3</b> (yellow; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5V">6D5V</a>) bound to SOS1 in the RAS:SOS1:RAS ternary complex. The RAS and SOS1 protein surfaces are colored yellow and gray, respectively. Areas identified for SAR development are highlighted, including: (i) a water-mediated interaction between the 2-amine functionality with Asp887 (blue oval), (ii) occupation of a hydrophobic subpocket beneath Phe890 (red arrows), (iii) occupation of a hydrophobic region along the wall of the CDC25 domain (pink rectangle), (iv) occupation of a hydrophobic subpocket behind Glu902 and adjacent to Phe890 (green circle), and (v) interaction with proximal residues of SOS1 from the 4-position of the benzimidazole scaffold (white arrows).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> C-2 Substituent SAR</h3><div class="NLM_p">Analysis of the X-ray co-crystal structure of compound <b>3</b> revealed several opportunities to improve binding to SOS1 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). We initiated our SAR studies by focusing on the 2-position of the benzimidazole core with the goal of deploying a Lewis base closer to Asp887 in an attempt to establish a direct, rather than water-mediated, interaction (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Notably, improved potency and efficacy were observed with several 2-amine variants. This was highlighted by 2-piperazino <b>10</b>, which demonstrated a ∼4-fold and ∼3-fold improvement in nucleotide exchange EC<sub>50</sub> and relative percent activation, respectively. Conversely, negligible nucleotide exchange activation was observed when the Lewis base was removed, as exemplified by 2<i>H</i>-benzimidazole <b>4</b>. The X-ray co-crystal structure of compound <b>10</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A) revealed that the piperazine moiety occluded the water molecule that facilitated the hydrogen bonding interaction between Asp887 and <b>3</b>. As a result, the piperazine nitrogen atom of <b>10</b> achieved a direct charge–charge interaction with the carboxylate side chain of Asp887. On the basis of its combination of potent and efficacious nucleotide exchange activity and limited number of hydrogen bond donors,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> piperazino-analogue <b>10</b> was selected as a template for continued structural modification.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. 2-Amino Substituents<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0011.gif" alt="" id="GRAPHIC-d7e582-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0012.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Measurements are reported as the mean ± SD of two or more independent experiments, each conducted in duplicate.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Activation values represent percentage relative to control.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">“--” denotes an EC<sub>50</sub> value of >100 μM, an EC<sub>50</sub> value that was not calculated due to low efficacy, or an activation value that was not determined due to low efficacy.</p></div></div><div></div></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) X-ray co-crystal structure of <b>10</b> (magenta; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5M">6D5M</a>) bound to SOS1 in the RAS:SOS1:RAS ternary complex. The curved blue line highlights the subpocket near His905. The RAS and SOS1 protein surfaces are colored yellow and gray, respectively. (B) <b>28</b> (green; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5L">6D5L</a>) overlaid with <b>10</b>. The green sphere represents space filling of the 6-chlorine atom in <b>28</b>, whereas the magenta and white spheres represent space filling of the 6-methyl group in <b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Benzyl Substituent SAR</h3><div class="NLM_p">With improvements in potency and efficacy achieved via the inclusion of the 2-piperazine moiety, we turned our focus to investigating the chemical space around the benzyl group (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). While ortho-substitutions were generally poorly tolerated (not shown), the contribution of the aromatic halogen atoms in other positions was quite evident, as unsubstituted benzyl analogue <b>12</b> showed an EC<sub>50</sub> that was ∼4-fold worse than <b>10</b>. Interestingly, of the 4′-monosubstituted derivatives, only the 4′-fluoro compound <b>13</b> demonstrated improved nucleotide exchange potency relative to <b>12</b>, and the activity dropped off sharply with larger 4′-moieties. The benefit of meta-substitution also appeared to be limited by size as evidenced by the drop in potency observed for compounds featuring a 3′-trifluoromethyl (<b>19</b>) or a 3′-cyclopropyl (<b>20</b>) group relative to <b>10</b>. Together, these data suggested that limited steric bulk at the para- and meta-positions provided improved potency. We noted that compound potency (EC<sub>50</sub>) was observed to correlate poorly with compound efficacy (Act.). Empirically, it had been previously determined that SOS1 agonists achieving Act. values greater than ∼50% elicited more robust increases in cellular RAS–GTP levels.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Beyond this perceived minimum threshold, the origin and consequences of varying degrees of percent relative activation is not well understood and is currently under further investigation.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Benzyl Substituents<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0013.gif" alt="" id="GRAPHIC-d7e682-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0014.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Measurements are reported as the mean ± SD of two or more independent experiments, each conducted in duplicate.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Activation values represent percentage relative to control.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">“--” denotes an EC<sub>50</sub> value of >100 μM, an EC<sub>50</sub> value that was not calculated due to low efficacy, or an activation value that was not determined due to low efficacy.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Arene 5,6-Substitution SAR</h3><div class="NLM_p">Having learned much about the tolerance of substitution around the benzyl group, we transitioned to examining various hydrophobic substitutions at the 5- and 6-positions of the benzimidazole core to optimize the occupancy of the small hydrophobic subpocket near His905 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). For this, the 2-piperazino and 3′-chloro-4′-fluoro benzyl moieties were held constant to isolate the effects of the 5- and 6-positions of the benzimidazole nucleus (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Removal of the 5-position substituent had a relatively minor effect on compound potency. Compare, for example, the 5<i>H</i>-6-methyl derivative, <b>24</b>, and the 5<i>H</i>-6-chloro derivative, <b>28</b>, to their respective 5-methyl analogues <b>10</b> and <b>22</b>. It is interesting to note, however, that 5<i>H</i>-substitution resulted in a strong decrease in relative percent activation. The X-ray co-crystal structure of <b>28</b> overlaid with that of <b>10</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) showed that both ligands rested in the hydrophobic subpocket near His905 and effected minimal differences in the positioning of the SOS1 binding pocket residues. This suggests that the differences in observed Act. levels between analogues <b>10</b> and <b>28</b> are not due to a significant discrepancy in compound binding mode. From these same co-crystal structures, it is apparent that there is little room in the hydrophobic subpocket near His905 for 6-position moieties much larger than a methyl group. This observation is supported by the substantial loss in potency observed for the 6-cyclopropyl compound <b>26</b>. Notably, removal of both 5- and 6-substitution, exemplified by compound <b>23</b>, resulted in a ∼5-fold reduction in potency relative to <b>28</b>. These data suggested that an appropriately sized 6-substituent was the primary contributor to potency in this region of the binding pocket.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. 5,6-Substituents<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0015.gif" alt="" id="GRAPHIC-d7e775-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0016.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Measurements are reported as the mean ± SD of two or more independent experiments, each conducted in duplicate.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Activation values represent percentage relative to control.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></p></div></div><div></div></div><div class="NLM_p">The SAR developed in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> prompted the synthesis of several matched pairs of analogues to investigate the interplay between substituents on the aromatic ring of the benzyl moiety and the substituents at the 5- and 6-positions of the benzimidazole nucleus. From this effort, crossover analogue <b>29</b>, containing the 3′,5′-dimethyl-4′-fluorobenzyl moiety and a 6-position chlorine atom, was found to exhibit an EC<sub>50</sub> value below 1 μM in the nucleotide exchange assay (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). As compounds continued to improve, we observed a loss of SAR texture for derivatives with EC<sub>50</sub> values in this range. To effectively differentiate more potent compounds, a fluorescence polarization anisotropy (FPA) assay, based on the displacement of a labeled probe from SOS1 (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_001.pdf" class="ext-link">Figure S2</a>), was developed to provide a measurement of binding affinity (<i>K</i><sub>d</sub>) to SOS1.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> Several earlier compounds were re-evaluated using this FPA assay, showing a general agreement between <i>K</i><sub>d</sub> and nucleotide exchange EC<sub>50</sub> for previously investigated SAR trends (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_001.pdf" class="ext-link">Figure S3</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_001.pdf" class="ext-link">Table S1</a>). This reaffirmed our established SAR and prompted a switch to the FPA assay as the primary tool for evaluating analogues. Moving forward with a new biochemical assay to drive optimization, compound <b>29</b> was selected as a template upon which to conduct further work.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Nucleotide exchange and binding affinity data for compound <b>29</b>. (B) X-ray co-crystal structure of compound <b>29</b> (teal; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5J">6D5J</a>) bound to SOS1 in the RAS:SOS1:RAS ternary complex. The red dotted spheres represent molecules of water and the space they occupy. The RAS and SOS1 protein surfaces are colored yellow and gray, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> C-4 Substituent SAR</h3><div class="NLM_p">The binding mode of compound <b>29</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B) highlighted several opportunities for continued optimization. First, a largely hydrophobic space proximal to the 4-position of the benzimidazole remained unoccupied, as demonstrated by the two molecules of water occupying the back of the binding pocket. Additionally, several residues at the lip of the binding pocket, primarily Glu902, His905, and Tyr884, seemed accessible for interaction. As these regions are largely solvent-exposed, a considerable tolerance for groups that may offer the ability to tune the overall molecular properties was expected. To exploit these opportunities, we explored a wide range of chemical diversity at the 4-position. A selection of these results is shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. C-4 SAR<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0017.gif" alt="" id="GRAPHIC-d7e881-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0018.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Measurements are reported as the mean ± SD of two or more independent experiments, each conducted in duplicate.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Evaluated through displacement of probe <b>S1</b> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_001.pdf" class="ext-link">Figure S2</a>).</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Evaluated through displacement of probe <b>S2</b> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_001.pdf" class="ext-link">Figure S2</a>).</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">LipE was not determined.</p></div></div><div></div></div><div class="NLM_p">In an effort to fill the neighboring hydrophobic subpocket, several biaryl derivatives with lipophilic substitutions were synthesized and evaluated by FPA (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Multiple 4-phenyl analogues demonstrated improved binding affinity relative to the 4<i>H</i>-parent <b>29</b>. In some instances, ortho-substitution of the 4-phenyl ring offered further enhancement, best exemplified by the ortho-trifluoromethyl analogue <b>35</b> and the ortho-chloro compound <b>38</b>, relative to the unsubstituted phenyl derivative <b>30</b>. Increasing the size of the ortho-alkyl groups resulted in a decline in binding affinity from <b>30</b>, suggesting that the nearby pocket has a limited size tolerance. Notably, biaryl analogues, such as <b>36</b> and <b>37</b>, bearing meta- or para-substituents, exhibited diminished affinity when compared to their ortho-substituted or unsubstituted comparators.</div><div class="NLM_p">Analysis of the X-ray co-crystal structure of <b>38</b> revealed that the aryl group is rotated out of plane from the benzimidazole scaffold (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Further, when the co-crystal structure of <b>38</b> was overlaid with that of <b>29</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D), it was evident that <b>38</b> leaned over into the SOS1 binding pocket to drive the ortho-chlorine atom down into the available lipophilic space, thus displacing the previously bound waters from this subpocket. The presence of the hydrophobic aryl group in <b>38</b> disrupted the positioning of Glu902, rotating the carboxylic acid side chain upward toward solvent compared to the downward pose observed in the co-crystal structure of <b>29</b>. The observed gains in binding affinity from the addition of phenyl groups at the 4-position corresponded with an increase in compound lipophilicity as evidenced by a rise in ALogP and correspondingly poor lipophilic ligand efficiency (LipE)<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> when compared with the 4<i>H</i>-compound, <b>29</b>.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray co-crystal structures of (A) <b>38</b> (salmon; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5H">6D5H</a>), (B) <b>43</b> (orange; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5G">6D5G</a>), (C) <b>47</b> (green; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5E">6D5E</a>), and (D) <b>38</b>, <b>43</b>, and <b>47</b> overlaid with <b>29</b> (teal) bound to SOS1 in the RAS:SOS1:RAS ternary complex. The RAS and SOS1 protein surfaces are colored yellow and gray, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We hypothesized that directly engaging residues Glu902, His905, and Tyr884 with heteroatoms might provide significant affinity enhancements. Furthermore, successful incorporation of polar functionality at the 4-position was expected to result in improved solubility and lower lipophilicity relative to the biaryl compounds. We thus explored the use of a protonatable nitrogen atom to target the carboxylate of Glu902 with a potential charge–charge interaction. As the data in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> illustrate, amine substitutions at the 4-position were well-tolerated and generally demonstrated lower lipophilicity. This is best exemplified by the <i>N</i>-methylpiperazine analogue, <b>42</b>, which demonstrated a greater than 3-fold improvement over the 4<i>H</i>-benzimidazole predecessor <b>29</b>. Notably, <b>42</b> had a similar binding affinity to that of <b>38</b> but with much improved AlogP and LipE values. The X-ray co-crystal structure of the tetrahydropyridine analogue <b>43</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B) revealed that Glu902 was rotated down toward the nitrogen atom of <b>43</b> compared to the position of the same residue in the X-ray co-crystal structure of <b>38</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). In contrast to <b>29</b> and <b>38</b>, compound <b>43</b> leaned toward the RAS:SOS1 interface to accommodate the positioning of Glu902 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D), confirming that the tetrahydropyridine moiety of <b>43</b> did indeed interact with the carboxylate of Glu902. However, replacement of the basic nitrogen atom in the piperazine moiety with a methylene group (<b>40</b>) or oxygen atom (<b>41</b>) proved to have little effect on binding affinity, suggesting that the charge–charge interaction with Glu902 offered minimal benefit to binding.</div><div class="NLM_p">Because engaging Glu902 from the 4-position of the benzimidazole scaffold improved lipophilicity but provided only limited binding affinity improvements over 4-aryl analogues, the focus turned toward creating a vector for a heteroatom to engage His905 or Tyr884 via a hydrogen bond, as exemplified by compounds <b>45</b>–<b>49</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). These entities also proved to be widely tolerated, affording binding affinities similar to those of other 4-substituents highlighted thus far. The X-ray co-crystal structure for <b>47</b> revealed that the extended nitrogen atom did not engage His905 but was orientated toward Tyr884 instead (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). Interaction with the phenol of Tyr884 caused compound <b>47</b> to lean toward the RAS:SOS1 interface, in a similar fashion to <b>43</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). Notably, Glu902 was rotated upward toward solvent, as it was in the X-ray co-crystal structure of <b>38</b>, to accommodate the hydrocarbon portion of the pyrrolidine ring.</div><div class="NLM_p">Importantly, the examples incorporating polar functionality at the 4-position of the benzimidazole scaffold were widely tolerated and resulted in compounds with greatly improved physical metrics relative to the highly lipophilic biaryl analogues. It was hypothesized that heteroaromatic substituents at the 4-position might merge the observed tolerance of polar functionality with occupation of the proximal hydrophobic subpocket and generate compounds with a favorable combination of potency, physiochemical properties, and a reduced number of hydrogen bond donors (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Unsubstituted heterocyclic compounds generally showed a marginal decrease in binding affinity relative to unsubstituted phenyl congener <b>30</b> but exhibited improved AlogP and LipE values. As was the case in the 4-phenyl series, ortho-substitution provided a marked boost in ligand binding affinity, exemplified by the 3-fold decrease in <i>K</i><sub>d</sub> from pyrimidine <b>54</b> to ortho-methyl pyrimidine <b>55</b> and ortho<i>-</i>isopropyl pyrimidine <b>56</b>. Furthermore, disubstituted pyrazole <b>58</b> generated an affinity below the reliable detection limit (<i>K</i><sub>d</sub> < 0.10 μM) afforded by the assay using the fluorescent probe <b>S2</b> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_001.pdf" class="ext-link">Figure S2</a>).</div><div class="NLM_p">Inspection of the X-ray co-crystal structure of <b>58</b> revealed that the disubstituted pyrazole functionality was rotated out of plane from the benzimidazole scaffold (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). This oriented the lipophilic methyl group toward the back of the hydrophobic pocket in a comparable fashion to the ortho-chloro derivative <b>38</b>. This caused the ligand to lean away from the RAS:SOS1 interface (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D) and overrode a potential interaction between the pyrazole nitrogen atoms and Glu902, as evidenced by the rotation of Glu902 up toward solvent. The ortho-substituted heterocycle subset of compounds consistently offered the best SOS1 affinities measured to this point. In addition, these compounds possessed improved physical properties relative to their more lipophilic phenyl counterparts.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray co-crystal structure of (A) <b>58</b> (pink; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D59">6D59</a>), (B) <b>65</b> (yellow; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D56">6D56</a>), (C) <b>64</b> (white; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D55">6D55</a>), and (D) <b>58</b>, <b>64</b>, and <b>65</b> overlaid with <b>29</b> (teal) bound to SOS1 in the RAS:SOS1:RAS ternary complex. The RAS and SOS1 protein surfaces are colored yellow and gray, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> C-2 Diazaspiro[3.3]heptane Analogues</h3><div class="NLM_p">After a thorough structure-guided SAR study, several compounds were discovered to bind to SOS1 with binding affinities near or below 0.10 μM (e.g., <b>58</b>). We postulated that the numerous modifications to the benzimidazole scaffold may have affected earlier investigated SAR. Thus, the 2-position was re-evaluated using several amines in the context of our more advanced benzimidazole derivatives. From these efforts, a multitude of C-2 diazaspiro[3.3]heptane derivatives were found to have binding affinities below 0.10 μM,<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41−43)</a> leading to the synthesis of a new fluorescent probe (<b>S3</b>, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_001.pdf" class="ext-link">Figure S2</a>) bearing this moiety. The FPA competition assay with this probe proved capable of reproducible measurement of affinities well below 0.10 μM. Indeed, data for these analogues (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) showed up to an order of magnitude improvement in affinity from their 2-piperazino counterparts.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. C-2 Diazaspiro[3.3]heptane Derivatives<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0019.gif" alt="" id="GRAPHIC-d7e1248-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0020.gif" alt="" id="gr15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Measurements are reported as the mean ± SD of two or more independent experiments, each conducted in duplicate.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Evaluated through displacement of fluorescent probe <b>S3</b> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_001.pdf" class="ext-link">Figure S2</a>).</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Evaluated through displacement of fluorescent probe <b>S2</b> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_001.pdf" class="ext-link">Figure S2</a>).</p></div></div><div></div></div><div class="NLM_p">Analysis of the X-ray co-crystal structure for pyrazole <b>65</b> showed a very similar binding pose to that demonstrated by <b>58</b>, with Glu902 rotated up and the ligand leaning in the pocket to place the methyl group of <b>65</b> into the hydrophobic subpocket (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B,D). The X-ray co-crystal structure for <b>64</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C) showed a similar binding pose to 4-tetrahydropyridine <b>43</b>, with Glu902 rotated down to establish a charge–charge interaction with the piperazine nitrogen atom and causing the ligand to lean toward the RAS:SOS1 interface (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D). Because little difference in the binding mode for either <b>64</b> or <b>65</b> from comparable 2-piperazine variants was evident, it was speculated that the more rigid C-2-diazaspiro[3.3]heptane moiety benefited from a lower entropic penalty as a result of binding compared with the more flexible C-2 piperazine functionality. Additionally, the diazaspiro[3.3]heptane functionality is more basic than its piperazine counterpart,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> which might potentiate a stronger charge–charge interaction with Asp887.</div><div class="NLM_p last">In addition to improved binding affinities, compounds featuring the diazaspiro[3.3]heptane moiety demonstrated improved ALogP and LipE values compared to previously examined SOS1 ligands. Compound lipophilicity was further reduced by appending an amine to the para-position of the pyrimidine, as exemplified by <b>62</b>. Removal of the 3′- and 5′-methyl substituents, as in <b>63</b>, generated the best ALogP and LipE metrics for this series of SOS1 agonists, albeit with a binding affinity ∼3-fold worse than the parent molecule <b>62</b>, as might be expected from the decreased occupancy of the hydrophobic pocket beneath Phe890. As a result of this extensive SAR campaign, these analogues represent the best binders to SOS1 reported to date, highlighted by pyrazole <b>65</b> with a binding affinity of 9 nM.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Cellular Analysis</h3><div class="NLM_p">With compounds that bind tightly to SOS1 in hand, we sought to assess whether this series of benzimidazole-derived molecules also elicited the previously observed, characteristic biphasic ERK modulation and RAS-GTP activation in cancer cells.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> To assess the effects on pERK signaling, an In-Cell Western (ICW) assay was used to evaluate cellular pERK1/2<sup>T202/Y204</sup> levels relative to total ERK1/2 levels in response to treatment with varying concentrations of compounds (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Two different cell lines, HeLa (WT KRAS) and NCI-H727 (G12V KRAS), were treated with compounds at concentrations ranging from 1.5 to 100 μM for 30 min. The levels of pERK1/2<sup>T202/Y204</sup> were normalized to the levels of total ERK1/2 protein and the DMSO vehicle control. Accordingly, the ICW EC<sub>50</sub> values reported in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> represent the half-maximal concentration of compound required to elicit peak induction of pERK1/2<sup>T202/Y204</sup> levels. Thus, a lower value is considered indicative of a more potent SOS1 agonist. Guided by our previous mechanistic observations,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> we hypothesized that potent SOS1 agonists would typically demonstrate biphasic modulation of pERK1/2<sup>T202/Y204</sup>. This is characterized by an increase in pERK1/2<sup>T202/Y204</sup> levels at lower doses of compound followed by a decrease below baseline in pERK1/2<sup>T202/Y204</sup> levels at higher doses (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Observing an increase in pERK1/2<sup>T202/Y204</sup> levels with no corresponding decrease over the concentration range of compound tested (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B) was considered to indicate an insufficiently potent SOS1 agonist. Alongside EC<sub>50</sub> values, <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> also indicates whether biphasic modulation of pERK1/2<sup>T202/Y204</sup> was elicited by each derivative. A selection of molecules featuring diverse chemical motifs and binding affinities spanning 5 orders of magnitude were examined by ICW to evaluate whether any inferences could be drawn between structural features, binding affinities, and phenotypic cellular responses.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Representative ICW data for benzimidazole compounds that elicit (A) biphasic modulation of pERK1/2<sup>T202/Y204</sup> protein levels, or (B) only an increase in pERK1/2<sup>T202/Y204</sup> protein levels. The green channel of the LI-COR infrared scanner was used to detect pERK1/2<sup>T202/Y204</sup> protein levels. In the same well, the red channel of the LI-COR infrared scanner was used to detect total ERK1/2 protein levels. The graphs represent the quantified immunofluorescence data, where pERK1/2<sup>T202/Y204</sup> levels were normalized to total ERK1/2 levels from the same well and to the vehicle control treated well. The vertical black dotted line indicates how EC<sub>50</sub> values were determined, and the horizontal black dotted line indicates the baseline pERK1/2<sup>T202/Y204</sup> signal. Each ICW experiment was conducted three independent times, and in duplicate on each plate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In-Cell Western Analysis of pERK1/2<sup>T202/Y204</sup> Levels<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0024.gif" alt="" id="gr20" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">ICW EC<sub>50</sub> measurements are reported as the mean ± SD of three individual experiments, each conducted in duplicate. <i>K</i><sub>d</sub> measurements are reported as the mean of two or more independent experiments, each conducted in duplicate. A “+” is used to indicate biphasic modulation of pERK1/2<sup>T202/Y204</sup>, as characterized by an increase in pERK1/2<sup>T202/Y204</sup> levels at lower concentrations and a decrease in pERK1/2<sup>T202/Y204</sup> levels below baseline at higher concentrations. A “–” sign indicates that compound treatment caused an increase in pERK1/2<sup>T202/Y204</sup> levels, but no subsequent decrease below baseline over the concentrations tested. All pERK1/2<sup>T202/Y204</sup> data are normalized to the DMSO vehicle control and to the total ERK1/2 protein levels from the same well.</p></div></div><div></div></div><div class="NLM_p">The majority of compounds examined by ICW exhibited the characteristic biphasic modulation that we have come to expect from potent activators of SOS1-mediated nucleotide exchange, based on prior work.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25−27)</a> On the other hand, less potent compounds with higher ICW EC<sub>50</sub> values were less likely to elicit biphasic modulation of ERK1/2 phosphorylation within the concentration range tested. We hypothesized that compounds with higher binding affinities would modulate pERK1/2<sup>T202/Y204</sup> signaling with greater potency. Indeed, analogues with weaker binding affinities, such as <b>3</b>, <b>23</b>, and <b>10</b>, all modulated pERK<sup>T202/Y204</sup> signaling with low potency. However, compounds with higher binding affinities did not necessarily modulate pERK1/2<sup>T202/Y204</sup> signaling with the greatest potencies. This is best illustrated by comparing the data for <b>47</b> and <b>65</b>. Although the <i>K</i><sub>d</sub> value for <b>47</b> is an order of magnitude higher than that of <b>65</b>, the ICW EC<sub>50</sub> values for <b>47</b> were 3–4-fold better than those of <b>65</b> in both cell lines. These data suggest that other factors beyond only SOS1 binding affinity can influence pERK1/2<sup>T202/Y204</sup> modulation in cells. These factors may include the physical properties of the compounds such as lipophilicity and solubility or issues with membrane permeability and/or plasma protein binding.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> Indeed, 4-<i>N</i>-methylpiperazino <b>64</b> displayed superior solubility at pH 6.8 (>110 μg/mL) relative to its direct comparator 4-pyrimidino <b>60</b> (3 μg/mL). Furthermore, several compounds, while capable of showing adequate passive permeability, appear to suffer from excessive efflux (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_001.pdf" class="ext-link">Table S2</a>). In addition to these characteristics, cellular considerations such as protein localization,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> post-translational modifications,<a onclick="showRef(event, 'ref27 ref47'); return false;" href="javascript:void(0);" class="ref ref27 ref47">(27,47)</a> and additional layers of allosteric regulation<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> that are not accounted for in a biochemical system could play a role in a disconnect between binding affinity to SOS1 and cellular activity.</div><div class="NLM_p">Finally, to assess whether compounds from the benzimidazole series activate RAS signaling in cells, we measured RAS-GTP levels and accompanying pERK<sup>T202/Y204</sup> levels in HeLa cells (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). We chose to test matched sets of compounds that featured the same substituents at the 4-position of the benzimidazole scaffold, but between these sets, differed in their ability to modulate pERK1/2<sup>T202/Y204</sup> signaling as measured by ICW. Regardless of the increase in binding affinity afforded by the diazaspiro[3.3]heptane substituent at the 2-position, an <i>N</i>-methylpiperazine substituent at the 4-position, as in <b>42</b> and <b>64</b>, resulted in enhanced potency by pERK1/2<sup>T202/Y204</sup> ICW, relative to the ortho-methylpyrimidine of <b>55</b>, <b>60</b>, and <b>61</b>, which modulated pERK1/2<sup>T202/Y204</sup> signaling less potently.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. RAS-GTP levels and corresponding pERK1/2<sup>T202/Y204</sup> levels from HeLa cells that were treated for 10 min with up to 30 μM of compound <b>42</b>, <b>64</b>, <b>55</b>, <b>60</b>, or <b>61</b>. EGF (50 ng/mL for 5 min) was used as a positive control for pathway stimulation. Data are representative of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Treatment with compounds <b>42</b> or <b>64</b> caused substantial increases in RAS-GTP levels at 10–30 μM and induced small increases in RAS-GTP at concentrations as low as 0.3 μM. On the other hand, only modest increases in RAS-GTP levels were observed with <b>55</b>, <b>60</b>, and <b>61</b> over the same range of dosage concentrations. These findings are consistent with ICW pERK1/2<sup>T202/Y204</sup> EC<sub>50</sub> data, which identified compounds <b>42</b> and <b>64</b> as among the most potent compounds tested in cells. Our laboratory has typically assessed RAS-GTP levels after 30 min of compound treatment with all previous chemical series of SOS1 agonists that we have discovered, and generally, treatment concentrations up to 100 μM were required to observe notable changes in RAS-GTP levels.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> However, compounds <b>42</b> and <b>64</b> activated RAS-GTP and caused biphasic modulation of pERK1/2<sup>T202/Y204</sup> signaling with such high potencies that a lower maximum concentration of 30 μM and only 10 min of treatment were required to sufficiently visualize their effects. Furthermore, <b>64</b> elicited robust activation of RAS-GTP at lower concentrations than <b>42</b>, which may be a result of the higher SOS1 binding affinity of <b>64</b> compared to <b>42</b>. Overall, compared to the other series of SOS1 agonists discovered in our lab, advanced examples from this series of benzimidazole-derived compounds modulate RAS-GTP and associated downstream signaling with the greatest potency that we have observed, to date.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Compound Synthesis</h3><div class="NLM_p">To access various benzimidazoles with 5,6-dimethyl moieties, commercially available bisaniline derivative <b>66</b> was acylated with 1,1-carbonyldiimidazole (CDI) and then chlorinated in refluxing POCl<sub>3</sub> to afford 2-chloro benzimidazole <b>67</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). From there, alkylation of the benzimidazole nitrogen atom with a variety of substituted benzyl bromides and subsequent displacement of the 2-chlorine atom with an array of amines via an S<sub>N</sub>Ar-type reaction furnished analogues <b>5</b>–<b>8</b>, <b>10</b>–<b>19</b>, and <b>21</b>. The 5,6<i>H</i>-derivative <b>23</b> was constructed in a similar manner, beginning from commercially available benzene-1,2-diamine (<b>68</b>). Compound <b>20</b> was accessed via a Suzuki coupling between <b>10</b> and cyclopropylboronic acid. 2-Amino and 2<i>H</i>-derivatives <b>3</b> and <b>4</b> were prepared by alkylation of commercially available compounds <b>69</b> and <b>70</b>, respectively, with 3-chloro-4-fluorobenzyl bromide. Lastly, <b>66</b> was condensed with piperidine-4-carboxylic acid followed by Boc-protection of the piperidine nitrogen atom to afford intermediate <b>71</b>. Subsequent benzylation of the benzimidazole nitrogen atom and Boc-removal furnished analogue <b>9</b>.</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Various Benzimidazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) CDI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt; (b) POCl<sub>3</sub>, 90 °C; (c) benzyl bromide derivative, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (d) diamine, DMA, 165 °C in microwave, then TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt when Boc removal necessary; (e) K<sub>3</sub>PO<sub>4</sub>, cyclopropylboronic acid, Pd(OAc)<sub>2</sub>, PCy<sub>3</sub>·HBF<sub>4</sub>, DME/H<sub>2</sub>O, 90 °C; (f) urea, xylenes, 130 °C; (g) piperidine-4-carboxylic acid, 4 M HCl(aq), 105 °C; (h) Boc<sub>2</sub>O, Et<sub>3</sub>N, THF/DMF, 35 °C; (i) NaH, 3-chloro-4-fluorobenzyl bromide, DMF, rt; (j) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><div class="NLM_p">To synthesize derivatives with varying 5,6-substitution patterns, commercially available 1-fluoro-2-nitrobenzenes, represented by <b>72</b>, were treated with 3-chloro-4-fluorobenzylamine via an S<sub>N</sub>Ar-type reaction and then reduced using Zn/HCl to provide anilines <b>73</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). These intermediates were acylated using CDI and then chlorinated by heating with POCl<sub>3</sub> to form 2-chlorobenzimidazoles <b>74</b>. Substitution of the 2-chlorine atom with piperazine afforded derivatives <b>22</b>, <b>24</b>, <b>25</b>, <b>27</b>, and <b>28</b>. Compound <b>26</b> was accessed via a Suzuki coupling between <b>27</b> and cyclopropylboronic acid.</div><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 5,6-Substituted Benzimidazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) <i>i</i>-Pr<sub>2</sub>NEt, 3-chloro-4-fluorobenzylamine, NMP, rt; (b) Zn°, 12 M HCl, EtOH/CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) CDI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) POCl<sub>3</sub>, 100 °C; (e) piperazine, DMA, 165 °C in microwave; (f) K<sub>3</sub>PO<sub>4</sub>, PdCl<sub>2</sub>dppf·CH<sub>2</sub>Cl<sub>2</sub>, cyclopropylboronic acid, dioxane, 100 °C.</p></p></figure><div class="NLM_p">Compounds with various 4-position substituents were constructed by treating 3-bromo-5-chlorobenzene-1,2-diamine <b>75</b> with CDI and then POCl<sub>3</sub> to furnish 2-chlorobenzimidazole intermediate <b>76</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Benzylation with 4-fluoro-3,5-dimethylbenzyl bromide or 4-fluorobenzyl bromide and successive displacement of the 2-chlorine atom with piperazine, 1-Boc-piperazine, or 1-Boc-2,6-diazaspiro[3.3]heptane provided 4-bromo compounds <b>77</b>, <b>78</b>, <b>79</b>, or <b>80</b>. These intermediates were functionalized at C-4 by various metal-catalyzed C–C and C–N bond forming reactions or reduced via palladium-catalyzed hydrogenolysis to afford analogues <b>29</b>–<b>51</b> and <b>54</b>–<b>65</b> after exposure to trifluoroacetic acid to effect <i>N</i>-Boc deprotection.</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 4-Substituted Benzimidazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) CDI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt; (b) POCl<sub>3</sub>, 110 °C; (c) 4-fluoro-3,5-dimethylbenzyl bromide or 4-fluorobenzyl bromide, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (d) diamine, K<sub>2</sub>CO<sub>3</sub> or <i>i</i>-Pr<sub>2</sub>NEt, DMF or DMSO, 80–100 °C; (e) Pd cat. C–C or C–N coupling; (f) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (g) 10% Pd/C, H<sub>2</sub>, AcOH, <i>i</i>-PrOH, rt; (h) NaBH<sub>4</sub>, MeOH, rt; 4 M HCl in dioxane.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A set of early hit molecules based on a benzimidazole scaffold were found to activate SOS1-mediated nucleotide exchange on RAS. The SAR of these compounds was systematically investigated by using two different biochemical assays and X-ray co-crystal structures of select SOS1 ligands bound to the RAS:SOS1:RAS complex were used as guides for analogue design. Through these studies, several novel derivatives were found to exhibit low double-digit nanomolar affinity for SOS1, which represent the tightest binders of SOS1 reported to date. These compounds also elicited increases of RAS-GTP levels in cells with the highest potency observed from any SOS1 ligands yet tested while inducing a robust biphasic response in downstream pERK1/2<sup>T202/Y204</sup> signaling that is characteristic of SOS1 agonists. These observations are in agreement with our proposed mechanism that compound-mediated agonism of SOS1 can modulate RAS signaling via negative feedback on SOS1 by active pERK1/2<sup>T202/Y204</sup>. The benzimidazole-derived compounds described here and future derivatives may serve as chemical tools for studying modulation of RAS signaling via binding to SOS1 and could inform future discoveries regarding small molecule therapeutics for the treatment of RAS-driven malignancies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84037" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84037" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedures</h3><div class="NLM_p last">All chemical reagents and reaction solvents were purchased from commercial suppliers and used as received. Proton nuclear magnetic resonance (<sup>1</sup>H NMR) spectra were recorded at either 400 or 600 MHz on a Bruker spectrometer. For <sup>1</sup>H NMR spectra, chemical shifts are reported in parts per million (ppm) and are reported relative to residual nondeuterated solvent signals. Coupling constants are reported in hertz (Hz). The following abbreviations (or a combination, thereof) are used to describe splitting patterns: s, singlet; d, doublet; t, triplet; q, quartet; quint, quintet; m, multiplet; comp, overlapping multiplets of nonmagnetically equivalent protons; br, broad. All final compounds were of 95% purity or higher, unless otherwise noted, as measured by analytical reversed-phase HPLC. Analytical HPLC was performed on an Agilent 1200 series system with UV detection at 214 and 254 nm, along with evaporative light scattering detection (ELSD). Low-resolution mass spectra were obtained on an Agilent 6140 mass spectrometer with electrospray ionization (ESI). LC-MS experiments were performed with the following parameters: Phenomenex Kinetex 2.6 μm XB-C18 100 Å, LC column 50 mm × 2.1 mm; 2 min gradient, 5%–95% MeCN in H<sub>2</sub>O, and 0.1% TFA or 0.1% formic acid. Analytical thin layer chromatography (TLC) was performed on Kieselgel 60 F<sub>254</sub> glass plates precoated with a 0.25 mm thickness of silica gel. TLC plates were visualized with UV light and iodine. Silica gel chromatography was performed using a Teledyne ISCO Combiflash Rf system, eluting with varying concentrations of EtOAc in hexanes or MeOH in CH<sub>2</sub>Cl<sub>2</sub>. Preparative reversed-phase HPLC was performed on a Gilson instrument equipped with a Phenomenex Kinetex C18 column, using varying concentrations of MeCN in H<sub>2</sub>O, and 0.1% TFA. Compounds <b>1</b> and <b>2</b> were purchased from ChemDiv and used as received. Compounds <b>52</b> and <b>53</b> were purchased from Viva Biotech (Shanghai, China) and used as received. Starting materials <b>66</b>, <b>68</b>, <b>69</b>, <b>70</b>, and 1-fluoro-2-nitrobenzene derivatives, represented by <b>72</b>, were purchased from commercial suppliers and used as received. Compound <b>75</b> was prepared according to a previously reported protocol.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure A: Synthesis of <b>5</b>–<b>8</b>, <b>10</b>–<b>19</b>, <b>21</b>, and <b>23</b></h3><div class="NLM_p last"><i>Step 1</i>: A mixture of <b>67</b> (1.0 equiv), an appropriate benzyl bromide derivative (1.1 equiv), and K<sub>2</sub>CO<sub>3</sub> (2.0 equiv) in DMF (0.25 M) was stirred at rt for 16 h. The mixture was diluted with EtOAc, poured into a 50% satd brine solution, and extracted with EtOAc (3×). The combined organics were washed with a 50% satd brine solution, a satd brine solution, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography. <i>Step 2</i>: The material obtained from step 1 (1.0 equiv) was mixed with an appropriate diamine (10.0 equiv) in <i>N</i>,<i>N</i>-dimethylacetamide (0.2 M) and heated to 165 °C in a microwave reactor for 45 min. The mixture was cooled to rt, diluted with EtOAc, poured into a 50% satd brine solution, and extracted with EtOAc (3×). The combined organics were washed with a 50% satd brine solution, a satd brine solution, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The crude residue was purified by reversed-phase preparative HPLC and the pure fractions were concentrated under a stream of warm air to afford the target compound as a TFA salt. Alternatively, the free base was obtained by neutralizing the pure HPLC fractions with solid Na<sub>2</sub>CO<sub>3</sub>, extraction with CH<sub>2</sub>Cl<sub>2</sub> (3×), drying over Na<sub>2</sub>SO<sub>4</sub>, and concentrating under reduced pressure.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure B: Synthesis of <b>22</b> and <b>24</b>–<b>28</b></h3><div class="NLM_p last"><i>Step 1</i>: A mixture of an appropriately substituted 1-fluoro-2-nitrobenzene derivative <b>72</b> (1.0 equiv) and <i>N</i>,<i>N</i>-diisopropylethylamine (1.5 equiv) in <i>N</i>-methyl-2-pyrrolidinone (0.5 M) was charged with 3-chloro-4-fluorobenzylamine (1.2 equiv) and stirred at rt for 16 h. The reaction mixture was poured into ice-cold brine and stirred for 5 min. The resultant yellow precipitate was collected via filtration, rinsed with water, and dried under reduced pressure. <i>Step 2</i>: The crude material obtained from step 1 was suspended in a mixture of EtOH/CH<sub>2</sub>Cl<sub>2</sub>/12 M HCl (3:1:1 v/v/v, 0.2 M) and Zn dust (10.0 equiv) was added. After the reaction was complete, as indicated by LC-MS, the reaction mixture was filtered. Water was added to the filtrate, and the suspension was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. <i>Step 3</i>: The crude residue obtained from step 2 was resuspended in CH<sub>2</sub>Cl<sub>2</sub> (0.3 M), charged with DMAP (0.1 equiv) and CDI (2.0 equiv), and stirred at rt. After 2 h, 1 M HCl was added and the mixture was stirred rapidly. The resultant solid was collected via filtration, rinsed with water, rinsed with CH<sub>2</sub>Cl<sub>2</sub>, and dried under reduced pressure. <i>Step 4</i>: The crude solid obtained from step 3 was suspended in POCl<sub>3</sub> (1.0 M) and heated to 100 °C. After the reaction was complete, as indicated by LC-MS, the mixture was cooled to 0 °C and poured slowly into water. After all the POCl<sub>3</sub> was quenched, the mixture was slowly neutralized with solid NaOH. The resulting precipitate was collected via filtration, rinsed with water, and dried under reduced pressure. <i>Step 5</i>: The crude solid obtained from step 4 and piperazine (10.0 equiv) were dissolved in a mixture of <i>N</i>,<i>N</i>-dimethylacetamide (0.2 M) and heated to 165 °C in a microwave reactor for 45 min. The mixture was cooled to rt, diluted with EtOAc, poured into a 50% satd brine solution, and extracted with EtOAc (3×). The combined organics were washed with a 50% satd brine solution, a satd brine solution, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The crude residue was purified by reversed-phase preparative HPLC, and the pure fractions were concentrated under a stream of warm air to afford the target compound as a TFA salt.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure C: Synthesis of <b>30</b>–<b>39</b>, <b>43</b>, <b>54</b>–<b>63</b>, and <b>65</b></h3><div class="NLM_p last"><i>Step 1</i>: A mixture of an appropriate boronic acid or boronic acid pinacol ester (1.5 equiv), PdCl<sub>2</sub>dppf·CH<sub>2</sub>Cl<sub>2</sub> (0.1 equiv), K<sub>2</sub>CO<sub>3</sub> (3.0 equiv), and <b>77</b>, <b>78</b>, <b>79</b>, or <b>80</b> (1.0 equiv) under Ar(g) was charged with degassed DMF/ethanol (4:1 v/v, 0.35 M) and heated to a temperature of 90 °C. After 18 h, the reaction mixture was cooled to rt, diluted with satd aqueous ammonium chloride, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The organic phases were combined, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography. <i>Step 2</i>: The compound obtained from step 1 (1.0 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (0.05 M) and stirred at rt. TFA (0.2 M) was added, and the mixture was stirred for 2 h before being concentrated under reduced pressure. The residue was purified by reversed-phase preparative HPLC, and the pure fractions were concentrated under a stream of warm air to afford the target compound as a TFA salt. Alternatively, the free base was obtained by neutralizing the pure HPLC fractions with solid Na<sub>2</sub>CO<sub>3</sub>, extraction with CH<sub>2</sub>Cl<sub>2</sub> (3×), drying over Na<sub>2</sub>SO<sub>4</sub>, and concentrating under reduced pressure.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure D: Synthesis of <b>40</b>–<b>42</b>, <b>44</b>–<b>48</b>, and <b>64</b></h3><div class="NLM_p last">A mixture of amine (2.0 equiv), Pd(OAc)<sub>2</sub> (0.1 equiv), BINAP (0.2 equiv), and K<sub>3</sub>PO<sub>4</sub> (3.0 equiv) under Ar(g) was charged with a solution of either <b>77</b> or <b>79</b> (1.0 equiv) in degassed toluene (0.1 M) and heated to 100 °C with vigorous stirring. Once the starting material was consumed, as indicated by LC-MS, the mixture was diluted with EtOAc, filtered over diatomaceous earth, and concentrated under reduced pressure. The crude residue was dissolved in a mixture of TFA and CH<sub>2</sub>Cl<sub>2</sub> (1:2 v/v, 0.05 M) and stirred at rt for 1 h. The reaction mixture was concentrated under reduced pressure and purified by reversed-phase preparative HPLC. The pure fractions were concentrated under a stream of warm air to afford the target compound as a TFA salt. Alternatively, the free base was obtained by neutralizing the pure HPLC fractions with solid Na<sub>2</sub>CO<sub>3</sub>, extraction with CH<sub>2</sub>Cl<sub>2</sub> (3×), drying over Na<sub>2</sub>SO<sub>4</sub>, and concentrating under reduced pressure.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedure E: Synthesis of <b>50</b> and <b>51</b></h3><div class="NLM_p last"><i>Step 1</i>: A mixture of <b>77</b> (1.0 equiv), an appropriate potassium pyridine trifluoroborate (1.1 equiv), Pd(OAc)<sub>2</sub> (0.1 equiv), RuPhos (0.2 equiv), and Na<sub>2</sub>CO<sub>3</sub> (2.0 equiv) under Ar(g) was charged with degassed ethanol (0.2 M). The reaction mixture was heated to 80 °C for 48 h. The reaction mixture was cooled to rt, diluted with satd aqueous ammonium chloride, and extracted with dichloromethane (3×). The organic phases were combined, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The residue was purified by silica gel chromatography. <i>Step 2</i>: The compound obtained from step 1 (1.0 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (0.05 M), and TFA (0.2 M) was added. The mixture was stirred for 2 h before being concentrated under reduced pressure. The crude residue was purified by reversed-phase preparative HPLC, and the pure fractions were concentrated under a stream of warm air to afford the target compound as a TFA salt.</div></div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-(3-Chloro-4-fluorobenzyl)-5,6-dimethyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-amine (<b>3</b> as TFA Salt)</h3><div class="NLM_p last">A mixture of <b>69</b> (50 mg, 0.31 mmol), 3-chloro-4-fluorobenzyl bromide (50 μL, 0.37 mmol), and NaH (60% dispersion in mineral oil, 25 mg, 0.63 mmol) in EtOH (4 mL) was stirred at 60 °C until starting material was completely consumed, as indicated by LC-MS. The mixture was cooled to rt, acidified with a 10% HCl solution, extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The crude residue was purified by reversed-phase preparative HPLC, and the pure fractions were concentrated under a stream of warm air to afford 8 mg of the title compound as the corresponding TFA salt (6% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.41 (dd, <i>J</i> = 6.8, 2.2 Hz, 1H), 7.25 (t, <i>J</i> = 8.8 Hz, 1H), 7.22–7.16 (comp, 2H), 7.14 (s, 1H), 5.35 (s, 2H), 2.34 (s, 3H), 2.32 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 304.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-(3-Chloro-4-fluorobenzyl)-5,6-dimethyl-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>4</b> as TFA Salt)</h3><div class="NLM_p last">A mixture of <b>70</b> (50 mg, 0.34 mmol), 3-chloro-4-fluorobenzyl bromide (50 μL, 0.38 mmol), and K<sub>2</sub>CO<sub>3</sub> (71 mg, 0.51 mmol) in DMF (3 mL) was stirred at rt for 1 h. The mixture was acidified with a 10% HCl solution, diluted with EtOAc, poured into a 50% satd brine solution, and extracted with EtOAc (3×). The combined organics were washed with a 50% satd brine solution, a satd brine solution, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The crude residue was purified by reversed-phase preparative HPLC, and the pure fractions were concentrated under a stream of warm air to afford 15 mg of the title compound as the corresponding TFA salt (11%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 9.28 (s, 1H), 7.64–7.59 (comp, 2H), 7.58 (br s, 1H), 7.40 (dq, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.29 (t, <i>J</i> = 8.8 Hz, 1H), 5.66 (s, 2H), 2.44 (s, 3H), 2.43 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 289.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1-(3-Chloro-4-fluorobenzyl)-5,6-dimethyl-<i>N</i>-(piperidin-4-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-amine (<b>5</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared from 3-chloro-4-fluorobenzyl bromide and <i>tert</i>-butyl 4-aminopiperidine-1-carboxylate in a similar fashion to general procedure A with a slight modification. Prior to purification as described in step 2 of general procedure A, the crude residue obtained was dissolved in a solution of TFA (0.2 M) in CH<sub>2</sub>Cl<sub>2</sub> and stirred at ambient temperature for 2 h before being concentrated under reduced pressure. Purification as described in step 2 of general procedure A afforded the title compound as the corresponding TFA salt in 7% yield over three steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.44 (dd, <i>J</i> = 6.8, 2.2 Hz, 1H), 7.35 (s, 1H), 7.29 (t, <i>J</i> = 8.7 Hz, 1H), 7.20 (ddd, <i>J</i> = 8.5, 4.4, 2.3 Hz, 1H), 7.14 (s, 1H), 5.41 (s, 2H), 3.79 (app d, <i>J</i> = 13.0 Hz, 2H), 3.46–3.33 (comp, 3H), 2.38 (s, 3H), 2.33 (s, 3H), 2.13 (app d, <i>J</i> = 12.6 Hz, 2H), 1.81 (dq, <i>J</i> = 12.3, 4.2 Hz, 2H). MS (ESI) <i>m</i>/<i>z</i> = 387.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 1-(3-Chloro-4-fluorobenzyl)-5,6-dimethyl-2-(4-methylpiperazin-1-yl)-1<i>H-</i>benzo[<i>d</i>]imidazole (<b>6</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 3-chloro-4-fluorobenzyl bromide and <i>N</i>-methyl piperazine in a similar fashion to general procedure A in 38% yield over two steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.38 (s, 1H), 7.25 (m, 2H), 7.14 (m, 1H), 7.09 (s, 1H), 5.40 (s, 2H), 3.59–3.52 (comp, 4H), 3.51–3.45 (comp, 4H), 2.99 (s, 3H), 2.38 (s, 3H), 2.34 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 387.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-(3-Chloro-4-fluorobenzyl)-2-(1,4-diazepan-1-yl)-5,6-dimethyl-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>7</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 3-chloro-4-fluorobenzyl bromide and homopiperazine in a similar fashion to general procedure A in 47% yield over two steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.48 (d, <i>J</i> = 6.6 Hz, 1H), 7.36 (s, 1H), 7.32 (t, <i>J</i> = 8.7 Hz, 1H), 7.26–7.21 (m, 1H), 7.19 (s, 1H), 5.51 (s, 2H), 3.99 (t, <i>J</i> = 2.3 Hz, 2H), 3.83 (t, <i>J</i> = 2.3 Hz, 2H), 3.55 (t, <i>J</i> = 4.8 Hz, 2H), 3.43 (t, <i>J</i> = 5.4 Hz, 2H), 2.41 (s, 3H), 2.36 (s, 3H), 2.26 (t, <i>J</i> = 4.9 Hz, 2H). MS (ESI) <i>m</i>/<i>z</i> = 387.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-(1-(3-Chloro-4-fluorobenzyl)-5,6-dimethyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)piperidin-4-amine (<b>8</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared from 3-chloro-4-fluorobenzyl bromide and <i>tert</i>-butyl piperidin-4-ylcarbamate in a similar fashion to general procedure A with a slight modification. Prior to purification as described in step 2 of general procedure A, the crude residue obtained was dissolved in a solution of TFA (0.2 M) in CH<sub>2</sub>Cl<sub>2</sub> and stirred at ambient temperature for 2 h before being concentrated under reduced pressure. Purification as described in step 2 of general procedure A afforded the title compound as the free base in 56% yield over three steps. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.41–7.31 (comp, 2H), 7.20 (s, 1H), 7.09–7.04 (m, 1H), 6.99 (s, 1H), 5.20 (s, 2H), 3.17 (s, 1H), 2.87 (t, <i>J</i> = 11.1 Hz, 2H), 2.76–2.66 (m, 1H), 2.24 (s, 3H), 2.21 (s, 3H), 1.78–1.30 (comp, 5H). MS (ESI) <i>m</i>/<i>z</i> = 387.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 1-(3-Chloro-4-fluorobenzyl)-5,6-dimethyl-2-(piperidin-4-yl)-1<i>H-</i>benzo[<i>d</i>]imidazole (<b>9</b> as TFA Salt)</h3><div class="NLM_p last">A mixture of compound <b>66</b> (375 mg, 2.75 mmol) and piperidine-4-carboxylic acid (1.04 g, 8.26 mmol) in HCl(aq) (4 M, 10 mL) was heated at 105 °C for 18 h. The reaction mixture was cooled to rt and neutralized by slowly adding solid NaOH. The resulting precipitate was filtered, washed with water, and dried by pulling air through the solid to afford 400 mg of crude 5,6-dimethyl-2-(piperidin-4-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole. This material (200 mg, 0.873 mmol) was then dissolved in a THF/DMF mixture (1:1 v/v, 10 mL), charged with Boc<sub>2</sub>O (335 mg, 1.53 mmol) and Et<sub>3</sub>N (160 μL, 1.15 mmol), and heated at 35 °C for 2 h. The reaction mixture was poured into 50% satd brine (20 mL) and extracted with EtOAc (3 × 10 mL). The combined extracts were washed with 50% satd brine (10 mL) followed by satd brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography to afford <i>tert</i>-butyl 4-(5,6-dimethyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)piperidine-1-carboxylate (80 mg, 0.24 mmol). This material (80 mg, 0.24 mmol) was subsequently dissolved in DMF (4 mL) and charged with NaH (60% dispersion in mineral oil, 61 mg, 1.5 mmol) followed by 3-chloro-4-fluorobenzyl bromide (154 uL, 1.14 mmol). After 1 h, the mixture was poured into 50% satd brine (20 mL) and extracted with EtOAc (3×). The combined extracts were washed with 50% satd brine (10 mL) followed by satd brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The crude residue was redissolved in a mixture of CH<sub>2</sub>Cl<sub>2</sub> (1 mL) and TFA (2 mL). Upon complete conversion of starting material, as indicated by LC-MS, the mixture was concentrated and purified via reversed-phase preparative HPLC. The resultant pure fractions were concentrated under a stream of warm air to afford 37 mg of the title compound as the corresponding TFA salt (41% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.60 (s, 1H), 7.46 (s, 1H), 7.46–7.43 (comp, 1H), 7.28 (t, <i>J</i> = 8.8 Hz, 1H), 7.17–7.12 (m, 1H), 5.76 (s, 2H), 3.79–3.67 (m, 1H), 3.59 (d, <i>J</i> = 13.2 Hz, 2H), 3.25–3.13 (m, 2H), 2.46 (s, 3H), 2.43 (s, 3H), 2.24–2.16 (m, 4H). MS (ESI) <i>m</i>/<i>z</i> = 372.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-(3-Chloro-4-fluorobenzyl)-5,6-dimethyl-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>10</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from 3-chloro-4-fluorobenzyl bromide and piperazine in a similar fashion to general procedure A in 27% yield over two steps. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.40 (dd, <i>J</i> = 7.1, 2.0 Hz, 1H), 7.36 (t, <i>J</i> = 9.0 Hz, 1H), 7.22 (s, 1H), 7.06 (ddd, <i>J</i> = 8.6, 4.5, 2.1 Hz, 1H), 7.00 (s, 1H), 5.22 (s, 2H), 3.04–3.02 (comp, 4H), 2.82–2.79 (comp, 4H), 2.24 (s, 3H), 2.22 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 372.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i><sup>1</sup>-(1-(3-Chloro-4-fluorobenzyl)-5,6-dimethyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)ethane-1,2-diamine (<b>11</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 3-chloro-4-fluorobenzyl bromide and ethane-1,2-diamine in a similar fashion to general procedure A in 21% yield over two steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.43 (dd, <i>J</i> = 7.0, 1.9 Hz, 1H), 7.29 (s, 1H), 7.27–7.17 (comp, 2H), 7.13 (s, 1H), 5.39 (s, 2H), 3.85 (t, <i>J</i> = 6.0 Hz, 2H), 3.33 (m, 2H), 2.36 (s, 3H), 2.32 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 347.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-Benzyl-5,6-dimethyl-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>12</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from benzyl bromide and piperazine in a similar fashion to general procedure A in 39% yield over two steps. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.97 (s, 2H), 7.39–7.27 (comp, 4H), 7.23–7.18 (comp, 2H), 7.09 (s, 1H), 5.39 (s, 2H), 3.52–3.46 (comp, 4H), 3.30–3.24 (comp, 4H), 2.29 (s, 3H), 2.23 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 321.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-(4-Fluorobenzyl)-5,6-dimethyl-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>13</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 4-fluorobenzyl bromide and piperazine in a similar fashion to general procedure A in 32% yield over two steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.40 (s, 1H), 7.30 (dd, <i>J</i> = 8.6, 5.2 Hz, 2H), 7.18 (s, 1H), 7.18–7.11 (comp, 2H), 5.49 (s, 2H), 3.74–3.69 (comp, 4H), 3.46–3.40 (comp, 4H), 2.39 (s, 3H), 2.33 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 339.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-(4-Chlorobenzyl)-5,6-dimethyl-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>14</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 4-chlorobenzyl bromide and piperazine in a similar fashion to general procedure A in 29% yield over two steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.44–7.39 (comp, 3H), 7.26 (d, <i>J</i> = 8.4 Hz, 2H), 7.17 (s, 1H), 5.49 (s, 2H), 3.71–3.67 (comp, 4H), 3.45–3.41 (comp, 4H), 2.39 (s, 3H), 2.33 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 355.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5,6-Dimethyl-1-(4-methylbenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>15</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 4-methylbenzyl bromide and piperazine in a similar fashion to general procedure A in 14% yield over two steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.39 (s, 1H), 7.22 (d, <i>J</i> = 7.8 Hz, 2H), 7.17 (s, 1H), 7.13 (d, <i>J</i> = 8.2 Hz, 2H), 5.44 (s, 2H), 3.71–3.66 (comp, 4H), 3.43–3.38 (comp, 4H), 2.39 (s, 3H), 2.33 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> = 335.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5,6-Dimethyl-2-(piperazin-1-yl)-1-(4-(trifluoromethyl)benzyl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>16</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 4-trifluoromethylbenzyl bromide and piperazine in a similar fashion to general procedure A in 15% yield over two steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.70 (d, <i>J</i> = 8.5 Hz, 2H), 7.42 (d, <i>J</i> = 8.1 Hz, 2H), 7.39 (s, 1H), 7.10 (s, 1H), 5.55 (s, 2H), 3.64–3.59 (comp, 4H), 3.44–3.39 (comp, 4H), 2.38 (s, 3H), 2.32 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 389.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-(3,4-Difluorobenzyl)-5,6-dimethyl-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>17</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 3,4-difluorobenzyl bromide and piperazine in a similar fashion to general procedure A in 25% yield over two steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.41 (s, 1H), 7.36–7.21 (comp, 2H), 7.16 (s, 1H), 7.12–7.06 (m, 1H), 5.49 (s, 2H), 3.76–3.70 (comp, 4H), 3.48–3.43 (comp, 4H), 2.39 (s, 3H), 2.34 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 357.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-(4-Fluoro-3-methylbenzyl)-5,6-dimethyl-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>18</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 4-fluoro-3-methylbenzyl bromide and piperazine in a similar fashion to general procedure A in 33% yield over two steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.39 (s, 1H), 7.19–7.15 (comp, 2H), 7.07 (d, <i>J</i> = 1.3 Hz, 1H), 7.06–7.04 (m, 1H), 5.44 (s, 2H), 3.73–3.67 (comp, 4H), 3.45–3.39 (comp, 4H), 2.39 (s, 3H), 2.33 (s, 3H), 2.25 (d, <i>J</i> = 1.6 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 353.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-(4-Fluoro-3-(trifluoromethyl)benzyl)-5,6-dimethyl-2-(piperazin-1-yl)-1<i>H-</i>benzo[<i>d</i>]imidazole (<b>19</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 4-fluoro-3-(trifluoromethyl)benzyl bromide and piperazine in a similar fashion to general procedure A in 1.2% yield over two steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.74 (s, 1H) 7.53 (s, 1H), 7.43 (s, 1H), 7.39 (t, <i>J</i> = 9.5 Hz, 1H), 7.18 (s, 1H), 5.58 (s, 2H), 3.49 (d, <i>J</i> = 5.1 Hz, 4H), 3.49 (d, <i>J</i> = 5.1 Hz, 4H), 2.41 (s, 3H), 2.35 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 407.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 1-(3-Cyclopropyl-4-fluorobenzyl)-5,6-dimethyl-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>20</b> as TFA Salt)</h3><div class="NLM_p last">A mixture of <b>10</b> (36 mg, 0.097 mmol), K<sub>3</sub>PO<sub>4</sub> (62 mg, 0.29 mmol), cyclopropylboronic acid (13 mg, 0.15 mmol), Pd(OAc)<sub>2</sub> (2.2 mg, 0.0097 mmol), and PCy<sub>3</sub>·HBF<sub>4</sub> (7.0 mg, 0.019 mmol) under Ar(g) was charged with a degassed mixture of 1,2-dimethoxyethane and water (3:1 v/v, 1 mL) and stirred at 90 °C for 16 h. The mixture was cooled to rt, poured into water (10 mL), extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The crude residue was purified by reversed-phase preparative HPLC and the pure fractions were concentrated under a stream of warm air to afford 7 mg of the title compound as the corresponding TFA salt (15%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.41 (s, 1H), 7.17 (s, 1H), 7.08–6.95 (comp, 3H), 5.44 (s, 2H), 3.76–3.70 (comp, 4H), 3.46–3.40 (comp, 4H), 2.40 (s, 3H), 2.34 (s, 3H), 2.12–2.04 (m, 1H), 1.01 (ddd, <i>J</i> = 6.4, 4.5, 2.0 Hz, 2H), 0.70 (ddd, <i>J</i> = 5.0, 4.5, 1.6 Hz, 2H). MS (ESI) <i>m</i>/<i>z</i> = 379.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1-(4-Fluoro-3,5-dimethylbenzyl)-5,6-dimethyl-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>21</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 3,5-dimethyl-4-fluorobenzyl bromide and piperazine in a similar fashion to general procedure A in 13% yield over two steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.39 (s, 1H), 7.14 (s, 1H), 6.94 (s, 1H), 6.93 (s, 1H), 5.37 (s, 2H), 3.70–3.64 (comp, 4H), 3.45–3.39 (comp, 4H), 2.39 (s, 3H), 2.33 (s, 3H), 2.21 (d, <i>J</i> = 2.1 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 367.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 6-Chloro-1-(3-chloro-4-fluorobenzyl)-5-methyl-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>22</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 1-chloro-5-fluoro-2-methyl-4-nitrobenzene in a similar fashion to general procedure B in 5% yield over five steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.56 (s, 1H), 7.49 (dd, <i>J</i> = 6.8, 2.2 Hz, 1H), 7.41 (s, 1H), 7.30 (t, <i>J</i> = 8.8 Hz, 1H), 7.26–7.21 (m, 1H), 5.49 (s, 2H), 3.76 (t, <i>J</i> = 5.2 Hz, 4H), 3.47 (t, <i>J</i> = 5.2 Hz, 4H), 2.49 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 393.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1-(3-Chloro-4-fluorobenzyl)-2-(piperazin-1-yl)-1<i>H-</i>benzo[<i>d</i>]imidazole (<b>23</b> as TFA Salt)</h3><div class="NLM_p last">A mixture of 1,2-diaminobenzene (5.0 g, 46 mmol) and urea (3.11 g, 51.8 mmol) in xylenes (100 mL) was heated at 130 °C in a flask equipped with a reflux condenser. The mixture became a solution at elevated temperatures. After 18 h, the reaction was cooled to rt, and the solid product was collected via filtration and dried over air to afford crude 1,3-dihydro-2<i>H</i>-benzo[<i>d</i>]imidazol-2-one. This crude material was suspended in POCl<sub>3</sub> (100 mL) and heated to 100 °C. After complete conversion of starting material, as indicated by LC-MS, the reaction mixture was cooled to 0 °C, slowly added to ice water, stirred at 0 °C until all of the POCl<sub>3</sub> was quenched, and then neutralized with solid NaOH. The resulting solid was collected via filtration, washed with water, and dried under reduced pressure to afford 5.5 g of crude 2-chlorobenzimidazole as a white solid. The title compound was prepared as the corresponding TFA salt from crude 2-chlorobenzimidazole used in place of <b>67</b> with 3-chloro-4-fluorobenzyl bromide, and piperazine in a similar fashion to general procedure A in 32% yield over two steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.62 (d, <i>J</i> = 7.8 Hz, 1H), 7.43 (dd, <i>J</i> = 6.9, 2.2 Hz, 1H), 7.40–7.34 (m, 1H), 7.33–7.30 (comp, 2H), 7.27 (t, <i>J</i> = 8.8 Hz, 1H), 7.20–7.16 (m, 1H), 5.47 (s, 2H), 3.64 (t, <i>J</i> = 5.2 Hz, 4H), 3.46 (t, <i>J</i> = 5.2 Hz, 4H). MS (ESI) <i>m</i>/<i>z</i> = 345.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-(3-Chloro-4-fluorobenzyl)-6-methyl-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>24</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 2-fluoro-4-methyl-1-nitrobenzene in a similar fashion to general procedure B in 3% yield over five steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.49 (d, <i>J</i> = 8.3 Hz, 1H), 7.43 (dd, <i>J</i> = 6.8, 2.1 Hz, 1H), 7.30–7.22 (comp, 2H), 7.18 (ddd, <i>J</i> = 8.6, 4.4, 2.3 Hz, 1H), 7.15 (s, 1H), 5.45 (s, 2H), 3.67–3.62 (comp, 4H), 3.47–3.41 (comp, 4H), 2.42 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 359.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 1-(3-Chloro-4-fluorobenzyl)-2-(piperazin-1-yl)-6-(trifluoromethyl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>25</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 2-fluoro-1-nitro-4-(trifluoromethyl)benzene in a similar fashion to general procedure B in 6% yield over five steps. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.82 (br s, 2H), 7.70 (s, 1H), 7.66 (d, <i>J</i> = 8.6 Hz, 1H), 7.51 (dd, <i>J</i> = 7.2, 1.6 Hz, 1H), 7.47 (d, <i>J</i> = 8.4 Hz, 1H), 7.37 (t, <i>J</i> = 8.8 Hz, 1H), 7.14–7.09 (m, 1H), 5.47 (s, 2H), 3.46 (br s, 4H), 3.29 (br s, 4H). MS (ESI) <i>m</i>/<i>z</i> = 413.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1-(3-Chloro-4-fluorobenzyl)-6-cyclopropyl-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>26</b> as Free Base)</h3><div class="NLM_p last">A mixture of <b>27</b> (50 mg, 0.093 mmol), K<sub>3</sub>PO<sub>4</sub> (79 mg, 0.37 mmol), PdCl<sub>2</sub>dppf·CH<sub>2</sub>Cl<sub>2</sub> (7.6 mg, 0.009 mmol), and cyclopropylboronic acid (16 mg, 0.19 mmol) in degassed dioxane (1.0 mL) was heated to 100 °C under Ar(g) for 2 h. The reaction mixture was cooled to rt, diluted with EtOAc, filtered through diatomaceous earth, and concentrated under reduced pressure. The crude residue was purified by reversed-phase preparative HPLC, and the pure fractions were neutralized with solid Na<sub>2</sub>CO<sub>3</sub> and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined organics were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure to afford 11 mg of the title compound as the free base (31% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.38 (d, <i>J</i> = 8.0 Hz, 1H), 7.31 (dd, <i>J</i> = 6.8, 2.0 Hz, 1H), 7.19 (t, <i>J</i> = 8.8 Hz, 1H), 7.06 (dq, <i>J</i> = 8.6, 2.2 Hz, 1H), 6.93 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 6.89 (d, <i>J</i> = 1.3 Hz, 1H), 5.28 (s, 2H), 3.21–3.14 (comp, 4H), 3.00–2.93 (comp, 4H), 1.98–1.90 (m, 1H), 0.94–0.88 (comp, 2H), 0.63–0.57 (comp, 2H). MS (ESI) <i>m</i>/<i>z</i> = 385.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 6-Bromo-1-(3-chloro-4-fluorobenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>27</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 4-bromo-2-fluoro-1-nitrobenzene in a similar fashion to general procedure B in 24% yield over five steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.48 (d, <i>J</i> = 8.6 Hz, 1H), 7.44 (d, <i>J</i> = 1.7 Hz, 1H), 7.38 (dd, <i>J</i> = 8.5, 1.9 Hz, 1H), 7.36 (dd, <i>J</i> = 6.9, 2.2 Hz, 1H), 7.24 (t, <i>J</i> = 8.8 Hz, 1H), 7.08 (dq, <i>J</i> = 8.5, 2.2 Hz, 1H), 5.38 (s, 2H), 3.54–3.49 (comp, 4H), 3.43–3.38 (comp, 4H). MS (ESI) <i>m</i>/<i>z</i> = 422.8 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 6-Chloro-1-(3-chloro-4-fluorobenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>28</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from 4-chloro-2-fluoro-1-nitrobenzene in a similar fashion to general procedure B in 20% yield over five steps. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.54 (d, <i>J</i> = 8.5 Hz, 1H), 7.38 (dd, <i>J</i> = 6.8, 2.0 Hz, 1H), 7.32 (d, <i>J</i> = 1.8 Hz, 1H), 7.28 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.23 (d, <i>J</i> = 8.8 Hz, 1H), 7.11 (ddd, <i>J</i> = 8.5, 4.4, 2.3 Hz, 1H), 5.40 (s, 2H), 3.57–3.52 (comp, 4H), 3.44–3.40 (comp, 4H). MS (ESI) <i>m</i>/<i>z</i> = 379.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>29</b> as TFA Salt)</h3><div class="NLM_p last">Intermediate <b>77</b> (20 mg, 0.36 mmol) was dissolved in 2-propanol (1 mL), and acetic acid (3 drops) was added. The vial was sealed, evacuated, and refilled with Ar(g). Palladium/carbon (10% w/w, 10 mg) was added. The vial was resealed, evacuated, and refilled with H<sub>2</sub>(g) via balloon. After 18 h, the vial was purged with Ar(g), and the reaction mixture was filtered over silica gel with the aid of EtOAc. The filtrate was concentrated under reduced pressure. The residue was purified by reversed-phase preparative HPLC. The resultant material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) and stirred at rt. TFA (0.5 mL) was added, and the mixture was stirred for 2 h and then concentrated under reduced pressure. The residue was purified by reversed-phase preparative HPLC, and the pure fractions were concentrated under a stream of warm air to afford 7 mg of the title compound as the corresponding TFA salt as a white solid (38% yield, two steps). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.52 (dd, <i>J</i> = 8.3, 0.7 Hz, 1H), 7.28–7.25 (comp, 2H), 6.87 (d, <i>J</i> = 6.6 Hz, 2H), 5.30 (s, 2H), 3.55–3.52 (comp, 4H), 3.41–3.39 (comp, 4H), 2.20 (d, <i>J</i> = 2.1 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 373.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-4-phenyl-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>30</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and phenylboronic acid in a similar fashion to general procedure C in 75% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.94–7.91 (comp, 2H), 7.50–7.46 (comp, 2H), 7.42–7.38 (m, 1H), 7.34 (d, <i>J</i> = 2.0 Hz, 1H), 7.21 (d, <i>J</i> = 2.0 Hz, 1H), 6.88 (d, <i>J</i> = 6.7 Hz, 2H), 5.30 (s, 2H), 3.52–3.49 (comp, 4H), 3.40–3.38 (comp, 4H), 2.21 (d, <i>J</i> = 2.1 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 449.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-4-(<i>o</i>-tolyl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>31</b> as TFA salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and ortho-tolylboronic acid in a similar fashion to general procedure C in 73% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.35–7.28 (comp, 5H), 7.12 (d, <i>J</i> = 1.9 Hz, 1H), 6.93 (d, <i>J</i> = 6.6 Hz, 2H), 5.35 (s, 2H), 3.53–3.50 (comp, 4H), 3.37–3.34 (comp, 4H), 2.22 (d, <i>J</i> = 2.0 Hz, 6H), 2.20 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 463.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 6-Chloro-4-(2-ethylphenyl)-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>32</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and (2-ethylphenyl)boronic acid in a similar fashion to general procedure C in 24% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.39–7.38 (comp, 2H), 7.30–7.24 (comp, 3H), 7.10–7.09 (m, 1H), 6.90 (d, <i>J</i> = 6.4 Hz, 2H), 5.33 (s, 2H), 3.49–3.45 (comp, 4H), 3.35–3.33 (comp, 4H), 2.54 (q, <i>J</i> = 7.6 Hz, 2H), 2.22 (d, <i>J</i> = 2.0 Hz, 6H), 1.04 (t, <i>J</i> = 7.6 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> = 477.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-4-(2-isopropylphenyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>33</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and (2-isopropylphenyl)boronic acid in a similar fashion to general procedure C in 19% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.47 (d, <i>J</i> = 7.6 Hz, 1H), 7.41 (td, <i>J</i> = 8.0, 1.7 Hz, 1H), 7.29–7.21 (comp, 3H), 7.06 (d, <i>J</i> = 1.9 Hz, 1H), 6.89 (d, <i>J</i> = 6.6 Hz, 2H), 5.32 (s, 2H), 3.44–3.42 (comp, 4H), 3.35–3.33 (comp, 4H), 2.89–2.79 (m, 1H), 2.22 (d, <i>J</i> = 2.1 Hz, 6H), 1.16 (br s, 6H). MS (ESI) <i>m</i>/<i>z</i> = 490.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 6-Chloro-4-(2-cyclobutylphenyl)-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>34</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and (2-cyclobutylphenyl)boronic acid in a similar fashion to general procedure C in 8% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.47 (d, <i>J</i> = 7.8 Hz, 1H), 7.41 (dt, <i>J</i> = 7.9, 2.0 Hz, 1H), 7.29–7.23 (comp, 3H), 7.01 (d, <i>J</i> = 2.0 Hz, 1H), 6.85 (d, <i>J</i> = 6.6 Hz, 2H), 5.32 (s, 2H), 3.66–3.57 (m, 1H), 3.43–3.40 (comp, 4H), 3.36–3.34 (comp, 4H), 2.21 (d, <i>J</i> = 2.0 Hz, 6H), 2.04–1.99 (comp, 2H), 1.85–1.65 (comp, 4H). MS (ESI) <i>m</i>/<i>z</i> = 502.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-4-(2-(trifluoromethyl)phenyl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>35</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and (2-(trifluoromethyl)phenyl)boronic acid in a similar fashion to general procedure C in 67% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.85 (d, <i>J</i> = 7.7 Hz, 1H), 7.70 (t, <i>J</i> = 7.2 Hz, 1H), 7.63 (t, <i>J</i> = 7.6 Hz, 1H), 7.48 (d, <i>J</i> = 7.4 Hz, 1H), 7.32 (d, <i>J</i> = 1.8 Hz, 1H), 7.08 (s, 1H), 6.86 (d, <i>J</i> = 6.6 Hz, 2H), 5.31 (s, 2H), 3.44–3.39 (comp, 4H), 3.35–3.33 (comp, 4H), 2.22 (d, <i>J</i> = 2.0 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 516.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-4-(3-(trifluoromethyl)phenyl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>36</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and (3-(trifluoromethyl)phenyl)boronic acid in a similar fashion to general procedure C in 24% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.46 (s, 1H), 8.18–8.15 (m, 1H), 7.70–7.65 (comp, 2H), 7.43 (d, <i>J</i> = 1.9 Hz, 1H), 7.25 (d, <i>J</i> = 1.9 Hz, 1H), 6.88 (d, <i>J</i> = 6.6 Hz, 2H), 5.31 (s, 2H), 3.54–3.52 (comp, 4H), 3.42–3.39 (comp, 4H), 2.21 (d, <i>J</i> = 1.9 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 516.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-4-(4-(trifluoromethyl)phenyl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>37</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and (4-(trifluoromethyl)phenyl)boronic acid in a similar fashion to general procedure C in 43% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.18 (d, <i>J</i> = 8.3 Hz, 2H), 7.78 (d, <i>J</i> = 8.3 Hz, 2H), 7.44 (d, <i>J</i> = 1.2 Hz, 1H), 7.27 (d, <i>J</i> = 1.8 Hz, 1H), 6.88 (d, <i>J</i> = 6.6 Hz, 2H), 5.31 (s, 2H), 3.53–3.51 (comp, 4H), 3.41–3.38 (comp, 4H), 2.21 (d, <i>J</i> = 1.9 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 516.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 6-Chloro-4-(2-chlorophenyl)-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>38</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from <b>77</b> and (2-chlorophenyl)boronic acid in a similar fashion to general procedure C in 43% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.56–7.51 (m, 1H), 7.49–7.45 (m, 1H), 7.42–7.36 (m, 2H), 7.19 (d, <i>J</i> = 1.9 Hz, 1H), 7.08 (d, <i>J</i> = 1.9 Hz, 1H), 6.87 (d, <i>J</i> = 6.7 Hz, 2H), 5.22 (s, 2H), 3.19–3.14 (m, 4H), 2.93–2.86 (m, 4H), 2.20 (d, <i>J</i> = 2.0 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 483.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 6-Chloro-4-(2,6-dimethylphenyl)-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>39</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and (2,6-dimethylphenyl)boronic acid in a similar fashion to general procedure C in 14% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.31 (d, <i>J</i> = 2.0 Hz, 1H), 7.23 (dd, <i>J</i> = 8.6, 6.5 Hz, 1H), 7.15 (d, <i>J</i> = 7.5 Hz, 2H), 7.00–6.99 (m, 1H), 6.89 (d, <i>J</i> = 6.7 Hz, 2H), 5.33 (s, 2H), 3.47–3.45 (comp, 4H), 3.36–3.32 (comp, 4H), 2.22 (d, <i>J</i> = 2.1 Hz, 6H), 2.02 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> = 477.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-4-(piperidin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>40</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and piperidine in a similar fashion to general procedure D in 45% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.21 (d, <i>J</i> = 1.7 Hz, 1H), 7.17 (d, <i>J</i> = 1.7 Hz, 1H), 6.86 (d, <i>J</i> = 6.8 Hz, 2H), 5.28 (s, 2H), 3.81 (t, <i>J</i> = 5.5 Hz, 4H), 3.56 (dd, <i>J</i> = 6.8, 5.0 Hz, 4H), 3.41 (dd, <i>J</i> = 5.5, 3.8 Hz, 4H), 2.20 (d, <i>J</i> = 2.0 Hz, 6H), 2.02–1.95 (m, 4H), 1.82–1.73 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> = 456.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 4-(6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-4-yl)morpholine (<b>41</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and morpholine in a similar fashion to general procedure D in 37% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 6.84–6.81 (comp, 3H), 6.61 (d, <i>J</i> = 1.8 Hz, 1H), 5.21 (s, 2H), 3.90 (dd, <i>J</i> = 5.4, 4.7 Hz, 4H), 3.50–3.42 (comp, 8H), 3.40–3.36 (comp, 4H), 2.19 (d, <i>J</i> = 2.0 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 458.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-4-(4-methylpiperazin-1-yl)-2-(piperazin-1-yl)-1<i>H-</i>benzo[<i>d</i>]imidazole (<b>42</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and <i>N</i>-methylpiperazine in a similar fashion to general procedure D in 35% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 6.90 (d, <i>J</i> = 1.6 Hz, 1H), 6.83 (d, <i>J</i> = 6.8 Hz, 2H), 6.71 (d, <i>J</i> = 1.6 Hz, 1H), 5.24 (s, 2H), 4.40 (d, <i>J</i> = 13.6 Hz, 2H), 3.65 (d, <i>J</i> = 13.6 Hz, 2H), 3.59–3.34 (comp, 10H), 3.23–3.14 (m, 2H), 3.00 (s, 3H), 2.19 (d, <i>J</i> = 2.0 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 471.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-4-(1,2,3,6-tetrahydropyridin-4-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>43</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and <i>tert</i>-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydropyridine-1(2<i>H</i>)-carboxylate in a similar fashion to general procedure C in 36% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.20 (s, 2H), 6.84 (d, <i>J</i> = 6.7 Hz, 2H), 6.84–6.79 (m, 1H), 5.27 (s, 2H), 3.95–3.91 (comp, 2H), 3.56–3.48 (comp, 6H), 3.42–3.48 (comp, 4H), 3.08–3.01 (comp, 2H), 2.19 (d, <i>J</i> = 2.0 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 454.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 1-(6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-4-yl)piperidin-4-amine (<b>44</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and <i>tert</i>-butyl piperidin-4-ylcarbamate in a similar fashion to general procedure D in 8% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 6.84–6.82 (comp, 3H), 6.69 (d, <i>J</i> = 1.7 Hz, 1H), 5.23 (s, 2H), 4.26 (br d, <i>J</i> = 12.7 Hz, 2H), 3.47 (dd, <i>J</i> = 9.7, 4.5 Hz, 4H), 3.40 (dd, <i>J</i> = 8.1, 3.1 Hz, 4H), 3.34–3.28 (m, 1H), 2.91 (td, <i>J</i> = 12.2, 1.7 Hz, 2H), 2.19 (d, <i>J</i> = 2.0 Hz, 6H), 2.12 (br d, <i>J</i> = 12.2 Hz, 2H), 1.95–1.85 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> = 471.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (<i>S</i>)-(1-(6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-4-yl)pyrrolidin-2-yl)methanol (<b>45</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from <b>77</b> and (<i>S</i>)-pyrrolidin-2-ylmethanol in a similar fashion to general procedure D in 57% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.75 (d, <i>J</i> = 6.6 Hz, 2H), 6.40–6.33 (comp, 2H), 5.06–4.95 (comp, 3H), 3.80–3.59 (comp, 2H), 3.56–3.47 (m, 1H), 3.37–3.01 (comp, 8H), 2.68–2.50 (m, 1H), 2.20 (d, <i>J</i> = 1.7 Hz, 6H), 2.07–1.72 (comp, 4H). MS (ESI) <i>m</i>/<i>z</i> = 472.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (<i>R</i>)-(1-(6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-4-yl)pyrrolidin-2-yl)methanol (<b>46</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from <b>77</b> and (<i>R</i>)-pyrrolidin-2-ylmethanol in a similar fashion to general procedure D in 74% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.75 (d, <i>J</i> = 6.7 Hz, 2H), 6.40–6.32 (comp, 2H), 5.08–4.95 (comp, 3H), 3.80–3.61 (comp, 2H), 3.57–3.48 (m, 1H), 3.37–3.01 (comp, 8H), 2.67–2.51 (m, 1H), 2.20 (d, <i>J</i> = 1.8 Hz, 6H), 2.08–1.73 (comp, 4H). MS (ESI) <i>m</i>/<i>z</i> = 472.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (<i>S</i>)-(1-(6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[d]imidazol-4-yl)pyrrolidin-2-yl)methanamine (<b>47</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from <b>77</b> and <i>tert</i>-butyl (<i>S</i>)-(pyrrolidin-2-ylmethyl)carbamate in a similar fashion to general procedure D in 65% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.76 (d, <i>J</i> = 6.5 Hz, 2H), 6.34 (d, <i>J</i> = 1.3 Hz, 1H), 6.24 (d, <i>J</i> = 1.3 Hz, 1H), 5.04–4.94 (comp, 2H), 4.90–4.81 (m, 1H), 3.64–3.53 (m, 1H), 3.37–3.26 (m, 1H), 3.21–3.05 (comp, 5H), 3.04–2.92 (comp, 4H), 2.69–2.56 (m, 1H), 2.20 (d, <i>J</i> = 1.6 Hz, 6H), 2.07–1.96 (comp, 4H). MS (ESI) <i>m</i>/<i>z</i> = 471.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> (<i>R</i>)-(1-(6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-1H-benzo[d]imidazol-4-yl)pyrrolidin-2-yl)methanamine (<b>48</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from <b>77</b> and <i>tert</i>-butyl (<i>R</i>)-(pyrrolidin-2-ylmethyl)carbamate in a similar fashion to general procedure D in 75% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.78 (d, <i>J</i> = 6.5 Hz, 2H), 6.34 (d, <i>J</i> = 1.6 Hz, 1H), 6.24 (d, <i>J</i> = 1.6 Hz, 1H), 5.04–4.95 (comp, 2H), 4.90–4.81 (m, 1H), 3.64–3.55 (m, 1H), 3.38–3.27 (m, 1H), 3.19–3.03 (comp, 5H), 3.03–2.90 (comp, 4H), 2.68–2.55 (m, 1H), 2.20 (d, <i>J</i> = 1.7 Hz, 6H), 2.08–1.96 (comp, 4H). MS (ESI) <i>m</i>/<i>z</i> = 471.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> (2-(6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-4-yl)phenyl)methanol (<b>49</b> as Free Base)</h3><div class="NLM_p last">A mixture of <b>77</b> (75 mg, 0.14 mmol), (2-formylphenyl)boronic acid (41 mg, 0.27 mmol), PdCl<sub>2</sub>dppf·CH<sub>2</sub>Cl<sub>2</sub> (11 mg, 0.014 mmol), and K<sub>3</sub>PO<sub>4</sub> (87 mg, 0.41 mmol) was charged with degassed dioxane (1 mL) and heated to a temperature of 100 °C under Ar(g). After 2 h, the reaction mixture was cooled to rt, diluted with EtOAc, filtered through diatomaceous earth, and concentrated. The crude residue was dissolved in MeOH (2 mL), charged with NaBH<sub>4</sub> (26 mg, 0.68 mmol), and stirred for 1 h at rt. A solution of HCl in dioxane (4 M, 1 mL) was added, and the reaction mixture was stirred for 1 h at rt. The mixture was concentrated under reduced pressure and purified by reversed-phase preparative HPLC. The pure HPLC fractions were neutralized with solid Na<sub>2</sub>CO<sub>3</sub>, extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure to afford 44 mg of the title compound (68%) as a white solid. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 7.59 (d, <i>J</i> = 7.7 Hz, 1H), 7.45 (td, <i>J</i> = 7.6, 1.2 Hz, 1H), 7.39 (td, <i>J</i> = 7.6, 1.2 Hz, 1H), 7.30 (dd, <i>J</i> = 7.6, 1.2 Hz, 1H), 7.19 (d, <i>J</i> = 1.8 Hz, 1H), 7.07 (d, <i>J</i> = 1.8 Hz, 1H), 6.88 (d, <i>J</i> = 6.6 Hz, 2H), 5.24 (s, 2H), 4.44 (s, 2H), 3.20–3.16 (m, 4H), 2.94–2.91 (m, 4H), 2.21 (d, <i>J</i> = 1.8 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 478.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-4-(pyridin-4-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>50</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and potassium pyridine-4-trifluoroborate in a similar fashion to general procedure E in 27% yield over two steps as a yellow solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.94 (d, <i>J</i> = 6.9 Hz, 2H), 8.86 (d, <i>J</i> = 6.9 Hz, 2H), 7.85 (d, <i>J</i> = 1.8 Hz, 1H), 7.47 (d, <i>J</i> = 1.8 Hz, 1H), 6.88 (d, <i>J</i> = 6.7 Hz, 2H), 5.35 (s, 2H), 3.64–3.61 (comp, 4H), 3.43–3.41 (comp, 4H), 2.20 (d, <i>J</i> = 2.0 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 450.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-4-(pyridin-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>51</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and potassium pyridine-3-trifluoroborate in a similar fashion to general procedure E in 39% yield over two steps as a yellow solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 9.82 (d, <i>J</i> = 2.0 Hz, 1H), 9.23 (dt, <i>J</i> = 8.4, 1.5 Hz, 1H), 8.82 (d, <i>J</i> = 5.2 Hz, 1H), 8.14 (dd, <i>J</i> = 8.2, 5.9 Hz, 1H), 7.71 (d, <i>J</i> = 1.8 Hz, 1H), 7.39 (d, <i>J</i> = 1.9 Hz, 1H), 6.88 (d, <i>J</i> = 6.6 Hz, 2H), 5.34 (s, 2H), 3.61–3.58 (comp, 4H), 3.43–3.40 (comp, 4H), 2.20 (d, <i>J</i> = 2.0 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 450.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-4-(pyrimidin-5-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>54</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and pyrimidin-5-ylboronic acid in a similar fashion to general procedure C in 79% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 9.47 (s, 2H), 9.15 (s, 1H), 7.55 (t, <i>J</i> = 1.8 Hz, 1H), 7.32 (d, <i>J</i> = 1.8 Hz, 1H), 6.88 (d, <i>J</i> = 6.7 Hz, 2H), 5.32 (s, 2H), 3.56–3.54 (comp, 4H), 3.42–3.40 (comp, 4H), 2.20 (d, <i>J</i> = 2.0 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 451.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-4-(4-methylpyrimidin-5-yl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>55</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and 4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine in a similar fashion to general procedure C in 93% yield over two steps as a yellow solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 9.07 (s, 1H), 8.70 (s, 1H), 7.37 (d, <i>J</i> = 1.9 Hz, 1H), 7.24 (d, <i>J</i> = 1.9 Hz, 1H), 6.89 (d, <i>J</i> = 6.6 Hz, 2H), 5.32 (s, 2H), 3.45 (br s, 4H), 3.37–3.35 (comp, 4H), 2.49 (s, 3H), 2.22 (d, <i>J</i> = 2.2 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 465.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-4-(4-isopropylpyrimidin-5-yl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>56</b> as TFA Salt)</h3><div class="NLM_p last">The title compound was prepared as the corresponding TFA salt from <b>77</b> and (4-isopropylpyrimidin-5-yl)boronic acid in a similar fashion to general procedure C in 58% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 9.14 (s, 1H), 8.63 (s, 1H), 7.37 (d, <i>J</i> = 1.9 Hz, 1H), 7.19 (d, <i>J</i> = 1.9 Hz, 1H), 6.89 (d, <i>J</i> = 6.7 Hz, 2H), 5.32 (s, 2H), 3.45–3.42 (comp, 4H), 3.37–3.34 (comp, 4H), 3.11–3.04 (m, 1H), 2.22 (d, <i>J</i> = 2.0 Hz, 6H), 1.23 (d, <i>J</i> = 6.9 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 493.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-4-(1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>57</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from <b>78</b> and <i>tert</i>-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole-1-carboxylate in dioxane in a similar fashion to general procedure C in 31% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.97 (br s, 1H), 8.60 (br s, 1H), 8.38 (br s, 1H), 7.46 (d, <i>J</i> = 1.9 Hz, 1H), 7.05 (d, <i>J</i> = 2.0 Hz, 1H), 6.92 (d, <i>J</i> = 6.7 Hz, 2H), 5.20 (s, 2H), 3.22–3.15 (comp, 4H), 2.89–2.80 (comp, 4H), 2.16 (d, <i>J</i> = 1.6 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 439.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 6-Chloro-4-(3,5-dimethyl-1<i>H</i>-pyrazol-4-yl)-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>58</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from <b>78</b> and <i>tert</i>-butyl 3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole-1-carboxylate in dioxane in a similar fashion to general procedure C in 31% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.10 (d, <i>J</i> = 2.0 Hz, 1H), 7.00 (d, <i>J</i> = 1.9 Hz, 1H), 6.86 (d, <i>J</i> = 6.7 Hz, 2H), 5.21 (s, 2H), 3.23–3.17 (m, 4H), 2.98–2.93 (m, 4H), 2.32 (s, 6H), 2.19 (d, <i>J</i> = 2.0 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 467.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 6-Chloro-4-(2-chlorophenyl)-1-(4-fluoro-3,5-dimethylbenzyl)-2-(2,6-diazaspiro[3.3]heptan-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>59</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from <b>79</b> and (2-chlorophenyl)boronic acid in dioxane in a similar fashion to general procedure C in 46% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.55–7.50 (m, 1H), 7.48–7.44 (m, 1H), 7.41–7.36 (m, 2H), 7.13 (d, <i>J</i> = 2.0 Hz, 1H), 7.01 (d, <i>J</i> = 2.0 Hz, 1H), 6.83 (d, <i>J</i> = 6.9 Hz, 2H), 5.17 (s, 2H), 4.25 (s, 4H), 3.82 (s, 4H), 2.20 (d, <i>J</i> = 2.0 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 494.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-4-(4-methylpyrimidin-5-yl)-2-(2,6-diazaspiro[3.3]heptan-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>60</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from <b>79</b> and 4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine in dioxane in a similar fashion to general procedure C in 91% yield over two steps as a white solid. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 9.03 (s, 1H), 8.63 (s, 1H), 7.22 (d, <i>J</i> = 1.9 Hz, 1H), 7.06 (d, <i>J</i> = 1.9 Hz, 1H), 6.83 (d, <i>J</i> = 6.7 Hz, 2H), 5.18 (s, 2H), 4.27 (s, 4H), 3.84 (s, 4H), 2.46 (s, 3H), 2.19 (d, <i>J</i> = 2.0 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 477.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 6-Chloro-1-(4-fluorobenzyl)-4-(4-methylpyrimidin-5-yl)-2-(2,6-diazaspiro[3.3]heptan-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>61</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from <b>80</b> and 4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine in dioxane/water (5:1 v/v) in a similar fashion to general procedure C in 78% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.14 (s, 1H), 8.67 (s, 1H), 7.54 (d, <i>J</i> = 2.0 Hz, 1H), 7.36–7.32 (m, 3H), 7.21–7.16 (m, 2H), 5.45 (s, 2H), 4.63 (s, 4H), 4.30 (s, 4H), 2.45 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 449.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 5-(6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(2,6-diazaspiro[3.3]heptan-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-4-yl)-4-methylpyrimidin-2-amine (<b>62</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from <b>79</b> and 4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine in dioxane in a similar fashion to general procedure C in 27% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.13 (s, 1H), 7.13 (d, <i>J</i> = 2.0 Hz, 1H), 6.98 (d, <i>J</i> = 2.0 Hz, 1H), 6.82 (d, <i>J</i> = 6.4 Hz, 2H), 5.16 (s, 2H), 4.25 (s, 4H), 3.77 (s, 4H), 2.26 (s, 3H), 2.19 (d, <i>J</i> = 2.0 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 492.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 5-(6-Chloro-1-(4-fluorobenzyl)-2-(2,6-diazaspiro[3.3]heptan-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-4-yl)-4-methylpyrimidin-2-amine (<b>63</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from <b>80</b> and 4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine in dimethoxyethane/water (5:1 v/v) in a similar fashion to general procedure C in 73% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.02 (s, 1H), 7.09–7.05 (m, 3H), 7.00–6.96 (m, 2H), 6.87 (s, 1H), 5.14 (s, 2H), 4.74 (s, 4H), 4.21 (s, 4H), 2.15 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> = 464.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 6-Chloro-1-(4-fluoro-3,5-dimethylbenzyl)-4-(4-methylpiperazin-1-yl)-2-(2,6-diazaspiro[3.3]heptan-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>64</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from <b>79</b> and <i>N</i>-methylpiperazine in a similar fashion to general procedure D in 99% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 6.81 (d, <i>J</i> = 6.8 Hz, 2H), 6.75 (d, <i>J</i> = 1.8 Hz, 1H), 6.40 (d, <i>J</i> = 1.8 Hz, 1H), 5.06 (s, 2H), 4.13 (s, 4H), 3.58 (s, 4H), 3.45 (br s, 4H), 2.47–2.44 (comp, 4H), 2.22 (s, 3H), 2.15 (d, <i>J</i> = 1.8 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 483.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 6-Chloro-4-(3,5-dimethyl-1<i>H</i>-pyrazol-4-yl)-1-(4-fluoro-3,5-dimethylbenzyl)-2-(2,6-diazaspiro[3.3]heptan-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>65</b> as Free Base)</h3><div class="NLM_p last">The title compound was prepared as the free base from <b>79</b> and <i>tert</i>-butyl 3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole-1-carboxylate in dioxane in a similar fashion to general procedure C in 38% yield over two steps as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.05 (d, <i>J</i> = 1.9 Hz, 1H), 6.93 (d, <i>J</i> = 1.9 Hz, 1H), 6.83 (d, <i>J</i> = 6.4 Hz, 2H), 5.14 (s, 2H), 4.24 (s, 4H), 3.75 (s, 4H), 2.22 (s, 6H), 2.20 (d, <i>J</i> = 2.0 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 479.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 2-Chloro-5,6-dimethyl-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>67</b>)</h3><div class="NLM_p last">A mixture of compound <b>66</b> (2.0 g, 15 mmol), DMAP (183 mg, 1.5 mmol), and CDI (4.86 g, 30 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was stirred for 16 h at rt. The resulting precipitate was collected via filtration, rinsed with CH<sub>2</sub>Cl<sub>2</sub> (30 mL), and dried under reduced pressure. The crude solid was suspended in POCl<sub>3</sub> (15 mL) and heated to 90 °C. After 6 h, the suspension had become a clear solution and the reaction was complete, as indicated by LC-MS. The reaction mixture was cooled to 0 °C, and chilled water was added slowly with rapid stirring to avoid excessive exotherm. Solid pellets of KOH were then added portionwise until the mixture was neutral, at which time a solid precipitate formed. The solid was collected via filtration, rinsed with water, and dried under reduced pressure to provide 1.8 g of the title compound (67%) as an off-white powder. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.26 (s, 2H), 2.35 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> = 181.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 4-Bromo-2,6-dichloro-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>76</b>)</h3><div class="NLM_p last">A mixture of compound <b>75</b> (8.92 g, 40.3 mmol), DMAP (0.49 g, 4.0 mmol), and CDI (13.1 g, 80.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (400 mL) was stirred for 16 h at rt. The resulting precipitate was collected via filtration, rinsed with CH<sub>2</sub>Cl<sub>2</sub> (100 mL), and dried under reduced pressure. The crude solid was suspended in POCl<sub>3</sub> (23 mL) and heated to 110 °C. After 3 h, the suspension had become a clear solution and the reaction was complete, as indicated by LC-MS. The mixture was cooled to rt and added slowly to rapidly stirred water (200 mL), taking care to avoid excessive exotherm. The mixture was cooled in an ice bath, and solid pellets of KOH were then added portionwise until the mixture was neutral, at which time a solid precipitate formed. The solid was collected via filtration, rinsed with water, and dried under reduced pressure to provide 1.62 g of the title compound (75%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.52 (d, <i>J</i> = 1.8 Hz, 1H), 7.48 (d, <i>J</i> = 1.8 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> = 266.8 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> <i>tert</i>-Butyl-4-(4-bromo-6-chloro-1-(4-fluoro-3,5-dimethylbenzyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)piperazine-1-carboxylate (<b>77</b>)</h3><div class="NLM_p last">A mixture of <b>76</b> (5.08 g, 19.1 mmol), 4-fluoro-3,5-dimethylbenzyl bromide (4.35 g, 20.1 mmol), and K<sub>2</sub>CO<sub>3</sub> (5.28 g, 38.2 mmol) in DMF (38 mL) was stirred at rt for 16 h. The mixture was diluted with EtOAc, poured into a 50% satd brine solution, and extracted with EtOAc (3×). The combined organics were washed with a 50% satd brine solution, a satd brine solution, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography to provide 4.1 g of 4-bromo-2,6-dichloro-1-(4-fluoro-3,5-dimethylbenzyl)-1<i>H</i>-benzo[<i>d</i>]imidazole. A portion of this material (800 mg, 1.99 mmol) was mixed with 1-Boc-piperazine (1110 mg, 5.97 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (514 mg, 3.98 mmol) in DMF (0.69 mL) and heated to 80 °C for 16 h. The mixture was cooled to rt and poured into brine. The resulting precipitate was collected via filtration and dried under reduced pressure. The crude solid was purified by silica gel chromatography to afford 1.09 g of the title compound (99%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.38 (d, <i>J</i> = 1.8 Hz, 1H), 6.93 (d, <i>J</i> = 1.8 Hz, 1H), 6.72 (d, <i>J</i> = 6.5 Hz, 2H), 5.06 (s, 2H), 3.55–3.53 (m, 4H), 3.27–3.25 (m, 4H), 2.21 (d, <i>J</i> = 1.9 Hz, 6H), 1.46 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> = 552.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 4-Bromo-6-chloro-1-(4-fluoro-3,5-dimethylbenzyl)-2-(piperazin-1-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>78</b>)</h3><div class="NLM_p last">A mixture of <b>76</b> (5.08 g, 19.1 mmol), 4-fluoro-3,5-dimethylbenzyl bromide (4.35 g, 20.1 mmol), and K<sub>2</sub>CO<sub>3</sub> (5.28 g, 38.2 mmol) in DMF (38 mL) was stirred at rt for 16 h. The mixture was diluted with EtOAc, poured into a 50% satd brine solution, and extracted with EtOAc (3×). The combined organics were washed with a 50% satd brine solution, a satd brine solution, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography to provide 4.1 g of 4-bromo-2,6-dichloro-1-(4-fluoro-3,5-dimethylbenzyl)-1<i>H</i>-benzo[<i>d</i>]imidazole. A portion of this material (1.00 g, 2.49 mmol) was mixed with piperazine (1.29 g, 14.9 mmol) and K<sub>2</sub>CO<sub>3</sub> (1.03 g, 7.46 mmol) in DMSO (5.0 mL) and heated to 100 °C for 16 h. The mixture was cooled to rt and poured into brine, and the precipitate was collected via filtration. The solid was washed with water and then dried under reduced pressure to afford 1.06 g of the title compound (95%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.34 (d, <i>J</i> = 1.8 Hz, 1H), 7.14 (d, <i>J</i> = 1.8 Hz, 1H), 6.82 (d, <i>J</i> = 6.8 Hz, 2H), 5.19 (s, 2H), 3.28–3.24 (comp, 4H), 2.96–2.91 (comp, 4H), 2.19 (d, <i>J</i> = 2.0 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i> = 450.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> <i>tert</i>-Butyl-6-(4-bromo-6-chloro-1-(4-fluoro-3,5-dimethylbenzyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-2,6-diazaspiro[3.3]heptane-2-carboxylate (<b>79</b>)</h3><div class="NLM_p last">A mixture of <b>76</b> (5.08 g, 19.1 mmol), 4-fluoro-3,5-dimethylbenzyl bromide (4.35 g, 20.1 mmol), and K<sub>2</sub>CO<sub>3</sub> (5.28 g, 38.2 mmol) in DMF (38 mL) was stirred at rt for 16 h. The mixture was diluted with EtOAc, poured into a 50% satd brine solution, and extracted with EtOAc (3×). The combined organics were washed with a 50% satd brine solution, a satd brine solution, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography to provide 4.1 g of 4-bromo-2,6-dichloro-1-(4-fluoro-3,5-dimethylbenzyl)-1<i>H</i>-benzo[<i>d</i>]imidazole. A portion of this material (400 mg, 1 mmol) was mixed with 2,6-diazaspiro[3.3]heptane-2-carboxylic acid <i>tert</i>-butyl ester hemioxylate (290 mg, 1.19 mmol) and K<sub>2</sub>CO<sub>3</sub> (412 mg, 2.98 mmol) in DMSO (2 mL) and heated to 100 °C for 3 h. The mixture was cooled to rt and poured into brine. The resulting solid precipitate was collected via filtration, washed with water, and dried under reduced pressure to afford 554 mg of the title compound (99%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.28 (d, <i>J</i> = 1.9 Hz, 1H), 7.10 (d, <i>J</i> = 1.9 Hz, 1H), 6.78 (d, <i>J</i> = 6.6 Hz, 2H), 5.13 (s, 2H), 4.36 (s, 4H), 4.08 (s, 4H), 2.19 (d, <i>J</i> = 2.0 Hz, 6H), 1.43 (s, 9H)). MS (ESI) <i>m</i>/<i>z</i> = 562.8 [M + H]<sup>+</sup>.</div></div><div id="sec4_6_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> <i>tert</i>-Butyl-6-(4-bromo-6-chloro-1-(4-fluorobenzyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-2,6-diazaspiro[3.3]heptane-2-carboxylate (<b>80</b>)</h3><div class="NLM_p last">A mixture of <b>76</b> (1.06 g, 4 mmol), 4-fluorobenzyl bromide (907 mg, 4.8 mmol), and K<sub>2</sub>CO<sub>3</sub> (829 mg, 6 mmol) in DMF (14 mL) was stirred at rt for 16 h. The mixture was quenched with 10% HCl, extracted with EtOAc (3×), and washed with water. The combined organics were dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography to afford 1.07 g of 4-bromo-2,6-dichloro-1-(4-fluorobenzyl)-1<i>H</i>-benzo[<i>d</i>]imidazole. A portion of this material (374 mg, 1 mmol) was mixed with 2,6-diazaspiro[3.3]heptane-2-carboxylic acid <i>tert</i>-butyl ester hemioxylate (486 mg, 1.5 mmol) and K<sub>2</sub>CO<sub>3</sub> in DMSO (3 mL) and heated to 100 °C for 12 h. The mixture was cooled to rt, diluted with EtOAc, poured into a 50% satd brine solution, and extracted with EtOAc (3×). The combined organics were washed with a 50% satd brine solution, a satd brine solution, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure. The crude residue was purified by silica gel chromatography to afford 386 mg of the title compound (72%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.46 (d, <i>J</i> = 2.0 Hz, 2H), 7.11 (d, <i>J</i> = 2.0 Hz, 2H), 6.92 (br s, 1H), 6.81 (br s, 1H), 5.22 (s, 2H), 4.96 (s, 4H), 4.25 (s, 4H), 1.49 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> = 536.8 [M + H]<sup>+</sup>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i96"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01108" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61163" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61163" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01108" class="ext-link">10.1021/acs.jmedchem.8b01108</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Biochemical and cellular assay conditions; saturation binding curves for FPA probe molecules <b>S1</b>, <b>S2</b>, and <b>S3</b>; additional biochemical data; preliminary in vitro solubility and permeability data; experimental details for the syntheses of <b>S1</b>, <b>S2</b>, and <b>S3</b>; details regarding protein expression and purification; details regarding crystallization, X-ray data collection, structure solution, and refinement; and a table containing X-ray data collection and refinement statistics (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_001.pdf">jm8b01108_si_001.pdf (3.02 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_002.csv">jm8b01108_si_002.csv (5.62 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes: compounds <b>3</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5V">6D5V</a>), <b>10</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5M">6D5M</a>), <b>28</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5L">6D5L</a>), <b>29</b> ( <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5J">6D5J</a>), <b>38</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5H">6D5H</a>), <b>43</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5G">6D5G</a>), <b>47</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5E">6D5E</a>), <b>58</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D59">6D59</a>), <b>64</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D55">6D55</a>), <b>65</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D56">6D56</a>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b01108" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03041" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03041" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen W. Fesik</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, 
    Department of Pharmacology, 
    , , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Vanderbilt University, Nashville, Tennessee 37232-0146, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5957-6192" title="Orcid link">http://orcid.org/0000-0001-5957-6192</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#aedddacbdec6cbc080c8cbddc7c5eed8cfc0cacbdcccc7c2da80cbcadb"><span class="__cf_email__" data-cfemail="4a393e2f3a222f24642c2f3923210a3c2b242e2f382823263e642f2e3f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy
R. Hodges</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1216-9551" title="Orcid link">http://orcid.org/0000-0003-1216-9551</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason R. Abbott</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2291-2903" title="Orcid link">http://orcid.org/0000-0002-2291-2903</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew J. Little</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span>; 
    <span>Present Address:
                        For A.J.L.: AbbVie, Brighton, MA, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dhruba Sarkar</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0597-3066" title="Orcid link">http://orcid.org/0000-0003-0597-3066</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James M. Salovich</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer E. Howes</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1138-6183" title="Orcid link">http://orcid.org/0000-0003-1138-6183</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Denis T. Akan</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1476-4883" title="Orcid link">http://orcid.org/0000-0002-1476-4883</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiqing Sai</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allison L. Arnold</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carrie Browning</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael C. Burns</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span>; 
    <span>Present Address:
                        For M.C.B.: Northwestern University Feinberg School of Medicine, Chicago, IL, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tammy Sobolik</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span>; 
    <span>Present Address:
                        For T.S.: TerSera Therapeutics, Lake Forest, IL, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Sun</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span>; 
    <span>Present Address:
                        For Q.S.: AbbVie, Chicago, IL, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yugandhar Beesetty</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jesse A. Coker</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span>; 
    <span>Present Address:
                        For J.A.C.: University of Oxford, Oxford, UK</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dirk Scharn</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co. KG, Doktor-Boehringer-Gasse 5-11, 1120 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heinz Stadtmueller</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co. KG, Doktor-Boehringer-Gasse 5-11, 1120 Vienna, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olivia W. Rossanese</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span>; 
    <span>Present Address:
                        For O.W.R.: The Institute of Cancer Research, London, UK</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Phan</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alex G. Waterson</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology, 
    , , Vanderbilt
University School of Medicine, Nashville, Tennessee 37232-0146, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Vanderbilt University, Nashville, Tennessee 37232-0146, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darryl B. McConnell</span> - <span class="hlFld-Affiliation affiliation">Boehringer
Ingelheim RCV GmbH & Co. KG, Doktor-Boehringer-Gasse 5-11, 1120 Vienna, Austria</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>T.R.H., J.R.A., and A.J.L. contributed equally to this work. All authors have given approval to the final version of this manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): RAS activator compounds have been licensed to Boehringer Ingelheim.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i105">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30547" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30547" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Funding for this work came from the following sources: U.S. National Institutes of Health, NIH Director’s Pioneer Award (DP1OD006933/DP1CA174419) to S. W. Fesik; Lustgarten Foundation Research Investigator Grant to S. W. Fesik; National Cancer Institute SPORE Grant in GI Cancer (5P50A095103-09) to R. J. Coffey. We thank the Vanderbilt High Throughput Screening (HTS) Core Facility, with assistance provided by C. David Weaver, Paige Vinson, Chris Farmer, and Corbin Whitwell. This facility receives support from the Vanderbilt Institute of Chemical Biology and the Vanderbilt Ingram Cancer Center (P30 CA68485). We also thank the Vanderbilt University Biomolecular NMR Facility, with assistance provided by Donald Stec. This facility receives support from an NIH SIG grant (1S-10RR025677-01) and Vanderbilt University matching funds. Finally, we thank the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences for use of the Advanced Photon Source (contract: DE-AC02-06CH11357).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">1,1′-carbonyldiimidazole;</p></td></tr><tr><td class="NLM_term">EGF</td><td class="NLM_def"><p class="first last">epidermal growth factor</p></td></tr><tr><td class="NLM_term">ERK1/2</td><td class="NLM_def"><p class="first last">extracellular regulated kinases 1 and 2</p></td></tr><tr><td class="NLM_term">GEF</td><td class="NLM_def"><p class="first last">guanine nucleotide exchange factor</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">pERK1/2</td><td class="NLM_def"><p class="first last">phosphorylated ERK1/2</p></td></tr><tr><td class="NLM_term">Act.</td><td class="NLM_def"><p class="first last">relative percent activation</p></td></tr><tr><td class="NLM_term">SOS1</td><td class="NLM_def"><p class="first last">son of sevenless homologue 1.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i107">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 49 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I. R.</span></span> <span> </span><span class="NLM_article-title">The Guanine Nucleotide-Binding Switch in Three Dimensions</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>294</i></span> (<span class="NLM_issue">5545</span>),  <span class="NLM_fpage">1299</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.1126/science.1062023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1126%2Fscience.1062023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=11701921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlKnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2001&pages=1299-1304&issue=5545&author=I.+R.+Vetter&title=The+Guanine+Nucleotide-Binding+Switch+in+Three+Dimensions&doi=10.1126%2Fscience.1062023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transduction: The guanine nucleotide-binding switch in three dimensions</span></div><div class="casAuthors">Vetter, Ingrid R.; Wittinghofer, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">5545</span>),
    <span class="NLM_cas:pages">1299-1304</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Guanine nucleotide-binding proteins regulate a variety of processes, including sensual perception, protein synthesis, various transport processes, and cell growth and differentiation.  They act as mol. switches and timers that cycle between inactive guanosine diphosphate (GDP)-bound and active guanosine triphosphate (GTP)-bound states.  Recent structural studies show that the switch app. itself is a conserved fundamental module but that its regulators and effectors are quite diverse in their structures and modes of interaction.  Here we will try to define some. underlying principles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2o75cMejTrLVg90H21EOLACvtfcHk0lgmbWyOwy9hpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlKnu70%253D&md5=07d04400bf13ddb01daba8054d80fd28</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1062023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1062023%26sid%3Dliteratum%253Aachs%26aulast%3DVetter%26aufirst%3DI.%2BR.%26atitle%3DThe%2520Guanine%2520Nucleotide-Binding%2520Switch%2520in%2520Three%2520Dimensions%26jtitle%3DScience%26date%3D2001%26volume%3D294%26issue%3D5545%26spage%3D1299%26epage%3D1304%26doi%3D10.1126%2Fscience.1062023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schubbert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span> <span> </span><span class="NLM_article-title">Hyperactive Ras in Developmental Disorders and Cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1038/nrc2109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnrc2109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=17384584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlyhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=295-308&issue=4&author=S.+Schubbertauthor=K.+Shannonauthor=G.+Bollag&title=Hyperactive+Ras+in+Developmental+Disorders+and+Cancer&doi=10.1038%2Fnrc2109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperactive Ras in developmental disorders and cancer</span></div><div class="casAuthors">Schubbert, Suzanne; Shannon, Kevin; Bollag, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-308</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Ras genes are the most common targets for somatic gain-of-function mutations in human cancer.  Recently, germline mutations that affect components of the Ras-Raf-mitogen-activated and extracellular-signal regulated kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) pathway were shown to cause several developmental disorders, including Nonan, Costello and cardio-facio-cutaneous syndromes.  Many of these mutant alleles encode proteins with aberrant biochem. and functional properties.  Here we will discuss the implications of germline mutations in the Ras-Raf-MEK-ERK pathway for understanding normal developmental processes and cancer pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCRvjqrp1ho7Vg90H21EOLACvtfcHk0lgmbWyOwy9hpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlyhtLs%253D&md5=25fcaa959dae5e8512b959936bcbb347</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc2109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2109%26sid%3Dliteratum%253Aachs%26aulast%3DSchubbert%26aufirst%3DS.%26aulast%3DShannon%26aufirst%3DK.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DHyperactive%2520Ras%2520in%2520Developmental%2520Disorders%2520and%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26issue%3D4%26spage%3D295%26epage%3D308%26doi%3D10.1038%2Fnrc2109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">The Hallmarks of Cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81683-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&issue=1&author=D.+Hanahanauthor=R.+A.+Weinberg&title=The+Hallmarks+of+Cancer&doi=10.1016%2FS0092-8674%2800%2981683-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0lgAt6z2iNPNhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520Hallmarks%2520of%2520Cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26issue%3D1%26spage%3D57%26epage%3D70%26doi%3D10.1016%2FS0092-8674%2800%2981683-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of Cancer: The Next Generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&issue=5&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+Cancer%3A+The+Next+Generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lgAt6z2iNPNhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520Cancer%253A%2520The%2520Next%2520Generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26issue%3D5%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pylayeva-Gupta, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabocka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span> <span> </span><span class="NLM_article-title">RAS Oncogenes: Weaving a Tumorigenic Web</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1038/nrc3106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnrc3106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=21993244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlSkur7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=761-774&issue=11&author=Y.+Pylayeva-Guptaauthor=E.+Grabockaauthor=D.+Bar-Sagi&title=RAS+Oncogenes%3A+Weaving+a+Tumorigenic+Web&doi=10.1038%2Fnrc3106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">RAS oncogenes: weaving a tumorigenic web</span></div><div class="casAuthors">Pylayeva-Gupta, Yuliya; Grabocka, Elda; Bar-Sagi, Dafna</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">761-774</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  RAS proteins are essential components of signalling pathways that emanate from cell surface receptors.  Oncogenic activation of these proteins owing to missense mutations is frequently detected in several types of cancer.  A wealth of biochem. and genetic studies indicates that RAS proteins control a complex mol. circuitry that consists of a wide array of interconnecting pathways.  In this Review, we describe how RAS oncogenes exploit their extensive signalling reach to affect multiple cellular processes that drive tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdHRt0jsiXtLVg90H21EOLACvtfcHk0lgAt6z2iNPNhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlSkur7K&md5=d1be47023ab43a30cb81e71cb92bc0aa</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc3106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3106%26sid%3Dliteratum%253Aachs%26aulast%3DPylayeva-Gupta%26aufirst%3DY.%26aulast%3DGrabocka%26aufirst%3DE.%26aulast%3DBar-Sagi%26aufirst%3DD.%26atitle%3DRAS%2520Oncogenes%253A%2520Weaving%2520a%2520Tumorigenic%2520Web%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26issue%3D11%26spage%3D761%26epage%3D774%26doi%3D10.1038%2Fnrc3106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomerantz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holash, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardeesy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hagan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantginis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordon-Cardo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yancopoulos, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePinho, R. A.</span></span> <span> </span><span class="NLM_article-title">Essential Role for Oncogenic Ras in Tumour Maintenance</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>400</i></span> (<span class="NLM_issue">6743</span>),  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">472</span>, <span class="refDoi"> DOI: 10.1038/22788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2F22788" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=1999&pages=468-472&issue=6743&author=L.+Chinauthor=A.+Tamauthor=J.+Pomerantzauthor=M.+Wongauthor=J.+Holashauthor=N.+Bardeesyauthor=Q.+Shenauthor=R.+O%E2%80%99Haganauthor=J.+Pantginisauthor=H.+Zhouauthor=J.+W.+Hornerauthor=C.+Cordon-Cardoauthor=G.+D.+Yancopoulosauthor=R.+A.+DePinho&title=Essential+Role+for+Oncogenic+Ras+in+Tumour+Maintenance&doi=10.1038%2F22788"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F22788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F22788%26sid%3Dliteratum%253Aachs%26aulast%3DChin%26aufirst%3DL.%26aulast%3DTam%26aufirst%3DA.%26aulast%3DPomerantz%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DBardeesy%26aufirst%3DN.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DR.%26aulast%3DPantginis%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DHorner%26aufirst%3DJ.%2BW.%26aulast%3DCordon-Cardo%26aufirst%3DC.%26aulast%3DYancopoulos%26aufirst%3DG.%2BD.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26atitle%3DEssential%2520Role%2520for%2520Oncogenic%2520Ras%2520in%2520Tumour%2520Maintenance%26jtitle%3DNature%26date%3D1999%26volume%3D400%26issue%3D6743%26spage%3D468%26epage%3D472%26doi%3D10.1038%2F22788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vigil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherfils, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossman, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Der, C. J.</span></span> <span> </span><span class="NLM_article-title">Ras Superfamily GEFs and GAPs : Validated and Tractable Targets for Cancer Therapy ?</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">857</span>, <span class="refDoi"> DOI: 10.1038/nrc2960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnrc2960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=21102635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=842-857&author=D.+Vigilauthor=J.+Cherfilsauthor=K.+L.+Rossmanauthor=C.+J.+Der&title=Ras+Superfamily+GEFs+and+GAPs%E2%80%AF%3A+Validated+and+Tractable+Targets+for+Cancer+Therapy%E2%80%AF%3F&doi=10.1038%2Fnrc2960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?</span></div><div class="casAuthors">Vigil, Dominico; Cherfils, Jacqueline; Rossman, Kent L.; Der, Channing J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">842-857</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is now considerable and increasing evidence for a causal role for aberrant activity of the Ras superfamily of small GTPases in human cancers.  These GTPases function as GDP-GTP-regulated binary switches that control many fundamental cellular processes.  A common mechanism of GTPase deregulation in cancer is the deregulated expression and/or activity of their regulatory proteins, guanine nucleotide exchange factors (GEFs) that promote formation of the active GTP-bound state and GTPase-activating proteins (GAPs) that return the GTPase to its GDP-bound inactive state.  In this Review, we assess the assocn. of GEFs and GAPs with cancer and their druggability for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwbf8B7sLmb7Vg90H21EOLACvtfcHk0lgaaCyTC39hKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsbrM&md5=b7ad81f2fe0f7f7eaa5f015188f62e85</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc2960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2960%26sid%3Dliteratum%253Aachs%26aulast%3DVigil%26aufirst%3DD.%26aulast%3DCherfils%26aufirst%3DJ.%26aulast%3DRossman%26aufirst%3DK.%2BL.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26atitle%3DRas%2520Superfamily%2520GEFs%2520and%2520GAPs%25E2%2580%25AF%253A%2520Validated%2520and%2520Tractable%2520Targets%2520for%2520Cancer%2520Therapy%25E2%2580%25AF%253F%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D842%26epage%3D857%26doi%3D10.1038%2Fnrc2960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Gramont, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheithauer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smakal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kourteva, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iveson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andre, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dostalova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belly, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Ruixo, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, P. A.</span></span> <span> </span><span class="NLM_article-title">Phase III Double-Blind Placebo-Controlled Study of Farnesyl Transferase Inhibitor R115777 in Patients With Refractory Advanced Colorectal Cancer</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">3950</span>– <span class="NLM_lpage">3957</span>, <span class="refDoi"> DOI: 10.1200/JCO.2004.10.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1200%2FJCO.2004.10.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=15459217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVKitrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=3950-3957&issue=19&author=S.+Raoauthor=D.+Cunninghamauthor=A.+de+Gramontauthor=W.+Scheithauerauthor=M.+Smakalauthor=Y.+Humbletauthor=G.+Kourtevaauthor=T.+Ivesonauthor=T.+Andreauthor=J.+Dostalovaauthor=A.+Illesauthor=R.+Bellyauthor=J.+J.+Perez-Ruixoauthor=Y.+C.+Parkauthor=P.+A.+Palmer&title=Phase+III+Double-Blind+Placebo-Controlled+Study+of+Farnesyl+Transferase+Inhibitor+R115777+in+Patients+With+Refractory+Advanced+Colorectal+Cancer&doi=10.1200%2FJCO.2004.10.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer</span></div><div class="casAuthors">Rao, S.; Cunningham, D.; de Gramont, A.; Scheithauer, W.; Smakal, M.; Humblet, Y.; Kourteva, G.; Iveson, T.; Andre, T.; Dostalova, J.; Illes, A.; Belly, R.; Perez-Ruixo, J. J.; Park, Y. C.; Palmer, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3950-3957</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The aim was to det. whether R115777 improves survival in patients with refractory advanced colorectal cancer (CRC) in a multicenter, double-blind, prospective randomized study.  Three hundred sixty-eight patients were randomly assigned to R115777 (300 mg twice daily) orally for 21 days every 28 days or placebo in a 2:1 ratio.  All patients received best supportive care.  The primary end point was overall survival; secondary end points were progression free survival, tumor response, toxicity, and quality of life.  The two treatment groups were well balanced for baseline demographics, including previous chemotherapy for advanced CRC.  The median overall survival for R115777 was 174 days (95% CI, 157 to 198 days), and 185 days (95% CI, 158 to 238 days) for those patients receiving placebo (P = .376).  One patient achieved a partial response in the R115777 arm.  Stable disease (> 3 mo) was obsd. in 24.3% patients in the R115777 group compared to 12.8% in the placebo arm.  This did not translate into a statistically significant increase in progression-free survival.  Overall, treatment was well tolerated.  There was an increased incidence of reversible myelosuppression (neutropenia, thrombocytopenia), rash, and grade 1 to 2 diarrhea in the R115777 arm.  There was no statistically significant difference in quality of life between arms.  Single agent R115777, given at this dose and schedule, has an acceptable toxicity profile, but does not improve overall survival compared to best supportive care alone in refractory advanced CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2zHZh3aOg_LVg90H21EOLACvtfcHk0lgaaCyTC39hKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVKitrk%253D&md5=ad4efce8b8dcd644afca5e7ff6842a49</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.10.037%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DS.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3Dde%2BGramont%26aufirst%3DA.%26aulast%3DScheithauer%26aufirst%3DW.%26aulast%3DSmakal%26aufirst%3DM.%26aulast%3DHumblet%26aufirst%3DY.%26aulast%3DKourteva%26aufirst%3DG.%26aulast%3DIveson%26aufirst%3DT.%26aulast%3DAndre%26aufirst%3DT.%26aulast%3DDostalova%26aufirst%3DJ.%26aulast%3DIlles%26aufirst%3DA.%26aulast%3DBelly%26aufirst%3DR.%26aulast%3DPerez-Ruixo%26aufirst%3DJ.%2BJ.%26aulast%3DPark%26aufirst%3DY.%2BC.%26aulast%3DPalmer%26aufirst%3DP.%2BA.%26atitle%3DPhase%2520III%2520Double-Blind%2520Placebo-Controlled%2520Study%2520of%2520Farnesyl%2520Transferase%2520Inhibitor%2520R115777%2520in%2520Patients%2520With%2520Refractory%2520Advanced%2520Colorectal%2520Cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26issue%3D19%26spage%3D3950%26epage%3D3957%26doi%3D10.1200%2FJCO.2004.10.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrenton, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skelton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokoe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludlam, M. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannetti, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Ligands Bind to a Distinct Pocket in Ras and Inhibit SOS-Mediated Nucleotide Exchange Activity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5299</span>– <span class="NLM_lpage">5304</span>, <span class="refDoi"> DOI: 10.1073/pnas.1116510109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1073%2Fpnas.1116510109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=22431598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslOjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=5299-5304&issue=14&author=T.+Maurerauthor=L.+S.+Garrentonauthor=A.+Ohauthor=K.+Pittsauthor=D.+J.+Andersonauthor=N.+J.+Skeltonauthor=B.+P.+Fauberauthor=B.+Panauthor=S.+Malekauthor=D.+Stokoeauthor=M.+J.+C.+Ludlamauthor=K.+K.+Bowmanauthor=J.+Wuauthor=A.+M.+Giannettiauthor=M.+A.+Starovasnikauthor=I.+Mellmanauthor=P.+K.+Jacksonauthor=J.+Rudolphauthor=W.+Wangauthor=G.+Fang&title=Small-Molecule+Ligands+Bind+to+a+Distinct+Pocket+in+Ras+and+Inhibit+SOS-Mediated+Nucleotide+Exchange+Activity&doi=10.1073%2Fpnas.1116510109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity</span></div><div class="casAuthors">Maurer, Till; Garrenton, Lindsay S.; Oh, Angela; Pitts, Keith; Anderson, Daniel J.; Skelton, Nicholas J.; Fauber, Benjamin P.; Pan, Borlan; Malek, Shiva; Stokoe, David; Ludlam, Mary J. C.; Bowman, Krista K.; Wu, Jiansheng; Giannetti, Anthony M.; Starovasnik, Melissa A.; Mellman, Ira; Jackson, Peter K.; Rudolph, Joachim; Wang, Weiru; Fang, Guowei</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5299-5304, S5299/1-S5299/13</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Ras gene is frequently mutated in cancer, and mutant Ras drives tumorigenesis.  Although Ras is a central oncogene, small mols. that bind to Ras in a well-defined manner and exert inhibitory effects have not been uncovered to date.  Through an NMR-based fragment screen, we identified a group of small mols. that all bind to a common site on Ras.  High-resoln. cocrystal structures delineated a unique ligand-binding pocket on the Ras protein that is adjacent to the switch I/II regions and can be expanded upon compd. binding.  Structure anal. predicts that compd.-binding interferes with the Ras/SOS interactions.  Indeed, selected compds. inhibit SOS-mediated nucleotide exchange and prevent Ras activation by blocking the formation of intermediates of the exchange reaction.  The discovery of a small-mol. binding pocket on Ras with functional significance provides a new direction in the search of therapeutically effective inhibitors of the Ras oncoprotein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAXIzMe7yBqrVg90H21EOLACvtfcHk0lhNdMQJtVoEdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslOjsrc%253D&md5=a7210cad45154c42eb2a1faeabf88c20</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1116510109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1116510109%26sid%3Dliteratum%253Aachs%26aulast%3DMaurer%26aufirst%3DT.%26aulast%3DGarrenton%26aufirst%3DL.%2BS.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DPitts%26aufirst%3DK.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DSkelton%26aufirst%3DN.%2BJ.%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DPan%26aufirst%3DB.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DLudlam%26aufirst%3DM.%2BJ.%2BC.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGiannetti%26aufirst%3DA.%2BM.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DMellman%26aufirst%3DI.%26aulast%3DJackson%26aufirst%3DP.%2BK.%26aulast%3DRudolph%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DFang%26aufirst%3DG.%26atitle%3DSmall-Molecule%2520Ligands%2520Bind%2520to%2520a%2520Distinct%2520Pocket%2520in%2520Ras%2520and%2520Inhibit%2520SOS-Mediated%2520Nucleotide%2520Exchange%2520Activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26issue%3D14%26spage%3D5299%26epage%3D5304%26doi%3D10.1073%2Fpnas.1116510109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of Small Molecules That Bind to K-Ras and Inhibit Sos-Mediated Activation</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">6140</span>– <span class="NLM_lpage">6143</span>, <span class="refDoi"> DOI: 10.1002/anie.201201358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1002%2Fanie.201201358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1entr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=6140-6143&issue=25&author=Q.+Sunauthor=J.+P.+Burkeauthor=J.+Phanauthor=M.+C.+Burnsauthor=E.+T.+Olejniczakauthor=A.+G.+Watersonauthor=T.+Leeauthor=O.+W.+Rossaneseauthor=S.+W.+Fesik&title=Discovery+of+Small+Molecules+That+Bind+to+K-Ras+and+Inhibit+Sos-Mediated+Activation&doi=10.1002%2Fanie.201201358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation</span></div><div class="casAuthors">Sun, Qi; Burke, Jason P.; Phan, Jason; Burns, Michael C.; Olejniczak, Edward T.; Waterson, Alex G.; Lee, Taekyu; Rossanese, Olivia W.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6140-6143, S6140/1-S6140/17</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">K-Ras inhibition represents an attractive therapeutic strategy for many cancers.  We report on the discovery of novel small mols. that bind directly to K-Ras between switch I and switch II and inhibit Sos-catalyzed K-Ras activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy5Cx7BSO1pLVg90H21EOLACvtfcHk0lhNdMQJtVoEdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1entr4%253D&md5=7d579523462aaf7eac1890643f91fab3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fanie.201201358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201201358%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DBurke%26aufirst%3DJ.%2BP.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520Small%2520Molecules%2520That%2520Bind%2520to%2520K-Ras%2520and%2520Inhibit%2520Sos-Mediated%2520Activation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26issue%3D25%26spage%3D6140%26epage%3D6143%26doi%3D10.1002%2Fanie.201201358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karaguni, I.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpintero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourzoulidou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brockmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oschkinat, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, O.</span></span> <span> </span><span class="NLM_article-title">Sulindac-Derived Ras Pathway Inhibitors Target the Ras–Raf Interaction and Downstream Effectors in the Ras Pathway</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1002/anie.200353089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1002%2Fanie.200353089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=454-458&issue=4&author=H.+Waldmannauthor=I.-M.+Karaguniauthor=M.+Carpinteroauthor=E.+Gourzoulidouauthor=C.+Herrmannauthor=C.+Brockmannauthor=H.+Oschkinatauthor=O.+M%C3%BCller&title=Sulindac-Derived+Ras+Pathway+Inhibitors+Target+the+Ras%E2%80%93Raf+Interaction+and+Downstream+Effectors+in+the+Ras+Pathway&doi=10.1002%2Fanie.200353089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fanie.200353089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200353089%26sid%3Dliteratum%253Aachs%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DKaraguni%26aufirst%3DI.-M.%26aulast%3DCarpintero%26aufirst%3DM.%26aulast%3DGourzoulidou%26aufirst%3DE.%26aulast%3DHerrmann%26aufirst%3DC.%26aulast%3DBrockmann%26aufirst%3DC.%26aulast%3DOschkinat%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DO.%26atitle%3DSulindac-Derived%2520Ras%2520Pathway%2520Inhibitors%2520Target%2520the%2520Ras%25E2%2580%2593Raf%2520Interaction%2520and%2520Downstream%2520Effectors%2520in%2520the%2520Ras%2520Pathway%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26issue%3D4%26spage%3D454%26epage%3D458%26doi%3D10.1002%2Fanie.200353089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosnizeck, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spoerner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tränkle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filchtinski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gremer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittinghofer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalbitzer, H. R.</span></span> <span> </span><span class="NLM_article-title">Stabilizing a Weak Binding State for Effectors in the Human Ras Protein by Cyclen Complexes</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">3830</span>– <span class="NLM_lpage">3833</span>, <span class="refDoi"> DOI: 10.1002/anie.200907002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1002%2Fanie.200907002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=3830-3833&issue=22&author=I.+C.+Rosnizeckauthor=T.+Grafauthor=M.+Spoernerauthor=J.+Tr%C3%A4nkleauthor=D.+Filchtinskiauthor=C.+Herrmannauthor=L.+Gremerauthor=I.+R.+Vetterauthor=A.+Wittinghoferauthor=B.+K%C3%B6nigauthor=H.+R.+Kalbitzer&title=Stabilizing+a+Weak+Binding+State+for+Effectors+in+the+Human+Ras+Protein+by+Cyclen+Complexes&doi=10.1002%2Fanie.200907002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fanie.200907002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200907002%26sid%3Dliteratum%253Aachs%26aulast%3DRosnizeck%26aufirst%3DI.%2BC.%26aulast%3DGraf%26aufirst%3DT.%26aulast%3DSpoerner%26aufirst%3DM.%26aulast%3DTr%25C3%25A4nkle%26aufirst%3DJ.%26aulast%3DFilchtinski%26aufirst%3DD.%26aulast%3DHerrmann%26aufirst%3DC.%26aulast%3DGremer%26aufirst%3DL.%26aulast%3DVetter%26aufirst%3DI.%2BR.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DK%25C3%25B6nig%26aufirst%3DB.%26aulast%3DKalbitzer%26aufirst%3DH.%2BR.%26atitle%3DStabilizing%2520a%2520Weak%2520Binding%2520State%2520for%2520Effectors%2520in%2520the%2520Human%2520Ras%2520Protein%2520by%2520Cyclen%2520Complexes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26issue%3D22%26spage%3D3830%26epage%3D3833%26doi%3D10.1002%2Fanie.200907002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, J.</span></span> <span> </span><span class="NLM_article-title">Ras Inhibition via Direct Ras Binding—is There a Path Forward?</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5766</span>– <span class="NLM_lpage">5776</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2Fj.bmcl.2012.07.082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5766-5776&issue=18&author=W.+Wangauthor=G.+Fangauthor=J.+Rudolph&title=Ras+Inhibition+via+Direct+Ras+Binding%E2%80%94is+There+a+Path+Forward%3F&doi=10.1016%2Fj.bmcl.2012.07.082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.082%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DRudolph%26aufirst%3DJ.%26atitle%3DRas%2520Inhibition%2520via%2520Direct%2520Ras%2520Binding%25E2%2580%2594is%2520There%2520a%2520Path%2520Forward%253F%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D18%26spage%3D5766%26epage%3D5776%26doi%3D10.1016%2Fj.bmcl.2012.07.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hocker, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rambahal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagineedu, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanslas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorfe, A. A.</span></span> <span> </span><span class="NLM_article-title">Andrographolide Derivatives Inhibit Guanine Nucleotide Exchange and Abrogate Oncogenic Ras Function</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">10201</span>– <span class="NLM_lpage">10206</span>, <span class="refDoi"> DOI: 10.1073/pnas.1300016110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1073%2Fpnas.1300016110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=23737504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOmsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10201-10206&issue=25&author=H.+J.+Hockerauthor=K.-J.+Choauthor=C.-Y.+K.+Chenauthor=N.+Rambahalauthor=S.+R.+Sagineeduauthor=K.+Shaariauthor=J.+Stanslasauthor=J.+F.+Hancockauthor=A.+A.+Gorfe&title=Andrographolide+Derivatives+Inhibit+Guanine+Nucleotide+Exchange+and+Abrogate+Oncogenic+Ras+Function&doi=10.1073%2Fpnas.1300016110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function</span></div><div class="casAuthors">Hocker, Harrison J.; Cho, Kwang-Jin; Chen, Chung-Ying K.; Rambahal, Nandini; Sagineedu, Sreenivasa Rao; Shaari, Khozirah; Stanslas, Johnson; Hancock, John F.; Gorfe, Alemayehu A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">10201-10206, S10201/1-S10201/12</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aberrant signaling by oncogenic mutant rat sarcoma (Ras) proteins occurs in ∼15% of all human tumors, yet direct inhibition of Ras by small mols. has remained elusive.  Recently, several small-mol. ligands have been discovered that directly bind Ras and inhibit its function by interfering with exchange factor binding.  However, it is unclear whether, or how, these ligands could lead to drugs that act against constitutively active oncogenic mutant Ras.  Using a dynamics-based pocket identification scheme, ensemble docking, and innovative cell-based assays, here we show that andrographolide (AGP) - a bicyclic diterpenoid lactone isolated from Andrographis paniculata - and its benzylidene derivs. bind to transient pockets on Kirsten-Ras (K-Ras) and inhibit GDP-GTP exchange.  As expected for inhibitors of exchange factor binding, AGP derivs. reduced GTP loading of wild-type K-Ras in response to acute EGF stimulation with a concomitant redn. in MAPK activation.  Remarkably, however, prolonged treatment with AGP derivs. also reduced GTP loading of, and signal transmission by, oncogenic mutant K-RasG12V.  In sum, the combined anal. of our computational and cell biol. results show that AGP derivs. directly bind Ras, block GDP-GTP exchange, and inhibit both wild-type and oncogenic K-Ras signaling.  Importantly, our findings not only show that nucleotide exchange factors are required for oncogenic Ras signaling but also demonstrate that inhibiting nucleotide exchange is a valid approach to abrogating the function of oncogenic mutant Ras.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCdMqypiyfGrVg90H21EOLACvtfcHk0lg59EviKLtUDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOmsLzP&md5=7d39d426f5b107b87ad76cb8eb9a7f26</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1300016110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1300016110%26sid%3Dliteratum%253Aachs%26aulast%3DHocker%26aufirst%3DH.%2BJ.%26aulast%3DCho%26aufirst%3DK.-J.%26aulast%3DChen%26aufirst%3DC.-Y.%2BK.%26aulast%3DRambahal%26aufirst%3DN.%26aulast%3DSagineedu%26aufirst%3DS.%2BR.%26aulast%3DShaari%26aufirst%3DK.%26aulast%3DStanslas%26aufirst%3DJ.%26aulast%3DHancock%26aufirst%3DJ.%2BF.%26aulast%3DGorfe%26aufirst%3DA.%2BA.%26atitle%3DAndrographolide%2520Derivatives%2520Inhibit%2520Guanine%2520Nucleotide%2520Exchange%2520and%2520Abrogate%2520Oncogenic%2520Ras%2520Function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D25%26spage%3D10201%26epage%3D10206%26doi%3D10.1073%2Fpnas.1300016110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostrem, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sos, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">K-Ras(G12C) Inhibitors Allosterically Control GTP Affinity and Effector Interactions</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>503</i></span> (<span class="NLM_issue">7477</span>),  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1038/nature12796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnature12796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=24256730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=548-551&issue=7477&author=J.+M.+Ostremauthor=U.+Petersauthor=M.+L.+Sosauthor=J.+A.+Wellsauthor=K.+M.+Shokat&title=K-Ras%28G12C%29+Inhibitors+Allosterically+Control+GTP+Affinity+and+Effector+Interactions&doi=10.1038%2Fnature12796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions</span></div><div class="casAuthors">Ostrem, Jonathan M.; Peters, Ulf; Sos, Martin L.; Wells, James A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">7477</span>),
    <span class="NLM_cas:pages">548-551</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Somatic mutations in the small GTPase K-Ras are the most common activating lesions found in human cancer, and are generally assocd. with poor response to std. therapies.  Efforts to target this oncogene directly have faced difficulties owing to its picomolar affinity for GTP/GDP and the absence of known allosteric regulatory sites.  Oncogenic mutations result in functional activation of Ras family proteins by impairing GTP hydrolysis.  With diminished regulation by GTPase activity, the nucleotide state of Ras becomes more dependent on relative nucleotide affinity and concn.  This gives GTP an advantage over GDP and increases the proportion of active GTP-bound Ras.  Here we report the development of small mols. that irreversibly bind to a common oncogenic mutant, K-Ras(G12C).  These compds. rely on the mutant cysteine for binding and therefore do not affect the wild-type protein.  Crystallog. studies reveal the formation of a new pocket that is not apparent in previous structures of Ras, beneath the effector binding switch-II region.  Binding of these inhibitors to K-Ras(G12C) disrupts both switch-I and switch-II, subverting the native nucleotide preference to favor GDP over GTP and impairing binding to Raf.  Our data provide structure-based validation of a new allosteric regulatory site on Ras that is targetable in a mutant-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokkgcVXuBn_rVg90H21EOLACvtfcHk0lg59EviKLtUDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO&md5=27c1e7d8ef6b7e4b2919e9f00a073923</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature12796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12796%26sid%3Dliteratum%253Aachs%26aulast%3DOstrem%26aufirst%3DJ.%2BM.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DK-Ras%2528G12C%2529%2520Inhibitors%2520Allosterically%2520Control%2520GTP%2520Affinity%2520and%2520Effector%2520Interactions%26jtitle%3DNature%26date%3D2013%26volume%3D503%26issue%3D7477%26spage%3D548%26epage%3D551%26doi%3D10.1038%2Fnature12796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shima, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijiri, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, K. -i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyakawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunishi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumasaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, T.</span></span> <span> </span><span class="NLM_article-title">In Silico Discovery of Small-Molecule Ras Inhibitors That Display Antitumor Activity by Blocking the Ras-Effector Interaction</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8182</span>– <span class="NLM_lpage">8187</span>, <span class="refDoi"> DOI: 10.1073/pnas.1217730110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1073%2Fpnas.1217730110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=23630290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2ksL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=8182-8187&issue=20&author=F.+Shimaauthor=Y.+Yoshikawaauthor=M.+Yeauthor=M.+Arakiauthor=S.+Matsumotoauthor=J.+Liaoauthor=L.+Huauthor=T.+Sugimotoauthor=Y.+Ijiriauthor=A.+Takedaauthor=Y.+Nishiyamaauthor=C.+Satoauthor=S.+Muraokaauthor=A.+Tamuraauthor=T.+Osodaauthor=K.+-i.+Tsudaauthor=T.+Miyakawaauthor=H.+Fukunishiauthor=J.+Shimadaauthor=T.+Kumasakaauthor=M.+Yamamotoauthor=T.+Kataoka&title=In+Silico+Discovery+of+Small-Molecule+Ras+Inhibitors+That+Display+Antitumor+Activity+by+Blocking+the+Ras-Effector+Interaction&doi=10.1073%2Fpnas.1217730110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction</span></div><div class="casAuthors">Shima, Fumi; Yoshikawa, Yoko; Ye, Min; Araki, Mitsugu; Matsumoto, Shigeyuki; Liao, Jingling; Hu, Lizhi; Sugimoto, Takeshi; Ijiri, Yuichi; Takeda, Azusa; Nishiyama, Yuko; Sato, Chie; Muraoka, Shin; Tamura, Atsuo; Osoda, Tsutomu; Tsuda, Ken-ichiro; Miyakawa, Tomoya; Fukunishi, Hiroaki; Shimada, Jiro; Kumasaka, Takashi; Yamamoto, Masaki; Kataoka, Tohru</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8182-8187, S8182/1-S8182/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutational activation of the Ras oncogene products (H-Ras, K-Ras, and N-Ras) is frequently obsd. in human cancers, making them promising anticancer drug targets.  Nonetheless, no effective strategy has been available for the development of Ras inhibitors, partly owing to the absence of well-defined surface pockets suitable for drug binding.  Only recently, such pockets have been found in the crystal structures of a unique conformation of Ras·GTP.  Here we report the successful development of small-mol. Ras inhibitors by an in silico screen targeting a pocket found in the crystal structure of M-Ras·GTP carrying an H-Ras-type substitution P40D.  The selected compd. Kobe0065 and its analog Kobe2602 exhibit inhibitory activity toward H-Ras·GTP-c-Raf-1 binding both in vivo and in vitro.  They effectively inhibit both anchorage-dependent and -independent growth and induce apoptosis of H-rasG12V-transformed NIH 3T3 cells, which is accompanied by down-regulation of downstream mols. such as MEK/ERK, Akt, and RalA as well as an upstream mol., Son of sevenless.  Moreover, they exhibit antitumor activity on a xenograft of human colon carcinoma SW480 cells carrying the K-rasG12V gene by oral administration.  The NMR structure of a complex of the compd. with H-Ras·GTPT355, exclusively adopting the unique conformation, confirms its insertion into one of the surface pockets and provides a mol. basis for binding inhibition toward multiple RasGTP-interacting mols.  This study proves the effectiveness of our strategy for structure-based drug design to target Ras·GTP, and the resulting Kobe0065-family compds. may serve as a scaffold for the development of Ras inhibitors with higher potency and specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWk-yi5md5AbVg90H21EOLACvtfcHk0lg7PszAXwBxPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2ksL3K&md5=aa6569874162595cf17825f2528b4cd3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1217730110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1217730110%26sid%3Dliteratum%253Aachs%26aulast%3DShima%26aufirst%3DF.%26aulast%3DYoshikawa%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DAraki%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DSugimoto%26aufirst%3DT.%26aulast%3DIjiri%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DNishiyama%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DC.%26aulast%3DMuraoka%26aufirst%3DS.%26aulast%3DTamura%26aufirst%3DA.%26aulast%3DOsoda%26aufirst%3DT.%26aulast%3DTsuda%26aufirst%3DK.%2B-i.%26aulast%3DMiyakawa%26aufirst%3DT.%26aulast%3DFukunishi%26aufirst%3DH.%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DKumasaka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKataoka%26aufirst%3DT.%26atitle%3DIn%2520Silico%2520Discovery%2520of%2520Small-Molecule%2520Ras%2520Inhibitors%2520That%2520Display%2520Antitumor%2520Activity%2520by%2520Blocking%2520the%2520Ras-Effector%2520Interaction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D20%26spage%3D8182%26epage%3D8187%26doi%3D10.1073%2Fpnas.1217730110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cromm, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Modulation of Ras Signaling</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnchembio.1560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=24929527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslGisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=613-622&issue=8&author=J.+Spiegelauthor=P.+M.+Crommauthor=G.+Zimmermannauthor=T.+N.+Grossmannauthor=H.+Waldmann&title=Small-Molecule+Modulation+of+Ras+Signaling&doi=10.1038%2Fnchembio.1560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule modulation of Ras signaling</span></div><div class="casAuthors">Spiegel, Jochen; Cromm, Philipp M.; Zimmermann, Gunther; Grossmann, Tom N.; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">613-622</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite intense efforts in pharmaceutical industry and academia, a therapeutic grip on oncogenic Ras proteins has remained elusive.  Mutated Ras is assocd. with ∼20-30% of all human cancers often not responsive to established therapies.  In particular, K-Ras, the most frequently mutated Ras isoform, is considered one of the most important but 'undruggable' targets in cancer research.  Recently, new cavities on Ras for small-mol. ligands were identified, and selective direct targeting of mutated K-RasG12C has become possible for what is to our knowledge the first time.  In addn., impairment of Ras spatial organization, in particular via targeting the prenyl-binding Ras chaperone PDEδ, has opened a fresh perspective in anticancer research.  These recent advances fuel hopes for the development of new drugs targeting Ras.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTcp4dzeVKK7Vg90H21EOLACvtfcHk0ljQHuCKxiiOwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslGisbw%253D&md5=f8d84f054e1b392cf6bfe55d5e235c28</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1560%26sid%3Dliteratum%253Aachs%26aulast%3DSpiegel%26aufirst%3DJ.%26aulast%3DCromm%26aufirst%3DP.%2BM.%26aulast%3DZimmermann%26aufirst%3DG.%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DSmall-Molecule%2520Modulation%2520of%2520Ras%2520Signaling%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D8%26spage%3D613%26epage%3D622%26doi%3D10.1038%2Fnchembio.1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leshchiner, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkhitko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luccarelli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellairs, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escudero, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opoku-Nsiah, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrimon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walensky, L. D.</span></span> <span> </span><span class="NLM_article-title">Direct Inhibition of Oncogenic KRAS by Hydrocarbon-Stapled SOS1 Helices</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1761</span>– <span class="NLM_lpage">1766</span>, <span class="refDoi"> DOI: 10.1073/pnas.1413185112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1073%2Fpnas.1413185112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=25624485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVehsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=1761-1766&issue=6&author=E.+S.+Leshchinerauthor=A.+Parkhitkoauthor=G.+H.+Birdauthor=J.+Luccarelliauthor=J.+A.+Bellairsauthor=S.+Escuderoauthor=K.+Opoku-Nsiahauthor=M.+Godesauthor=N.+Perrimonauthor=L.+D.+Walensky&title=Direct+Inhibition+of+Oncogenic+KRAS+by+Hydrocarbon-Stapled+SOS1+Helices&doi=10.1073%2Fpnas.1413185112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices</span></div><div class="casAuthors">Leshchiner, Elizaveta S.; Parkhitko, Andrey; Bird, Gregory H.; Luccarelli, James; Bellairs, Joseph A.; Escudero, Silvia; Opoku-Nsiah, Kwadwo; Godes, Marina; Perrimon, Norbert; Walensky, Loren D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1761-1766</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Activating mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS) underlie the pathogenesis and chemoresistance of ∼30% of all human tumors, yet the development of high-affinity inhibitors that target the broad range of KRAS mutants remains a formidable challenge.  Here, we report the development and validation of stabilized alpha helixes of son of sevenless 1 (SAH-SOS1) as prototype therapeutics that directly inhibit wild-type and mutant forms of KRAS.  SAH-SOS1 peptides bound in a sequence-specific manner to KRAS and its mutants, and dose-responsively blocked nucleotide assocn.  Importantly, this functional binding activity correlated with SAH-SOS1 cytotoxicity in cancer cells expressing wild-type or mutant forms of KRAS.  The mechanism of action of SAH-SOS1 peptides was demonstrated by sequence-specific down-regulation of the ERK-MAP kinase phosphosignaling cascade in KRAS-driven cancer cells and in a Drosophila melanogaster model of Ras85DV12 activation.  These studies provide evidence for the potential utility of SAH-SOS1 peptides in neutralizing oncogenic KRAS in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6mCxAisFrUrVg90H21EOLACvtfcHk0ljQHuCKxiiOwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVehsL4%253D&md5=76d80d9084cd9646485986cb9277a9c0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1413185112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1413185112%26sid%3Dliteratum%253Aachs%26aulast%3DLeshchiner%26aufirst%3DE.%2BS.%26aulast%3DParkhitko%26aufirst%3DA.%26aulast%3DBird%26aufirst%3DG.%2BH.%26aulast%3DLuccarelli%26aufirst%3DJ.%26aulast%3DBellairs%26aufirst%3DJ.%2BA.%26aulast%3DEscudero%26aufirst%3DS.%26aulast%3DOpoku-Nsiah%26aufirst%3DK.%26aulast%3DGodes%26aufirst%3DM.%26aulast%3DPerrimon%26aufirst%3DN.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26atitle%3DDirect%2520Inhibition%2520of%2520Oncogenic%2520KRAS%2520by%2520Hydrocarbon-Stapled%2520SOS1%2520Helices%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26issue%3D6%26spage%3D1761%26epage%3D1766%26doi%3D10.1073%2Fpnas.1413185112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostrem, J. M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Direct Small-Molecule Inhibitors of KRAS: From Structural Insights to Mechanism-Based Design</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnrd.2016.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=27469033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=771-785&issue=11&author=J.+M.+L.+Ostremauthor=K.+M.+Shokat&title=Direct+Small-Molecule+Inhibitors+of+KRAS%3A+From+Structural+Insights+to+Mechanism-Based+Design&doi=10.1038%2Fnrd.2016.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design</span></div><div class="casAuthors">Ostrem, Jonathan M. L.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">771-785</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">KRAS is the most frequently mutated oncogene in human cancer.  In addn. to holding this distinction, unsuccessful attempts to target this protein have led to the characterization of RAS as 'undruggable'.  However, recent advances in technol. and novel approaches to drug discovery have renewed hope that a direct KRAS inhibitor may be on the horizon.  In this Review, we provide an in-depth anal. of the structure, dynamics, mutational activation and inactivation, and signalling mechanisms of RAS.  From this perspective, we then consider potential mechanisms of action for effective RAS inhibitors.  Finally, we examine each of the many recent reports of direct RAS inhibitors and discuss promising avenues for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBobrhZLF3V7Vg90H21EOLACvtfcHk0ljQHuCKxiiOwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FK&md5=b0832c7ef45cc0555e11c59baccc5abd</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.139%26sid%3Dliteratum%253Aachs%26aulast%3DOstrem%26aufirst%3DJ.%2BM.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DDirect%2520Small-Molecule%2520Inhibitors%2520of%2520KRAS%253A%2520From%2520Structural%2520Insights%2520to%2520Mechanism-Based%2520Design%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26issue%3D11%26spage%3D771%26epage%3D785%26doi%3D10.1038%2Fnrd.2016.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, F.</span></span> <span> </span><span class="NLM_article-title">The GTPase Superfamily: A Conserved Switch for Diverse Cell Functions</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>348</i></span> (<span class="NLM_issue">6297</span>),  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1038/348125a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2F348125a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=2122258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADyaK3MXhvFyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=1990&pages=125-132&issue=6297&author=H.+R.+Bourneauthor=D.+A.+Sandersauthor=F.+McCormick&title=The+GTPase+Superfamily%3A+A+Conserved+Switch+for+Diverse+Cell+Functions&doi=10.1038%2F348125a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The GTPase superfamily:  a conserved switch for diverse cell functions</span></div><div class="casAuthors">Bourne, Henry R.; Sanders, David A.; McCormick, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">6297</span>),
    <span class="NLM_cas:pages">125-32</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">A review with 129 refs., on GTPases as mol. switches whose on and off states are triggered by binding and hydrolysis of GTP.  Conserved structure and mechanism in myriad versions of the switch, in bacteria, yeast, insects, and vertebrates, suggest that all derive from a single primordial protein, repeatedly modified in the course of evolution to perform a wide variety of functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3f0MIHO0zb7Vg90H21EOLACvtfcHk0lhQbh2l2TRxog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhvFyjtQ%253D%253D&md5=c2365e283558479acbdf5487709ceac2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2F348125a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F348125a0%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DH.%2BR.%26aulast%3DSanders%26aufirst%3DD.%2BA.%26aulast%3DMcCormick%26aufirst%3DF.%26atitle%3DThe%2520GTPase%2520Superfamily%253A%2520A%2520Conserved%2520Switch%2520for%2520Diverse%2520Cell%2520Functions%26jtitle%3DNature%26date%3D1990%26volume%3D348%26issue%3D6297%26spage%3D125%26epage%3D132%26doi%3D10.1038%2F348125a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konstantinopoulos, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karamouzis, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papavassiliou, A. G.</span></span> <span> </span><span class="NLM_article-title">Post-Translational Modifications and Regulation of the RAS Superfamily of GTPases as Anticancer Targets</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.1038/nrd2221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnrd2221" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=541-555&issue=7&author=P.+A.+Konstantinopoulosauthor=M.+V.+Karamouzisauthor=A.+G.+Papavassiliou&title=Post-Translational+Modifications+and+Regulation+of+the+RAS+Superfamily+of+GTPases+as+Anticancer+Targets&doi=10.1038%2Fnrd2221"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrd2221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2221%26sid%3Dliteratum%253Aachs%26aulast%3DKonstantinopoulos%26aufirst%3DP.%2BA.%26aulast%3DKaramouzis%26aufirst%3DM.%2BV.%26aulast%3DPapavassiliou%26aufirst%3DA.%2BG.%26atitle%3DPost-Translational%2520Modifications%2520and%2520Regulation%2520of%2520the%2520RAS%2520Superfamily%2520of%2520GTPases%2520as%2520Anticancer%2520Targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26issue%3D7%26spage%3D541%26epage%3D555%26doi%3D10.1038%2Fnrd2221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeng, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span> <span> </span><span class="NLM_article-title">Sos-Mediated Cross-Activation of Wild-Type Ras by Oncogenic Ras Is Essential for Tumorigenesis</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1168</span>, <span class="refDoi"> DOI: 10.1038/ncomms2173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fncomms2173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=23132018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A280%3ADC%252BC3s7hsVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1168&author=H.-H.+Jengauthor=L.+J.+Taylorauthor=D.+Bar-Sagi&title=Sos-Mediated+Cross-Activation+of+Wild-Type+Ras+by+Oncogenic+Ras+Is+Essential+for+Tumorigenesis&doi=10.1038%2Fncomms2173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sos-mediated cross-activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis</span></div><div class="casAuthors">Jeng Hao-Hsuan; Taylor Laura J; Bar-Sagi Dafna</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1168</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Mammalian cells contain three closely related ras genes, H-ras, K-ras and N-ras.  Although in a given tumour type, oncogenic mutations are selectively observed in only one of the ras genes, the acquisition of the transformed phenotype has been shown to require the contribution of the normal products of the other ras genes.  Here we demonstrate that oncogenic K-Ras promotes the activation of wild-type H- and N-Ras.  This activation is mediated by oncogenic K-Ras-dependent allosteric stimulation of Sos and confers a growth advantage to oncogenic K-Ras harbouring cancer cells.  These findings underscore the complementary functions of oncogenic and wild-type Ras in tumour cells and identify a potential new targeting strategy for Ras-driven tumours.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxasvmDUX5qczK395ZObgVfW6udTcc2eYwV2wba5yuUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7hsVCjsA%253D%253D&md5=6a6d220101045790cf83c770f11e78fe</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fncomms2173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms2173%26sid%3Dliteratum%253Aachs%26aulast%3DJeng%26aufirst%3DH.-H.%26aulast%3DTaylor%26aufirst%3DL.%2BJ.%26aulast%3DBar-Sagi%26aufirst%3DD.%26atitle%3DSos-Mediated%2520Cross-Activation%2520of%2520Wild-Type%2520Ras%2520by%2520Oncogenic%2520Ras%2520Is%2520Essential%2520for%2520Tumorigenesis%26jtitle%3DNat.%2520Commun.%26date%3D2012%26volume%3D3%26spage%3D1168%26doi%3D10.1038%2Fncomms2173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J. J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassington, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breeze, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chresta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embrey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairley, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadola, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, G.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Binding Sites on the Ras:SOS Complex Can Be Exploited for Inhibition of Ras Activation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2265</span>– <span class="NLM_lpage">2274</span>, <span class="refDoi"> DOI: 10.1021/jm501660t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501660t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2265-2274&issue=5&author=J.+J.+G.+Winterauthor=M.+Andersonauthor=K.+Bladesauthor=C.+Brassingtonauthor=A.+L.+Breezeauthor=C.+Chrestaauthor=K.+Embreyauthor=G.+Fairleyauthor=P.+Faulderauthor=M.+R.+V.+Finlayauthor=J.+G.+Kettleauthor=T.+Nowakauthor=R.+Overmanauthor=S.+J.+Patelauthor=P.+Perkinsauthor=L.+Spadolaauthor=J.+Tartauthor=J.+A.+Tuckerauthor=G.+Wrigley&title=Small+Molecule+Binding+Sites+on+the+Ras%3ASOS+Complex+Can+Be+Exploited+for+Inhibition+of+Ras+Activation&doi=10.1021%2Fjm501660t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm501660t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501660t%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DJ.%2BJ.%2BG.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DBrassington%26aufirst%3DC.%26aulast%3DBreeze%26aufirst%3DA.%2BL.%26aulast%3DChresta%26aufirst%3DC.%26aulast%3DEmbrey%26aufirst%3DK.%26aulast%3DFairley%26aufirst%3DG.%26aulast%3DFaulder%26aufirst%3DP.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DNowak%26aufirst%3DT.%26aulast%3DOverman%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%2BJ.%26aulast%3DPerkins%26aufirst%3DP.%26aulast%3DSpadola%26aufirst%3DL.%26aulast%3DTart%26aufirst%3DJ.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWrigley%26aufirst%3DG.%26atitle%3DSmall%2520Molecule%2520Binding%2520Sites%2520on%2520the%2520Ras%253ASOS%2520Complex%2520Can%2520Be%2520Exploited%2520for%2520Inhibition%2520of%2520Ras%2520Activation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D5%26spage%3D2265%26epage%3D2274%26doi%3D10.1021%2Fjm501660t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Approach for Targeting Ras with Small Molecules That Activate SOS-Mediated Nucleotide Exchange</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">3401</span>– <span class="NLM_lpage">3406</span>, <span class="refDoi"> DOI: 10.1073/pnas.1315798111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1073%2Fpnas.1315798111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=24550516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtl2mtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=3401-3406&author=M.+C.+Burnsauthor=Q.+Sunauthor=R.+N.+Danielsauthor=D.+Camperauthor=J.+P.+Kennedyauthor=J.+Phanauthor=E.+T.+Olejniczakauthor=T.+Leeauthor=A.+G.+Watersonauthor=O.+W.+Rossaneseauthor=S.+W.+Fesik&title=Approach+for+Targeting+Ras+with+Small+Molecules+That+Activate+SOS-Mediated+Nucleotide+Exchange&doi=10.1073%2Fpnas.1315798111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange</span></div><div class="casAuthors">Burns, Michael C.; Sun, Qi; Daniels, R. Nathan; Camper, DeMarco; Kennedy, J. Phillip; Phan, Jason; Olejniczak, Edward T.; Lee, Taekyu; Waterson, Alex G.; Rossanese, Olivia W.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3401-3406</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aberrant activation of the small GTPase Ras by oncogenic mutation or constitutively active upstream receptor tyrosine kinases results in the deregulation of cellular signals governing growth and survival in ∼30% of all human cancers.  However, the discovery of potent inhibitors of Ras has been difficult to achieve.  Here, we report the identification of small mols. that bind to a unique pocket on the Ras:Son of Sevenless (SOS):Ras complex, increase the rate of SOS-catalyzed nucleotide exchange in vitro, and modulate Ras signaling pathways in cells.  X-ray crystallog. of Ras:SOS:Ras in complex with these mols. reveals that the compds. bind in a hydrophobic pocket in the CDC25 domain of SOS adjacent to the Switch II region of Ras.  The structure-activity relationships exhibited by these compds. can be rationalized on the basis of multiple x-ray cocrystal structures.  Mutational analyses confirmed the functional relevance of this binding site and showed it to be essential for compd. activity.  These mols. increase Ras-GTP levels and disrupt MAPK and PI3K signaling in cells at low micromolar concns.  These small mols. represent tools to study the acute activation of Ras and highlight a pocket on SOS that may be exploited to modulate Ras signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl9pTZ-cO_8rVg90H21EOLACvtfcHk0lgmUlvKEcnwTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtl2mtrc%253D&md5=aefb332e4acb9de6731f206383bcca6f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1315798111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1315798111%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DCamper%26aufirst%3DD.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DApproach%2520for%2520Targeting%2520Ras%2520with%2520Small%2520Molecules%2520That%2520Activate%2520SOS-Mediated%2520Nucleotide%2520Exchange%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D3401%26epage%3D3406%26doi%3D10.1073%2Fpnas.1315798111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodges, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobolik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beesetty, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of Aminopiperidine Indoles That Activate the Guanine Nucleotide Exchange Factor SOS1 and Modulate RAS Signaling</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">6002</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00360</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00360" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6002-6017&issue=14&author=J.+R.+Abbottauthor=T.+R.+Hodgesauthor=R.+N.+Danielsauthor=P.+A.+Patelauthor=J.+P.+Kennedyauthor=J.+E.+Howesauthor=D.+T.+Akanauthor=M.+C.+Burnsauthor=J.+Saiauthor=T.+Sobolikauthor=Y.+Beesettyauthor=T.+Leeauthor=O.+W.+Rossaneseauthor=J.+Phanauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Discovery+of+Aminopiperidine+Indoles+That+Activate+the+Guanine+Nucleotide+Exchange+Factor+SOS1+and+Modulate+RAS+Signaling&doi=10.1021%2Facs.jmedchem.8b00360"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00360%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DJ.%2BR.%26aulast%3DHodges%26aufirst%3DT.%2BR.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DPatel%26aufirst%3DP.%2BA.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DSai%26aufirst%3DJ.%26aulast%3DSobolik%26aufirst%3DT.%26aulast%3DBeesetty%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520Aminopiperidine%2520Indoles%2520That%2520Activate%2520the%2520Guanine%2520Nucleotide%2520Exchange%2520Factor%2520SOS1%2520and%2520Modulate%2520RAS%2520Signaling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D14%26spage%3D6002%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.8b00360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browning, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of Quinazolines That Activate SOS1-Mediated Nucleotide Exchange on RAS</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">941</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00296</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00296" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOjsLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=941&author=J.+R.+Abbottauthor=P.+A.+Patelauthor=J.+E.+Howesauthor=D.+T.+Akanauthor=J.+P.+Kennedyauthor=M.+C.+Burnsauthor=C.+F.+Browningauthor=Q.+Sunauthor=O.+W.+Rossaneseauthor=J.+Phanauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Discovery+of+Quinazolines+That+Activate+SOS1-Mediated+Nucleotide+Exchange+on+RAS&doi=10.1021%2Facsmedchemlett.8b00296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Quinazolines That Activate SOS1-Mediated Nucleotide Exchange on RAS</span></div><div class="casAuthors">Abbott, Jason R.; Patel, Pratiq A.; Howes, Jennifer E.; Akan, Denis T.; Kennedy, J. Phillip; Burns, Michael C.; Browning, Carrie F.; Sun, Qi; Rossanese, Olivia W.; Phan, Jason; Waterson, Alex G.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">941-946</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proteins in the RAS family are important regulators of cellular signaling and, when mutated, can drive cancer pathogenesis.  Despite considerable effort over the last 30 years, RAS proteins have proven to be recalcitrant therapeutic targets.  One approach for modulating RAS signaling is to target proteins that interact with RAS, such as the guanine nucleotide exchange factor (GEF) son of sevenless homolog 1 (SOS1).  Here, we report hit-to-lead studies on quinazoline-contg. compds. that bind to SOS1 and activate nucleotide exchange on RAS.  Using structure-based design, we refined the substituents attached to the quinazoline nucleus and built in addnl. interactions not present in the initial HTS hit.  Optimized compds. activate nucleotide exchange at single-digit micromolar concns. in vitro.  In HeLa cells, these quinazolines increase the levels of RAS-GTP and cause signaling changes in the mitogen-activated protein kinase/extracellular regulated kinase (MAPK/ERK) pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQa6QZIgWHVrVg90H21EOLACvtfcHk0ljlQPpGa2eg-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOjsLzN&md5=54b395566e713f8debbc2de33cb92363</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00296%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DJ.%2BR.%26aulast%3DPatel%26aufirst%3DP.%2BA.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DBrowning%26aufirst%3DC.%2BF.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520Quinazolines%2520That%2520Activate%2520SOS1-Mediated%2520Nucleotide%2520Exchange%2520on%2520RAS%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D941%26doi%3D10.1021%2Facsmedchemlett.8b00296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Small Molecule–Mediated Activation of RAS Elicits Biphasic Modulation of Phospho-ERK Levels That Are Regulated through Negative Feedback on SOS1</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1060</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-17-0666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1158%2F1535-7163.MCT-17-0666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=29440291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosF2qsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=1051-1060&issue=5&author=J.+E.+Howesauthor=D.+T.+Akanauthor=M.+C.+Burnsauthor=O.+W.+Rossaneseauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Small+Molecule%E2%80%93Mediated+Activation+of+RAS+Elicits+Biphasic+Modulation+of+Phospho-ERK+Levels+That+Are+Regulated+through+Negative+Feedback+on+SOS1&doi=10.1158%2F1535-7163.MCT-17-0666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule-Mediated Activation of RAS Elicits Biphasic Modulation of Phospho-ERK Levels that Are Regulated through Negative Feedback on SOS1</span></div><div class="casAuthors">Howes, Jennifer E.; Akan, Denis T.; Burns, Michael C.; Rossanese, Olivia W.; Waterson, Alex G.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1051-1060</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Oncogenic mutation of RAS results in aberrant cellular signaling and is responsible for more than 30% of all human tumors.  Therefore, pharmacol. modulation of RAS has attracted great interest as a therapeutic strategy.  Our lab. has recently discovered small mols. that activate Son of Sevenless (SOS)-catalyzed nucleotide exchange on RAS and inhibit downstream signaling.  Here, we describe how pharmacol. targeting SOS1 induced biphasic modulation of RAS-GTP and ERK phosphorylation levels, which we obsd. in a variety of cell lines expressing different RAS-mutant isoforms.  We show that compd. treatment caused an increase in phosphorylation at ERK consensus motifs on SOS1 that was not obsd. with the expression of a non-phosphorylatable S1178A SOS1 mutant or after pretreatment with an ERK inhibitor.  Phosphorylation at S1178 on SOS1 is known to inhibit the assocn. between SOS1 and GRB2 and disrupt SOS1 membrane localization.  Consistent with this, we show that wild-type SOS1 and GRB2 dissocd. in a time-dependent fashion in response to compd. treatment, and conversely, this interaction was enhanced with the expression of an S1178A SOS1 mutant.  Furthermore, in cells expressing either S1178A SOS1 or a constitutively membrane-bound CAAX box tagged SOS1 mutant, we obsd. elevated RAS-GTP levels over time in response to compd., as compared with the biphasic changes in RAS-GTP exhibited in cells expressing wild-type SOS1.  These results suggest that small mol. targeting of SOS1 can elicit a biphasic modulation of RAS-GTP and phospho-ERK levels through neg. feedback on SOS1 that regulates the interaction between SOS1 and GRB2.  Mol Cancer Ther; 17(5); 1051-60. ©2018 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa-L8W-8tgq7Vg90H21EOLACvtfcHk0ljlQPpGa2eg-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosF2qsLc%253D&md5=e9a4fedac54fd873438cde20ce28f37d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-17-0666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-17-0666%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DSmall%2520Molecule%25E2%2580%2593Mediated%2520Activation%2520of%2520RAS%2520Elicits%2520Biphasic%2520Modulation%2520of%2520Phospho-ERK%2520Levels%2520That%2520Are%2520Regulated%2520through%2520Negative%2520Feedback%2520on%2520SOS1%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26issue%3D5%26spage%3D1051%26epage%3D1060%26doi%3D10.1158%2F1535-7163.MCT-17-0666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitanaka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochizuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagashima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himeno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchino, Y.</span></span> <span> </span><span class="NLM_article-title">Oncogenic Ras Triggers Cell Suicide through the Activation of a Caspase-Independent Cell Death Program in Human Cancer Cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2281</span>– <span class="NLM_lpage">2290</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1202538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fsj.onc.1202538" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=2281-2290&issue=13&author=S.+Chiauthor=C.+Kitanakaauthor=K.+Noguchiauthor=T.+Mochizukiauthor=Y.+Nagashimaauthor=M.+Shirouzuauthor=H.+Fujitaauthor=M.+Yoshidaauthor=W.+Chenauthor=A.+Asaiauthor=M.+Himenoauthor=S.+Yokoyamaauthor=Y.+Kuchino&title=Oncogenic+Ras+Triggers+Cell+Suicide+through+the+Activation+of+a+Caspase-Independent+Cell+Death+Program+in+Human+Cancer+Cells&doi=10.1038%2Fsj.onc.1202538"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1202538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1202538%26sid%3Dliteratum%253Aachs%26aulast%3DChi%26aufirst%3DS.%26aulast%3DKitanaka%26aufirst%3DC.%26aulast%3DNoguchi%26aufirst%3DK.%26aulast%3DMochizuki%26aufirst%3DT.%26aulast%3DNagashima%26aufirst%3DY.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DFujita%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DAsai%26aufirst%3DA.%26aulast%3DHimeno%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DKuchino%26aufirst%3DY.%26atitle%3DOncogenic%2520Ras%2520Triggers%2520Cell%2520Suicide%2520through%2520the%2520Activation%2520of%2520a%2520Caspase-Independent%2520Cell%2520Death%2520Program%2520in%2520Human%2520Cancer%2520Cells%26jtitle%3DOncogene%26date%3D1999%26volume%3D18%26issue%3D13%26spage%3D2281%26epage%3D2290%26doi%3D10.1038%2Fsj.onc.1202538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overmeyer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltese, W. A.</span></span> <span> </span><span class="NLM_article-title">Death Pathways Triggered by Activated Ras in Cancer Cells</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1693</span>– <span class="NLM_lpage">1713</span>, <span class="refDoi"> DOI: 10.2741/3814</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.2741%2F3814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=21196257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislCksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=1693-1713&author=J.+H.+Overmeyerauthor=W.+A.+Maltese&title=Death+Pathways+Triggered+by+Activated+Ras+in+Cancer+Cells&doi=10.2741%2F3814"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Death pathways triggered by activated Ras in cancer cells</span></div><div class="casAuthors">Overmeyer, Jean H.; Maltese, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Landmark Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1693-1713</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Ras GTPases are best known for their ability to serve as mol. switches regulating cell growth, differentiation and survival.  Gene mutations that result in expression of constitutively active forms of Ras have been linked to oncogenesis in animal models and humans.  However, over the past two decades, evidence has gradually accumulated to support a paradoxical role for Ras proteins in the initiation of cell death pathways.  In this review we survey the literature pointing to the ability of activated Ras to promote cell death under conditions where cancer cells encounter apoptotic stimuli or Ras is ectopically expressed.  In some of these cases Ras acts through known effectors and well defined apoptotic death pathways.  However, in other cases it appears that Ras operates by triggering novel non-apoptotic death mechanisms that are just beginning to be characterized.  Understanding these mechanisms and the factors that go into changing the nature of Ras signaling from pro-survival to pro-death could set the stage for development of novel therapeutic approaches aimed at manipulating pro-death Ras signaling pathways in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXifIvM6EFpbVg90H21EOLACvtfcHk0ljlQPpGa2eg-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislCksLo%253D&md5=621d16070dede0ac60ac1ed4767e3c25</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2741%2F3814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3814%26sid%3Dliteratum%253Aachs%26aulast%3DOvermeyer%26aufirst%3DJ.%2BH.%26aulast%3DMaltese%26aufirst%3DW.%2BA.%26atitle%3DDeath%2520Pathways%2520Triggered%2520by%2520Activated%2520Ras%2520in%2520Cancer%2520Cells%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2011%26volume%3D16%26spage%3D1693%26epage%3D1713%26doi%3D10.2741%2F3814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, B.</span></span> <span> </span><span class="NLM_article-title">Wentilactone A as a Novel Potential Antitumor Agent Induces Apoptosis and G2/M Arrest of Human Lung Carcinoma Cells and Is Mediated by HRas-GTP Accumulation to Excessively Activate the Ras/Raf/ERK/P53-P21 Pathway</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">e952</span>, <span class="refDoi"> DOI: 10.1038/cddis.2013.484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fcddis.2013.484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=24309939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCqt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e952&issue=12&author=C.+Lvauthor=Y.+Hongauthor=L.+Miaoauthor=C.+Liauthor=G.+Xuauthor=S.+Weiauthor=B.+Wangauthor=C.+Huangauthor=B.+Jiao&title=Wentilactone+A+as+a+Novel+Potential+Antitumor+Agent+Induces+Apoptosis+and+G2%2FM+Arrest+of+Human+Lung+Carcinoma+Cells+and+Is+Mediated+by+HRas-GTP+Accumulation+to+Excessively+Activate+the+Ras%2FRaf%2FERK%2FP53-P21+Pathway&doi=10.1038%2Fcddis.2013.484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Wentilactone A as a novel potential antitumor agent induces apoptosis and G2/M arrest of human lung carcinoma cells, and is mediated by HRas-GTP accumulation to excessively activate the Ras/Raf/ERK/p53-p21 pathway</span></div><div class="casAuthors">Lv, C.; Hong, Y.; Miao, L.; Li, C.; Xu, G.; Wei, S.; Wang, B.; Huang, C.; Jiao, B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Dec.</span>),
    <span class="NLM_cas:pages">e952</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemotherapy remains the common therapeutic for patients with lung cancer.  Novel, selective antitumor agents are pressingly needed.  This study is the first to investigate a different, however, effective antitumor drug candidate Wentilactone A (WA) for its development as a novel agent.  In NCI-H460 and NCI-H446 cell lines, WA triggered G2/M phase arrest and mitochondrial-related apoptosis, accompanying the accumulation of reactive oxygen species (ROS).  It also induced activation of mitogen-activated protein kinase and p53 and increased expression of p21.  When we pre-treated cells with ERK, JNK, p38, p53 inhibitor or NAC followed by WA treatment, only ERK and p53 inhibitors blocked WA-induced apoptosis and G2/M arrest.  We further obsd. Ras (HRas, KRas and NRas) and Raf activation, and found that WA treatment increased HRas-Raf activation.  Knockdown of HRas by using small interfering RNA (siRNA) abolished WA-induced apoptosis and G2/M arrest.  HRas siRNA also halted Raf, ERK, p53 activation and p21 accumulation.  Mol. docking anal. suggested that WA could bind to HRas-GTP, causing accumulation of Ras-GTP and excessive activation of Raf/ERK/p53-p21.  The direct binding affinity was confirmed by surface plasmon resonance (SPR).  In vivo, WA suppressed tumor growth without adverse toxicity and presented the same mechanism as that in vitro.  Taken together, these findings suggest WA as a promising novel, potent and selective antitumor drug candidate for lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLAvfEEmYMwLVg90H21EOLACvtfcHk0ljWP_kNZTERYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCqt7%252FL&md5=f93de635f1df60ed2b44eacd80ede458</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.484%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DC.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DJiao%26aufirst%3DB.%26atitle%3DWentilactone%2520A%2520as%2520a%2520Novel%2520Potential%2520Antitumor%2520Agent%2520Induces%2520Apoptosis%2520and%2520G2%252FM%2520Arrest%2520of%2520Human%2520Lung%2520Carcinoma%2520Cells%2520and%2520Is%2520Mediated%2520by%2520HRas-GTP%2520Accumulation%2520to%2520Excessively%2520Activate%2520the%2520Ras%252FRaf%252FERK%252FP53-P21%2520Pathway%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26issue%3D12%26spage%3De952%26doi%3D10.1038%2Fcddis.2013.484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. J.</span></span> <span> </span><span class="NLM_article-title">Oncogene-Induced Autophagy and the Goldilocks Principle</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">922</span>– <span class="NLM_lpage">923</span>, <span class="refDoi"> DOI: 10.4161/auto.7.8.15821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.4161%2Fauto.7.8.15821" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=922-923&issue=8&author=S.+J.+Martin&title=Oncogene-Induced+Autophagy+and+the+Goldilocks+Principle&doi=10.4161%2Fauto.7.8.15821"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.4161%2Fauto.7.8.15821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.7.8.15821%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DS.%2BJ.%26atitle%3DOncogene-Induced%2520Autophagy%2520and%2520the%2520Goldilocks%2520Principle%26jtitle%3DAutophagy%26date%3D2011%26volume%3D7%26issue%3D8%26spage%3D922%26epage%3D923%26doi%3D10.4161%2Fauto.7.8.15821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overmeyer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltese, W. A.</span></span> <span> </span><span class="NLM_article-title">Active Ras Triggers Death in Glioblastoma Cells through Hyperstimulation of Macropinocytosis</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">977</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-07-2036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1158%2F1541-7786.MCR-07-2036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=18567800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVKgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=965-977&issue=6&author=J.+H.+Overmeyerauthor=A.+Kaulauthor=E.+E.+Johnsonauthor=W.+A.+Maltese&title=Active+Ras+Triggers+Death+in+Glioblastoma+Cells+through+Hyperstimulation+of+Macropinocytosis&doi=10.1158%2F1541-7786.MCR-07-2036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Active Ras triggers death in glioblastoma cells through hyperstimulation of macropinocytosis</span></div><div class="casAuthors">Overmeyer, Jean H.; Kaul, Aparna; Johnson, Erin E.; Maltese, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">965-977</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Expression of activated Ras in glioblastoma cells induces accumulation of large phase-lucent cytoplasmic vacuoles, followed by cell death.  This was previously described as autophagic cell death.  However, unlike autophagosomes, the Ras-induced vacuoles are not bounded by a double membrane and do not sequester organelles or cytoplasm.  Moreover, they are not acidic and do not contain the autophagosomal membrane protein LC3-II.  Here we show that the vacuoles are enlarged macropinosomes.  They rapidly incorporate extracellular fluid-phase tracers but do not sequester transferrin or the endosomal protein EEA1.  Ultimately, the cells expressing activated Ras detach from the substratum and rupture, coincident with the displacement of cytoplasm with huge macropinosome-derived vacuoles.  These changes are accompanied by caspase activation, but the broad-spectrum caspase inhibitor carbobenzoxy-Val-Ala-Asp-fluoromethylketone does not prevent cell death.  Moreover, the majority of degenerating cells do not exhibit chromatin condensation typical of apoptosis.  These observations provide evidence for a necrosis-like form of cell death initiated by dysregulation of macropinocytosis, which we have dubbed "methuosis." An activated form of the Rac1 GTPase induces a similar form of cell death, suggesting that Ras acts through Rac-dependent signaling pathways to hyperstimulate macropinocytosis in glioblastoma.  Further study of these signaling pathways may lead to the identification of other chem. and physiol. triggers for this unusual form of cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4aZB2o658nbVg90H21EOLACvtfcHk0ljWP_kNZTERYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVKgsr8%253D&md5=21dda1b33870d9689003e95ede1c6480</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-07-2036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-07-2036%26sid%3Dliteratum%253Aachs%26aulast%3DOvermeyer%26aufirst%3DJ.%2BH.%26aulast%3DKaul%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DE.%2BE.%26aulast%3DMaltese%26aufirst%3DW.%2BA.%26atitle%3DActive%2520Ras%2520Triggers%2520Death%2520in%2520Glioblastoma%2520Cells%2520through%2520Hyperstimulation%2520of%2520Macropinocytosis%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2008%26volume%3D6%26issue%3D6%26spage%3D965%26epage%3D977%26doi%3D10.1158%2F1541-7786.MCR-07-2036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Unni, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockwood, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zejnullahu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee-Lin, S.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varmus, H.</span></span> <span> </span><span class="NLM_article-title">Evidence That Synthetic Lethality Underlies the Mutual Exclusivity of Oncogenic KRAS and EGFR Mutations in Lung Adenocarcinoma</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e06907</span>, <span class="refDoi"> DOI: 10.7554/eLife.06907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.7554%2FeLife.06907" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=e06907&author=A.+M.+Unniauthor=W.+W.+Lockwoodauthor=K.+Zejnullahuauthor=S.-Q.+Lee-Linauthor=H.+Varmus&title=Evidence+That+Synthetic+Lethality+Underlies+the+Mutual+Exclusivity+of+Oncogenic+KRAS+and+EGFR+Mutations+in+Lung+Adenocarcinoma&doi=10.7554%2FeLife.06907"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.7554%2FeLife.06907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.06907%26sid%3Dliteratum%253Aachs%26aulast%3DUnni%26aufirst%3DA.%2BM.%26aulast%3DLockwood%26aufirst%3DW.%2BW.%26aulast%3DZejnullahu%26aufirst%3DK.%26aulast%3DLee-Lin%26aufirst%3DS.-Q.%26aulast%3DVarmus%26aufirst%3DH.%26atitle%3DEvidence%2520That%2520Synthetic%2520Lethality%2520Underlies%2520the%2520Mutual%2520Exclusivity%2520of%2520Oncogenic%2520KRAS%2520and%2520EGFR%2520Mutations%2520in%2520Lung%2520Adenocarcinoma%26jtitle%3DeLife%26date%3D2015%26volume%3D4%26spage%3De06907%26doi%3D10.7554%2FeLife.06907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ambrogio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbacid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santamaría, D.</span></span> <span> </span><span class="NLM_article-title">In Vivo Oncogenic Conflict Triggered by Co-Existing KRAS and EGFR Activating Mutations in Lung Adenocarcinoma</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">2309</span>– <span class="NLM_lpage">2318</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fonc.2016.385" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=2309-2318&issue=16&author=C.+Ambrogioauthor=M.+Barbacidauthor=D.+Santamar%C3%ADa&title=In+Vivo+Oncogenic+Conflict+Triggered+by+Co-Existing+KRAS+and+EGFR+Activating+Mutations+in+Lung+Adenocarcinoma&doi=10.1038%2Fonc.2016.385"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.385%26sid%3Dliteratum%253Aachs%26aulast%3DAmbrogio%26aufirst%3DC.%26aulast%3DBarbacid%26aufirst%3DM.%26aulast%3DSantamar%25C3%25ADa%26aufirst%3DD.%26atitle%3DIn%2520Vivo%2520Oncogenic%2520Conflict%2520Triggered%2520by%2520Co-Existing%2520KRAS%2520and%2520EGFR%2520Activating%2520Mutations%2520in%2520Lung%2520Adenocarcinoma%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26issue%3D16%26spage%3D2309%26epage%3D2318%26doi%3D10.1038%2Fonc.2016.385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vegetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anichini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sensi, M.</span></span> <span> </span><span class="NLM_article-title">Coexpression of NRAS Q61R and BRAF V600E in Human Melanoma Cells Activates Senescence and Increases Susceptibility to Cell-Mediated Cytotoxicity</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">6503</span>– <span class="NLM_lpage">6511</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-4671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1158%2F0008-5472.CAN-05-4671" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=6503-6511&issue=13&author=C.+Pettiauthor=A.+Mollaauthor=C.+Vegettiauthor=S.+Ferroneauthor=A.+Anichiniauthor=M.+Sensi&title=Coexpression+of+NRAS+Q61R+and+BRAF+V600E+in+Human+Melanoma+Cells+Activates+Senescence+and+Increases+Susceptibility+to+Cell-Mediated+Cytotoxicity&doi=10.1158%2F0008-5472.CAN-05-4671"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-4671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-4671%26sid%3Dliteratum%253Aachs%26aulast%3DPetti%26aufirst%3DC.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DVegetti%26aufirst%3DC.%26aulast%3DFerrone%26aufirst%3DS.%26aulast%3DAnichini%26aufirst%3DA.%26aulast%3DSensi%26aufirst%3DM.%26atitle%3DCoexpression%2520of%2520NRAS%2520Q61R%2520and%2520BRAF%2520V600E%2520in%2520Human%2520Melanoma%2520Cells%2520Activates%2520Senescence%2520and%2520Increases%2520Susceptibility%2520to%2520Cell-Mediated%2520Cytotoxicity%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D13%26spage%3D6503%26epage%3D6511%26doi%3D10.1158%2F0008-5472.CAN-05-4671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">High-Throughput Screening Identifies Small Molecules That Bind to the RAS:SOS:RAS Complex and Perturb RAS Signaling</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>548</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2018.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2Fj.ab.2018.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=29444450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFaju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=548&publication_year=2018&pages=44-52&author=M.+C.+Burnsauthor=J.+E.+Howesauthor=Q.+Sunauthor=A.+J.+Littleauthor=D.+V.+Camperauthor=J.+R.+Abbottauthor=J.+Phanauthor=T.+Leeauthor=A.+G.+Watersonauthor=O.+W.+Rossaneseauthor=S.+W.+Fesik&title=High-Throughput+Screening+Identifies+Small+Molecules+That+Bind+to+the+RAS%3ASOS%3ARAS+Complex+and+Perturb+RAS+Signaling&doi=10.1016%2Fj.ab.2018.01.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling</span></div><div class="casAuthors">Burns, Michael C.; Howes, Jennifer E.; Sun, Qi; Little, Andrew J.; Camper, DeMarco V.; Abbott, Jason R.; Phan, Jason; Lee, Taekyu; Waterson, Alex G.; Rossanese, Olivia W.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">548</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44-52</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">K-RAS is mutated in approx. 30% of human cancers, resulting in increased RAS signaling and tumor growth.  Thus, RAS is a highly validated therapeutic target, esp. in tumors of the pancreas, lung and colon.  Although directly targeting RAS has proven to be challenging, it may be possible to target other proteins involved in RAS signaling, such as the guanine nucleotide exchange factor Son of Sevenless (SOS).  We have previously reported on the discovery of small mols. that bind to SOS1, activate SOS-mediated nucleotide exchange on RAS, and paradoxically inhibit ERK phosphorylation (Burns et al., PNAS, 2014).  Here, we describe the discovery of addnl., structurally diverse small mols. that also bind to SOS1 in the same pocket and elicit similar biol. effects.  We tested >160,000 compds. in a fluorescence-based assay to assess their effects on SOS-mediated nucleotide exchange.  X-Ray structures revealed that these small mols. bind to the CDC25 domain of SOS1.  Compds. that elicited high levels of nucleotide exchange activity in vitro increased RAS-GTP levels in cells, and inhibited phospho ERK levels at higher treatment concns.  The identification of structurally diverse SOS1 binding ligands may assist in the discovery of new mols. designed to target RAS-driven tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdp7gmEwzlMLVg90H21EOLACvtfcHk0ljwzdqzwin87g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFaju70%253D&md5=af853c79022b68839f53bfb11303b97a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2018.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2018.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DLittle%26aufirst%3DA.%2BJ.%26aulast%3DCamper%26aufirst%3DD.%2BV.%26aulast%3DAbbott%26aufirst%3DJ.%2BR.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DHigh-Throughput%2520Screening%2520Identifies%2520Small%2520Molecules%2520That%2520Bind%2520to%2520the%2520RAS%253ASOS%253ARAS%2520Complex%2520and%2520Perturb%2520RAS%2520Signaling%26jtitle%3DAnal.%2520Biochem.%26date%3D2018%26volume%3D548%26spage%3D44%26epage%3D52%26doi%3D10.1016%2Fj.ab.2018.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopple, K. D.</span></span> <span> </span><span class="NLM_article-title">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2615</span>– <span class="NLM_lpage">2623</span>, <span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&issue=12&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+Properties+That+Influence+the+Oral+Bioavailability+of+Drug+Candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0ljwzdqzwin87g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520Properties%2520That%2520Influence%2520the%2520Oral%2520Bioavailability%2520of%2520Drug%2520Candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26issue%3D12%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Souza-Fagundes, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldkamp, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorset, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chazin, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">A High-Throughput Fluorescence Polarization Anisotropy Assay for the 70N Domain of Replication Protein A</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>421</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">749</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2011.11.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2Fj.ab.2011.11.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2012&pages=742-749&issue=2&author=E.+M.+Souza-Fagundesauthor=A.+O.+Frankauthor=M.+D.+Feldkampauthor=D.+C.+Dorsetauthor=W.+J.+Chazinauthor=O.+W.+Rossaneseauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=A+High-Throughput+Fluorescence+Polarization+Anisotropy+Assay+for+the+70N+Domain+of+Replication+Protein+A&doi=10.1016%2Fj.ab.2011.11.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2011.11.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2011.11.025%26sid%3Dliteratum%253Aachs%26aulast%3DSouza-Fagundes%26aufirst%3DE.%2BM.%26aulast%3DFrank%26aufirst%3DA.%2BO.%26aulast%3DFeldkamp%26aufirst%3DM.%2BD.%26aulast%3DDorset%26aufirst%3DD.%2BC.%26aulast%3DChazin%26aufirst%3DW.%2BJ.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DA%2520High-Throughput%2520Fluorescence%2520Polarization%2520Anisotropy%2520Assay%2520for%2520the%252070N%2520Domain%2520of%2520Replication%2520Protein%2520A%26jtitle%3DAnal.%2520Biochem.%26date%3D2012%26volume%3D421%26issue%3D2%26spage%3D742%26epage%3D749%26doi%3D10.1016%2Fj.ab.2011.11.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Development and Optimization of a Binding Assay for the XIAP BIR3 Domain Using Fluorescence Polarization</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>332</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2004.05.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2Fj.ab.2004.05.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=15325294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFeltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2004&pages=261-273&issue=2&author=Z.+Nikolovska-Coleskaauthor=R.+Wangauthor=X.+Fangauthor=H.+Panauthor=Y.+Tomitaauthor=P.+Liauthor=P.+P.+Rollerauthor=K.+Krajewskiauthor=N.+G.+Saitoauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Development+and+Optimization+of+a+Binding+Assay+for+the+XIAP+BIR3+Domain+Using+Fluorescence+Polarization&doi=10.1016%2Fj.ab.2004.05.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization</span></div><div class="casAuthors">Nikolovska-Coleska, Zaneta; Wang, Renxiao; Fang, Xueliang; Pan, Hongguang; Tomita, York; Li, Peng; Roller, Peter P.; Krajewski, Krzysztof; Saito, Naoyuki G.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">261-273</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The X-linked inhibitor of apoptosis protein (XIAP) is a potent cellular inhibitor of apoptosis.  Designing small-mol. inhibitors that target the BIR3 domain of XIAP, where Smac/DIABLO (second mitochondria-derived activator of caspase/direct IAP-binding protein with low pI) and caspase-9 bind, is a promising strategy for inhibiting the antiapoptotic activity of XIAP and for overcoming apoptosis resistance of cancer cells mediated by XIAP.  Herein, we report the development of a homogeneous high-throughput assay based on fluorescence polarization for measuring the binding affinities of small-mol. inhibitors to the BIR3 domain of XIAP.  Among four fluorescent probes tested, a mutated N-terminal Smac peptide (AbuRPFK-(5-Fam)-NH2) showed the highest affinity (Kd = 17.92 nM) and a large dynamic range (ΔmP=231±0.9), and was selected as the most suitable probe for the binding assay.  The binding conditions (DMSO tolerance and stability) have been investigated.  Under optimized conditions, a Z' factor of 0.88 was achieved in a 96-well format for high-throughput screening.  It was found that the popular Cheng-Prusoff equation is invalid for the calcn. of the competitive inhibition consts. (Ki values) for inhibitors in the FP-based competitive binding assay conditions, and accordingly, a new math. equation was developed, validated, and used to compute the Ki values.  An assocd. Web-based computer program was also developed for this task.  Several known Smac peptides with high and low affinities have been evaluated under the assay conditions and the results obtained indicated that the FP-based competitive binding assay performs correctly as designed: it can quant. and accurately det. the binding affinities of Smac-based peptide inhibitors with a wide range of affinities, and is suitable for high-throughput screening of inhibitors binding to the XIAP BIR3 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWjEsqtWsZRbVg90H21EOLACvtfcHk0lhT08xOqLdQ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFeltL0%253D&md5=23cade47a4996c7ca4c01278d3e0d3a6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.05.055%26sid%3Dliteratum%253Aachs%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DN.%2BG.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDevelopment%2520and%2520Optimization%2520of%2520a%2520Binding%2520Assay%2520for%2520the%2520XIAP%2520BIR3%2520Domain%2520Using%2520Fluorescence%2520Polarization%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D332%26issue%3D2%26spage%3D261%26epage%3D273%26doi%3D10.1016%2Fj.ab.2004.05.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The Influence of Drug-like Concepts on Decision-Making in Medicinal Chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&issue=11&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+Influence+of+Drug-like+Concepts+on+Decision-Making+in+Medicinal+Chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lhT08xOqLdQ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520Influence%2520of%2520Drug-like%2520Concepts%2520on%2520Decision-Making%2520in%2520Medicinal%2520Chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26issue%3D11%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tice, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span> <span> </span><span class="NLM_article-title">The Use of Spirocyclic Scaffolds in Drug Discovery</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3673</span>– <span class="NLM_lpage">3682</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2Fj.bmcl.2014.06.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=25052427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFykt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3673-3682&issue=16&author=Y.+Zhengauthor=C.+M.+Ticeauthor=S.+B.+Singh&title=The+Use+of+Spirocyclic+Scaffolds+in+Drug+Discovery&doi=10.1016%2Fj.bmcl.2014.06.081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The use of spirocyclic scaffolds in drug discovery</span></div><div class="casAuthors">Zheng, Yajun; Tice, Colin M.; Singh, Suresh B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3673-3682</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Owing to their inherent three-dimensionality and structural novelty, spiro scaffolds have been increasingly utilized in drug discovery.  In this brief review, we highlight selected examples from the primary medicinal chem. literature during the last three years to demonstrate the versatility of spiro scaffolds.  With recent progress in synthetic methods providing access to spiro building blocks, spiro scaffolds are likely to be used more frequently in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqzTjJrsRkyLVg90H21EOLACvtfcHk0ljIIpVLNBGdlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFykt7bM&md5=9a2a644cf2b97edf7876b43b6457f6d5</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.081%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DTice%26aufirst%3DC.%2BM.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DThe%2520Use%2520of%2520Spirocyclic%2520Scaffolds%2520in%2520Drug%2520Discovery%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D3673%26epage%3D3682%26doi%3D10.1016%2Fj.bmcl.2014.06.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burkhard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreira, E. M.</span></span> <span> </span><span class="NLM_article-title">2,6-Diazaspiro[3.3]Heptanes: Synthesis and Application in Pd-Catalyzed Aryl Amination Reactions</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3525</span>– <span class="NLM_lpage">3526</span>, <span class="refDoi"> DOI: 10.1021/ol801293f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol801293f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=3525-3526&issue=16&author=J.+Burkhardauthor=E.+M.+Carreira&title=2%2C6-Diazaspiro%5B3.3%5DHeptanes%3A+Synthesis+and+Application+in+Pd-Catalyzed+Aryl+Amination+Reactions&doi=10.1021%2Fol801293f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fol801293f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol801293f%26sid%3Dliteratum%253Aachs%26aulast%3DBurkhard%26aufirst%3DJ.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26atitle%3D2%252C6-Diazaspiro%255B3.3%255DHeptanes%253A%2520Synthesis%2520and%2520Application%2520in%2520Pd-Catalyzed%2520Aryl%2520Amination%2520Reactions%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26issue%3D16%26spage%3D3525%26epage%3D3526%26doi%3D10.1021%2Fol801293f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burkhard, J. a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreira, E. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Azaspirocycles and Their Evaluation in Drug Discovery</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">3524</span>– <span class="NLM_lpage">3527</span>, <span class="refDoi"> DOI: 10.1002/anie.200907108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1002%2Fanie.200907108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFCnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=3524-3527&issue=20&author=J.+a.+Burkhardauthor=B.+Wagnerauthor=H.+Fischerauthor=F.+Schulerauthor=K.+M%C3%BCllerauthor=E.+M.+Carreira&title=Synthesis+of+Azaspirocycles+and+Their+Evaluation+in+Drug+Discovery&doi=10.1002%2Fanie.200907108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Azaspirocycles and their Evaluation in Drug Discovery</span></div><div class="casAuthors">Burkhard, Johannes A.; Wagner, Bjoern; Fischer, Holger; Schuler, Franz; Mueller, Klaus; Carreira, Erick M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3524-3527, S3524/1-S3524/60</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Readily synthesized heteroatom-substituted spiro[3.3]heptanes generally show higher aq. soly. than their cyclohexane analogs, and show a trend towards higher metabolic stability.  The novel framework can be mounted onto scaffolds of druglike structures, such as fluoroquinolones, to afford active compds. with similar or even improved metabolic stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW-R9uvaVrXLVg90H21EOLACvtfcHk0ljIIpVLNBGdlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFCnsbY%253D&md5=0367b2cb751889a3df1cb1c8d2b24bc6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fanie.200907108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200907108%26sid%3Dliteratum%253Aachs%26aulast%3DBurkhard%26aufirst%3DJ.%2Ba.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26atitle%3DSynthesis%2520of%2520Azaspirocycles%2520and%2520Their%2520Evaluation%2520in%2520Drug%2520Discovery%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26issue%3D20%26spage%3D3524%26epage%3D3527%26doi%3D10.1002%2Fanie.200907108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conradi, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, N. F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, P. S.</span></span> <span> </span><span class="NLM_article-title">Physicochemical Determinants of Passive Membrane Permeability: Role of Solute Hydrogen-Bonding Potential and Volume</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">3721</span>– <span class="NLM_lpage">3729</span>, <span class="refDoi"> DOI: 10.1021/jm010253i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010253i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3721-3729&issue=22&author=J.+T.+Goodwinauthor=R.+A.+Conradiauthor=N.+F.+H.+Hoauthor=P.+S.+Burton&title=Physicochemical+Determinants+of+Passive+Membrane+Permeability%3A+Role+of+Solute+Hydrogen-Bonding+Potential+and+Volume&doi=10.1021%2Fjm010253i"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm010253i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010253i%26sid%3Dliteratum%253Aachs%26aulast%3DGoodwin%26aufirst%3DJ.%2BT.%26aulast%3DConradi%26aufirst%3DR.%2BA.%26aulast%3DHo%26aufirst%3DN.%2BF.%2BH.%26aulast%3DBurton%26aufirst%3DP.%2BS.%26atitle%3DPhysicochemical%2520Determinants%2520of%2520Passive%2520Membrane%2520Permeability%253A%2520Role%2520of%2520Solute%2520Hydrogen-Bonding%2520Potential%2520and%2520Volume%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26issue%3D22%26spage%3D3721%26epage%3D3729%26doi%3D10.1021%2Fjm010253i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hop, C. E. C. A.</span></span> <span> </span><span class="NLM_article-title">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8238</span>– <span class="NLM_lpage">8248</span>, <span class="refDoi"> DOI: 10.1021/jm5007935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5007935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8238-8248&issue=20&author=X.+Liuauthor=M.+Wrightauthor=C.+E.+C.+A.+Hop&title=Rational+Use+of+Plasma+Protein+and+Tissue+Binding+Data+in+Drug+Design&doi=10.1021%2Fjm5007935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design</span></div><div class="casAuthors">Liu, Xingrong; Wright, Matthew; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8238-8248</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is a commonly accepted assumption that only unbound drug mols. are available to interact with their targets.  Therefore, one of the objectives in drug design is to optimize the compd. structure to increase in vivo unbound drug concn.  In this review, theor. analyses and exptl. observations are presented to illustrate that low plasma protein binding does not necessarily lead to high in vivo unbound plasma concn.  Similarly, low brain tissue binding does not lead to high in vivo unbound brain tissue concn.  Instead, low intrinsic clearance leads to high in vivo unbound plasma concn., and low efflux transport activity at the blood-brain barrier leads to high unbound brain concn.  Plasma protein and brain tissue binding are very important parameters in understanding pharmacokinetics, pharmacodynamics, and toxicities of drugs, but these parameters should not be targeted for optimization in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiYUz9ljIDrVg90H21EOLACvtfcHk0lhfUgW17zFCeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M&md5=53ffbdb88ddf500a90a0eee14b0e641f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm5007935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5007935%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26atitle%3DRational%2520Use%2520of%2520Plasma%2520Protein%2520and%2520Tissue%2520Binding%2520Data%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D20%26spage%3D8238%26epage%3D8248%26doi%3D10.1021%2Fjm5007935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aronheim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Alawi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlessinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Membrane Targeting of the Nucleotide Exchange Factor Sos Is Sufficient for Activating the Ras Signaling Pathway</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">949</span>– <span class="NLM_lpage">961</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(94)90271-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2F0092-8674%2894%2990271-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1994&pages=949-961&issue=6&author=A.+Aronheimauthor=D.+Engelbergauthor=N.+Liauthor=N.+Al-Alawiauthor=J.+Schlessingerauthor=M.+Karin&title=Membrane+Targeting+of+the+Nucleotide+Exchange+Factor+Sos+Is+Sufficient+for+Activating+the+Ras+Signaling+Pathway&doi=10.1016%2F0092-8674%2894%2990271-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2894%2990271-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252894%252990271-2%26sid%3Dliteratum%253Aachs%26aulast%3DAronheim%26aufirst%3DA.%26aulast%3DEngelberg%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DAl-Alawi%26aufirst%3DN.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DMembrane%2520Targeting%2520of%2520the%2520Nucleotide%2520Exchange%2520Factor%2520Sos%2520Is%2520Sufficient%2520for%2520Activating%2520the%2520Ras%2520Signaling%2520Pathway%26jtitle%3DCell%26date%3D1994%26volume%3D78%26issue%3D6%26spage%3D949%26epage%3D961%26doi%3D10.1016%2F0092-8674%2894%2990271-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, M.</span></span> <span> </span><span class="NLM_article-title">Multiple Decisive Phosphorylation Sites for the Negative Feedback Regulation of SOS1 via ERK</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">43</span>),  <span class="NLM_fpage">33540</span>– <span class="NLM_lpage">33548</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.135517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1074%2Fjbc.M110.135517" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=33540-33548&issue=43&author=Y.+Kamiokaauthor=S.+Yasudaauthor=Y.+Fujitaauthor=K.+Aokiauthor=M.+Matsuda&title=Multiple+Decisive+Phosphorylation+Sites+for+the+Negative+Feedback+Regulation+of+SOS1+via+ERK&doi=10.1074%2Fjbc.M110.135517"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.135517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.135517%26sid%3Dliteratum%253Aachs%26aulast%3DKamioka%26aufirst%3DY.%26aulast%3DYasuda%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DY.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DM.%26atitle%3DMultiple%2520Decisive%2520Phosphorylation%2520Sites%2520for%2520the%2520Negative%2520Feedback%2520Regulation%2520of%2520SOS1%2520via%2520ERK%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D43%26spage%3D33540%26epage%3D33548%26doi%3D10.1074%2Fjbc.M110.135517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iversen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gureasko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petit, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thill, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groves, J. T.</span></span> <span> </span><span class="NLM_article-title">Ras Activation by SOS: Allosteric Regulation by Altered Fluctuation Dynamics</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>345</i></span> (<span class="NLM_issue">6192</span>),  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1126/science.1250373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1126%2Fscience.1250373" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2014&pages=50-54&issue=6192&author=L.+Iversenauthor=H.-L.+Tuauthor=W.-C.+Linauthor=S.+M.+Christensenauthor=S.+M.+Abelauthor=J.+Iwigauthor=H.-J.+Wuauthor=J.+Gureaskoauthor=C.+Rhodesauthor=R.+S.+Petitauthor=S.+D.+Hansenauthor=P.+Thillauthor=C.-H.+Yuauthor=D.+Stamouauthor=A.+K.+Chakrabortyauthor=J.+Kuriyanauthor=J.+T.+Groves&title=Ras+Activation+by+SOS%3A+Allosteric+Regulation+by+Altered+Fluctuation+Dynamics&doi=10.1126%2Fscience.1250373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1126%2Fscience.1250373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1250373%26sid%3Dliteratum%253Aachs%26aulast%3DIversen%26aufirst%3DL.%26aulast%3DTu%26aufirst%3DH.-L.%26aulast%3DLin%26aufirst%3DW.-C.%26aulast%3DChristensen%26aufirst%3DS.%2BM.%26aulast%3DAbel%26aufirst%3DS.%2BM.%26aulast%3DIwig%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.-J.%26aulast%3DGureasko%26aufirst%3DJ.%26aulast%3DRhodes%26aufirst%3DC.%26aulast%3DPetit%26aufirst%3DR.%2BS.%26aulast%3DHansen%26aufirst%3DS.%2BD.%26aulast%3DThill%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DC.-H.%26aulast%3DStamou%26aufirst%3DD.%26aulast%3DChakraborty%26aufirst%3DA.%2BK.%26aulast%3DKuriyan%26aufirst%3DJ.%26aulast%3DGroves%26aufirst%3DJ.%2BT.%26atitle%3DRas%2520Activation%2520by%2520SOS%253A%2520Allosteric%2520Regulation%2520by%2520Altered%2520Fluctuation%2520Dynamics%26jtitle%3DScience%26date%3D2014%26volume%3D345%26issue%3D6192%26spage%3D50%26epage%3D54%26doi%3D10.1126%2Fscience.1250373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soll, M.</span>; <span class="NLM_string-name">Le Hir De Fallois, L.</span>; <span class="NLM_string-name">Huber, S.</span>; <span class="NLM_string-name">Lee, H.</span>; <span class="NLM_string-name">Douglas, E.</span>; <span class="NLM_string-name">Jacobs, R.</span>; <span class="NLM_string-name">Beck, B.</span></span> <span> </span><span class="NLM_article-title">Preparation of Enantiomerically Enriched Aryloazol-2-Yl Cyanoethylamino Parasiticidal Compounds</span>. <span class="NLM_patent">WO 2010056999</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+Soll&author=L.+Le+Hir+De+Fallois&author=S.+Huber&author=H.+Lee&author=E.+Douglas&author=R.+Jacobs&author=B.+Beck&title=Preparation+of+Enantiomerically+Enriched+Aryloazol-2-Yl+Cyanoethylamino+Parasiticidal+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSoll%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520Enantiomerically%2520Enriched%2520Aryloazol-2-Yl%2520Cyanoethylamino%2520Parasiticidal%2520Compounds%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Juergen Ramharter, Dirk Kessler, Peter Ettmayer, Marco H. Hofmann, Thomas Gerstberger, Michael Gmachl, Tobias Wunberg, Christiane Kofink, Michael Sanderson, Heribert Arnhof, Gerd Bader, Klaus Rumpel, Andreas Zöphel, Renate Schnitzer, Jark Böttcher, Jonathan C. O’Connell, Rachel L. Mendes, David Richard, Nikolai Pototschnig, Irene Weiner, Wolfgang Hela, Katja Hauer, Daniela Haering, Lyne Lamarre, Bernhard Wolkerstorfer, Christian Salamon, Patrick Werni, Silvia Munico-Martinez, Reiner Meyer, Matthew D. Kennedy, Norbert Kraut, <span class="NLM_string-name hlFld-ContribAuthor">Darryl B. McConnell</span>. </span><span class="cited-content_cbyCitation_article-title">One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6569-6580. <a href="https://doi.org/10.1021/acs.jmedchem.0c01949" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01949</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01949%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOne%252BAtom%252BMakes%252BAll%252Bthe%252BDifference%25253A%252BGetting%252Ba%252BFoot%252Bin%252Bthe%252BDoor%252Bbetween%252BSOS1%252Band%252BKRAS%26aulast%3DRamharter%26aufirst%3DJuergen%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D10112020%26date%3D15032021%26volume%3D64%26issue%3D10%26spage%3D6569%26epage%3D6580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dhruba Sarkar, Edward T. Olejniczak, Jason Phan, Jesse A. Coker, Jiqing Sai, Allison Arnold, Yugandhar Beesetty, Alex G. Waterson, <span class="NLM_string-name hlFld-ContribAuthor">Stephen W. Fesik</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Sulfonamide-Derived Agonists of SOS1-Mediated Nucleotide Exchange on RAS Using Fragment-Based Methods. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8325-8337. <a href="https://doi.org/10.1021/acs.jmedchem.0c00511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSulfonamide-Derived%252BAgonists%252Bof%252BSOS1-Mediated%252BNucleotide%252BExchange%252Bon%252BRAS%252BUsing%252BFragment-Based%252BMethods%26aulast%3DSarkar%26aufirst%3DDhruba%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08042020%26date%3D03082020%26date%3D16072020%26volume%3D63%26issue%3D15%26spage%3D8325%26epage%3D8337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jason G. Kettle, Sharan K. Bagal, Sue Bickerton, Michael S. Bodnarchuk, Jason Breed, Rodrigo J. Carbajo, Doyle J. Cassar, Atanu Chakraborty, Sabina Cosulich, Iain Cumming, Michael Davies, Andrew Eatherton, Laura Evans, Lyman Feron, Shaun Fillery, Emma S. Gleave, Frederick W. Goldberg, Stephanie Harlfinger, Lyndsey Hanson, Martin Howard, Rachel Howells, Anne Jackson, Paul Kemmitt, Jennifer K. Kingston, Scott Lamont, Hilary J. Lewis, Songlei Li, Libin Liu, Derek Ogg, Christopher Phillips, Radek Polanski, Graeme Robb, David Robinson, Sarah Ross, James M. Smith, Michael Tonge, Rebecca Whiteley, Junsheng Yang, Longfei Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Xiliang Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4468-4483. <a href="https://doi.org/10.1021/acs.jmedchem.9b01720" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01720%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Band%252BPharmacokinetic%252BOptimization%252Bof%252BCovalent%252BAllosteric%252BInhibitors%252Bof%252Bthe%252BMutant%252BGTPase%252BKRASG12C%26aulast%3DKettle%26aufirst%3DJason%2BG.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18102019%26date%3D13022020%26date%3D05022020%26volume%3D63%26issue%3D9%26spage%3D4468%26epage%3D4483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sébastien L. Degorce, Michael S. Bodnarchuk, <span class="NLM_string-name hlFld-ContribAuthor">James S. Scott</span>. </span><span class="cited-content_cbyCitation_article-title">Lowering Lipophilicity by Adding Carbon: AzaSpiroHeptanes, a logD Lowering Twist. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (8)
                                     , 1198-1204. <a href="https://doi.org/10.1021/acsmedchemlett.9b00248" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00248%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLowering%252BLipophilicity%252Bby%252BAdding%252BCarbon%25253A%252BAzaSpiroHeptanes%25252C%252Ba%252BlogD%252BLowering%252BTwist%26aulast%3DDegorce%26aufirst%3DS%25C3%25A9bastien%2BL.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06062019%26date%3D18072019%26date%3D25072019%26date%3D18072019%26volume%3D10%26issue%3D8%26spage%3D1198%26epage%3D1204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Denis
T. Akan, Jennifer E. Howes, Jiqing Sai, Allison L. Arnold, Yugandhar Beesetty, Jason Phan, Edward T. Olejniczak, Alex G. Waterson, <span class="NLM_string-name hlFld-ContribAuthor">Stephen W. Fesik</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule SOS1 Agonists Modulate MAPK and PI3K Signaling via Independent Cellular Responses. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2019,</strong> <em>14 </em>
                                    (3)
                                     , 325-331. <a href="https://doi.org/10.1021/acschembio.8b00869" title="DOI URL">https://doi.org/10.1021/acschembio.8b00869</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.8b00869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.8b00869%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DSmall%252BMolecule%252BSOS1%252BAgonists%252BModulate%252BMAPK%252Band%252BPI3K%252BSignaling%252Bvia%252BIndependent%252BCellular%252BResponses%26aulast%3DAkan%26aufirst%3DDenis%2BT.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D21092018%26date%3D08022019%26date%3D18022019%26date%3D08022019%26volume%3D14%26issue%3D3%26spage%3D325%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Severin  Thompson</span>, <span class="hlFld-ContribAuthor ">Andreas  Buckl</span>, <span class="hlFld-ContribAuthor ">Alexander G.  Dossetter</span>, <span class="hlFld-ContribAuthor ">Ed  Griffen</span>, <span class="hlFld-ContribAuthor ">Adrian  Gill</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule Son of Sevenless 1 (SOS1) inhibitors: a review of the patent literature. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.1080/13543776.2021.1952984" title="DOI URL">https://doi.org/10.1080/13543776.2021.1952984</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1952984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1952984%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall%252Bmolecule%252BSon%252Bof%252BSevenless%252B1%252B%252528SOS1%252529%252Binhibitors%25253A%252Ba%252Breview%252Bof%252Bthe%252Bpatent%252Bliterature%26aulast%3DThompson%26aufirst%3DSeverin%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dirk  Kessler</span>, <span class="hlFld-ContribAuthor ">Daniel  Gerlach</span>, <span class="hlFld-ContribAuthor ">Norbert  Kraut</span>, <span class="hlFld-ContribAuthor ">Darryl B.  McConnell</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Son of Sevenless 1: The pacemaker of KRAS. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2021,</strong> <em>62 </em>, 109-118. <a href="https://doi.org/10.1016/j.cbpa.2021.02.014" title="DOI URL">https://doi.org/10.1016/j.cbpa.2021.02.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2021.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2021.02.014%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DTargeting%252BSon%252Bof%252BSevenless%252B1%25253A%252BThe%252Bpacemaker%252Bof%252BKRAS%26aulast%3DKessler%26aufirst%3DDirk%26date%3D2021%26volume%3D62%26spage%3D109%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaista  Amin</span>, <span class="hlFld-ContribAuthor ">M. Mumtaz  Alam</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">A. K.  Najmi</span>, <span class="hlFld-ContribAuthor ">Nadeem  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Asif  Husain</span>, <span class="hlFld-ContribAuthor ">M.  Shaquiquzzaman</span>. </span><span class="cited-content_cbyCitation_article-title">A review on synthetic procedures and applications of phosphorus oxychloride (POCl
              3
              ) in the last biennial period (2018–19). </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2021,</strong> <em>196 </em>
                                    (3)
                                     , 211-274. <a href="https://doi.org/10.1080/10426507.2020.1831499" title="DOI URL">https://doi.org/10.1080/10426507.2020.1831499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2020.1831499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2020.1831499%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DA%252Breview%252Bon%252Bsynthetic%252Bprocedures%252Band%252Bapplications%252Bof%252Bphosphorus%252Boxychloride%252B%252528POCl%252B3%252B%252529%252Bin%252Bthe%252Blast%252Bbiennial%252Bperiod%252B%2525282018%2525E2%252580%25259319%252529%26aulast%3DAmin%26aufirst%3DShaista%26date%3D2021%26date%3D2020%26volume%3D196%26issue%3D3%26spage%3D211%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David P.  Rotella</span>. </span><span class="cited-content_cbyCitation_article-title">Heterocycles in drug discovery: Properties and preparation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 149-183. <a href="https://doi.org/10.1016/bs.aihch.2020.10.002" title="DOI URL">https://doi.org/10.1016/bs.aihch.2020.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2020.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2020.10.002%26sid%3Dliteratum%253Aachs%26atitle%3DHeterocycles%252Bin%252Bdrug%252Bdiscovery%25253A%252BProperties%252Band%252Bpreparation%26aulast%3DRotella%26aufirst%3DDavid%2BP.%26date%3D2021%26spage%3D149%26epage%3D183%26pub%3DElsevier%26atitle%3DApplications%252Bof%252BHeterocycles%252Bin%252Bthe%252BDesign%252Bof%252BDrugs%252Band%252BAgricultural%252BProducts%26date%3D2021%26volume%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando C.  Baltanás</span>, <span class="hlFld-ContribAuthor ">Natasha  Zarich</span>, <span class="hlFld-ContribAuthor ">Jose M.  Rojas-Cabañeros</span>, <span class="hlFld-ContribAuthor ">Eugenio  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">SOS GEFs in health and disease. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2020,</strong> <em>1874 </em>
                                    (2)
                                     , 188445. <a href="https://doi.org/10.1016/j.bbcan.2020.188445" title="DOI URL">https://doi.org/10.1016/j.bbcan.2020.188445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2020.188445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2020.188445%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DSOS%252BGEFs%252Bin%252Bhealth%252Band%252Bdisease%26aulast%3DBaltan%25C3%25A1s%26aufirst%3DFernando%2BC.%26date%3D2020%26volume%3D1874%26issue%3D2%26spage%3D188445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kinga  Nyíri</span>, <span class="hlFld-ContribAuthor ">Gergely  Koppány</span>, <span class="hlFld-ContribAuthor ">Beáta G.  Vértessy</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based inhibitor design of mutant RAS proteins—a paradigm shift. </span><span class="cited-content_cbyCitation_journal-name">Cancer and Metastasis Reviews</span><span> <strong>2020,</strong> <em>39 </em>
                                    (4)
                                     , 1091-1105. <a href="https://doi.org/10.1007/s10555-020-09914-6" title="DOI URL">https://doi.org/10.1007/s10555-020-09914-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10555-020-09914-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10555-020-09914-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520and%2520Metastasis%2520Reviews%26atitle%3DStructure-based%252Binhibitor%252Bdesign%252Bof%252Bmutant%252BRAS%252Bproteins%2525E2%252580%252594a%252Bparadigm%252Bshift%26aulast%3DNy%25C3%25ADri%26aufirst%3DKinga%26date%3D2020%26date%3D2020%26volume%3D39%26issue%3D4%26spage%3D1091%26epage%3D1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. Matthew  Rhett</span>, <span class="hlFld-ContribAuthor ">Imran  Khan</span>, <span class="hlFld-ContribAuthor ">John P.  O’Bryan</span>. </span><span class="cited-content_cbyCitation_article-title">Biology, pathology, and therapeutic targeting of RAS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 69-146. <a href="https://doi.org/10.1016/bs.acr.2020.05.002" title="DOI URL">https://doi.org/10.1016/bs.acr.2020.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.acr.2020.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.acr.2020.05.002%26sid%3Dliteratum%253Aachs%26atitle%3DBiology%25252C%252Bpathology%25252C%252Band%252Btherapeutic%252Btargeting%252Bof%252BRAS%26aulast%3DRhett%26aufirst%3DJ.%2BMatthew%26date%3D2020%26spage%3D69%26epage%3D146%26pub%3DElsevier%26date%3D2020%26volume%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdallah  Sayyed-Ahmad</span>, <span class="hlFld-ContribAuthor ">Alemayehu A.  Gorfe</span>. </span><span class="cited-content_cbyCitation_article-title">How to make an undruggable enzyme druggable: lessons from ras proteins. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 181-202. <a href="https://doi.org/10.1016/bs.apcsb.2020.05.003" title="DOI URL">https://doi.org/10.1016/bs.apcsb.2020.05.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apcsb.2020.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apcsb.2020.05.003%26sid%3Dliteratum%253Aachs%26atitle%3DHow%252Bto%252Bmake%252Ban%252Bundruggable%252Benzyme%252Bdruggable%25253A%252Blessons%252Bfrom%252Bras%252Bproteins%26aulast%3DSayyed-Ahmad%26aufirst%3DAbdallah%26date%3D2020%26spage%3D181%26epage%3D202%26pub%3DElsevier%26date%3D2020%26volume%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raphael  Gasper</span>, <span class="hlFld-ContribAuthor ">Fred  Wittinghofer</span>. </span><span class="cited-content_cbyCitation_article-title">The Ras switch in structural and historical perspective. </span><span class="cited-content_cbyCitation_journal-name">Biological Chemistry</span><span> <strong>2019,</strong> <em>401 </em>
                                    (1)
                                     , 143-163. <a href="https://doi.org/10.1515/hsz-2019-0330" title="DOI URL">https://doi.org/10.1515/hsz-2019-0330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hsz-2019-0330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhsz-2019-0330%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Chemistry%26atitle%3DThe%252BRas%252Bswitch%252Bin%252Bstructural%252Band%252Bhistorical%252Bperspective%26aulast%3DGasper%26aufirst%3DRaphael%26date%3D2019%26date%3D2019%26volume%3D401%26issue%3D1%26spage%3D143%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toma-Fukai</span>, <span class="hlFld-ContribAuthor ">Shimizu</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Insights into the Regulation Mechanism of Small GTPases by GEFs. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (18)
                                     , 3308. <a href="https://doi.org/10.3390/molecules24183308" title="DOI URL">https://doi.org/10.3390/molecules24183308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24183308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24183308%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructural%252BInsights%252Binto%252Bthe%252BRegulation%252BMechanism%252Bof%252BSmall%252BGTPases%252Bby%252BGEFs%26aulast%3DToma-Fukai%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D18%26spage%3D3308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra  Casnati</span>, <span class="hlFld-ContribAuthor ">Elena  Motti</span>, <span class="hlFld-ContribAuthor ">Raffaella  Mancuso</span>, <span class="hlFld-ContribAuthor ">Bartolo  Gabriele</span>, <span class="hlFld-ContribAuthor ">Nicola  Della Ca’</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Catalytic Synthesis of Imidazolidin-2-ones and Benzimidazolidin-2-ones. </span><span class="cited-content_cbyCitation_journal-name">Catalysts</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     , 28. <a href="https://doi.org/10.3390/catal9010028" title="DOI URL">https://doi.org/10.3390/catal9010028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/catal9010028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcatal9010028%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysts%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BCatalytic%252BSynthesis%252Bof%252BImidazolidin-2-ones%252Band%252BBenzimidazolidin-2-ones%26aulast%3DCasnati%26aufirst%3DAlessandra%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1%26spage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Early hit benzimidazole-derived activators of SOS1-mediated nucleotide exchange. (B) X-ray co-crystal structure of <b>3</b> (yellow; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5V">6D5V</a>) bound to SOS1 in the RAS:SOS1:RAS ternary complex. The RAS and SOS1 protein surfaces are colored yellow and gray, respectively. Areas identified for SAR development are highlighted, including: (i) a water-mediated interaction between the 2-amine functionality with Asp887 (blue oval), (ii) occupation of a hydrophobic subpocket beneath Phe890 (red arrows), (iii) occupation of a hydrophobic region along the wall of the CDC25 domain (pink rectangle), (iv) occupation of a hydrophobic subpocket behind Glu902 and adjacent to Phe890 (green circle), and (v) interaction with proximal residues of SOS1 from the 4-position of the benzimidazole scaffold (white arrows).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) X-ray co-crystal structure of <b>10</b> (magenta; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5M">6D5M</a>) bound to SOS1 in the RAS:SOS1:RAS ternary complex. The curved blue line highlights the subpocket near His905. The RAS and SOS1 protein surfaces are colored yellow and gray, respectively. (B) <b>28</b> (green; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5L">6D5L</a>) overlaid with <b>10</b>. The green sphere represents space filling of the 6-chlorine atom in <b>28</b>, whereas the magenta and white spheres represent space filling of the 6-methyl group in <b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Nucleotide exchange and binding affinity data for compound <b>29</b>. (B) X-ray co-crystal structure of compound <b>29</b> (teal; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5J">6D5J</a>) bound to SOS1 in the RAS:SOS1:RAS ternary complex. The red dotted spheres represent molecules of water and the space they occupy. The RAS and SOS1 protein surfaces are colored yellow and gray, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray co-crystal structures of (A) <b>38</b> (salmon; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5H">6D5H</a>), (B) <b>43</b> (orange; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5G">6D5G</a>), (C) <b>47</b> (green; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5E">6D5E</a>), and (D) <b>38</b>, <b>43</b>, and <b>47</b> overlaid with <b>29</b> (teal) bound to SOS1 in the RAS:SOS1:RAS ternary complex. The RAS and SOS1 protein surfaces are colored yellow and gray, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray co-crystal structure of (A) <b>58</b> (pink; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D59">6D59</a>), (B) <b>65</b> (yellow; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D56">6D56</a>), (C) <b>64</b> (white; PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D55">6D55</a>), and (D) <b>58</b>, <b>64</b>, and <b>65</b> overlaid with <b>29</b> (teal) bound to SOS1 in the RAS:SOS1:RAS ternary complex. The RAS and SOS1 protein surfaces are colored yellow and gray, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Representative ICW data for benzimidazole compounds that elicit (A) biphasic modulation of pERK1/2<sup>T202/Y204</sup> protein levels, or (B) only an increase in pERK1/2<sup>T202/Y204</sup> protein levels. The green channel of the LI-COR infrared scanner was used to detect pERK1/2<sup>T202/Y204</sup> protein levels. In the same well, the red channel of the LI-COR infrared scanner was used to detect total ERK1/2 protein levels. The graphs represent the quantified immunofluorescence data, where pERK1/2<sup>T202/Y204</sup> levels were normalized to total ERK1/2 levels from the same well and to the vehicle control treated well. The vertical black dotted line indicates how EC<sub>50</sub> values were determined, and the horizontal black dotted line indicates the baseline pERK1/2<sup>T202/Y204</sup> signal. Each ICW experiment was conducted three independent times, and in duplicate on each plate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. RAS-GTP levels and corresponding pERK1/2<sup>T202/Y204</sup> levels from HeLa cells that were treated for 10 min with up to 30 μM of compound <b>42</b>, <b>64</b>, <b>55</b>, <b>60</b>, or <b>61</b>. EGF (50 ng/mL for 5 min) was used as a positive control for pathway stimulation. Data are representative of two independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Various Benzimidazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) CDI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt; (b) POCl<sub>3</sub>, 90 °C; (c) benzyl bromide derivative, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (d) diamine, DMA, 165 °C in microwave, then TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt when Boc removal necessary; (e) K<sub>3</sub>PO<sub>4</sub>, cyclopropylboronic acid, Pd(OAc)<sub>2</sub>, PCy<sub>3</sub>·HBF<sub>4</sub>, DME/H<sub>2</sub>O, 90 °C; (f) urea, xylenes, 130 °C; (g) piperidine-4-carboxylic acid, 4 M HCl(aq), 105 °C; (h) Boc<sub>2</sub>O, Et<sub>3</sub>N, THF/DMF, 35 °C; (i) NaH, 3-chloro-4-fluorobenzyl bromide, DMF, rt; (j) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 5,6-Substituted Benzimidazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) <i>i</i>-Pr<sub>2</sub>NEt, 3-chloro-4-fluorobenzylamine, NMP, rt; (b) Zn°, 12 M HCl, EtOH/CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) CDI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) POCl<sub>3</sub>, 100 °C; (e) piperazine, DMA, 165 °C in microwave; (f) K<sub>3</sub>PO<sub>4</sub>, PdCl<sub>2</sub>dppf·CH<sub>2</sub>Cl<sub>2</sub>, cyclopropylboronic acid, dioxane, 100 °C.</p></p></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/medium/jm-2018-01108h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 4-Substituted Benzimidazole Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-19/acs.jmedchem.8b01108/20181004/images/large/jm-2018-01108h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01108&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) CDI, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt; (b) POCl<sub>3</sub>, 110 °C; (c) 4-fluoro-3,5-dimethylbenzyl bromide or 4-fluorobenzyl bromide, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (d) diamine, K<sub>2</sub>CO<sub>3</sub> or <i>i</i>-Pr<sub>2</sub>NEt, DMF or DMSO, 80–100 °C; (e) Pd cat. C–C or C–N coupling; (f) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (g) 10% Pd/C, H<sub>2</sub>, AcOH, <i>i</i>-PrOH, rt; (h) NaBH<sub>4</sub>, MeOH, rt; 4 M HCl in dioxane.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i107">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50581" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50581" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 49 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I. R.</span></span> <span> </span><span class="NLM_article-title">The Guanine Nucleotide-Binding Switch in Three Dimensions</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>294</i></span> (<span class="NLM_issue">5545</span>),  <span class="NLM_fpage">1299</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.1126/science.1062023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1126%2Fscience.1062023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=11701921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlKnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2001&pages=1299-1304&issue=5545&author=I.+R.+Vetter&title=The+Guanine+Nucleotide-Binding+Switch+in+Three+Dimensions&doi=10.1126%2Fscience.1062023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transduction: The guanine nucleotide-binding switch in three dimensions</span></div><div class="casAuthors">Vetter, Ingrid R.; Wittinghofer, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">5545</span>),
    <span class="NLM_cas:pages">1299-1304</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Guanine nucleotide-binding proteins regulate a variety of processes, including sensual perception, protein synthesis, various transport processes, and cell growth and differentiation.  They act as mol. switches and timers that cycle between inactive guanosine diphosphate (GDP)-bound and active guanosine triphosphate (GTP)-bound states.  Recent structural studies show that the switch app. itself is a conserved fundamental module but that its regulators and effectors are quite diverse in their structures and modes of interaction.  Here we will try to define some. underlying principles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2o75cMejTrLVg90H21EOLACvtfcHk0lhocLYpVPXbFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlKnu70%253D&md5=07d04400bf13ddb01daba8054d80fd28</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1062023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1062023%26sid%3Dliteratum%253Aachs%26aulast%3DVetter%26aufirst%3DI.%2BR.%26atitle%3DThe%2520Guanine%2520Nucleotide-Binding%2520Switch%2520in%2520Three%2520Dimensions%26jtitle%3DScience%26date%3D2001%26volume%3D294%26issue%3D5545%26spage%3D1299%26epage%3D1304%26doi%3D10.1126%2Fscience.1062023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schubbert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span> <span> </span><span class="NLM_article-title">Hyperactive Ras in Developmental Disorders and Cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1038/nrc2109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnrc2109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=17384584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlyhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=295-308&issue=4&author=S.+Schubbertauthor=K.+Shannonauthor=G.+Bollag&title=Hyperactive+Ras+in+Developmental+Disorders+and+Cancer&doi=10.1038%2Fnrc2109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperactive Ras in developmental disorders and cancer</span></div><div class="casAuthors">Schubbert, Suzanne; Shannon, Kevin; Bollag, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-308</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Ras genes are the most common targets for somatic gain-of-function mutations in human cancer.  Recently, germline mutations that affect components of the Ras-Raf-mitogen-activated and extracellular-signal regulated kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) pathway were shown to cause several developmental disorders, including Nonan, Costello and cardio-facio-cutaneous syndromes.  Many of these mutant alleles encode proteins with aberrant biochem. and functional properties.  Here we will discuss the implications of germline mutations in the Ras-Raf-MEK-ERK pathway for understanding normal developmental processes and cancer pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCRvjqrp1ho7Vg90H21EOLACvtfcHk0liLwDNn5iNo7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlyhtLs%253D&md5=25fcaa959dae5e8512b959936bcbb347</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc2109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2109%26sid%3Dliteratum%253Aachs%26aulast%3DSchubbert%26aufirst%3DS.%26aulast%3DShannon%26aufirst%3DK.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DHyperactive%2520Ras%2520in%2520Developmental%2520Disorders%2520and%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26issue%3D4%26spage%3D295%26epage%3D308%26doi%3D10.1038%2Fnrc2109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">The Hallmarks of Cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)81683-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&issue=1&author=D.+Hanahanauthor=R.+A.+Weinberg&title=The+Hallmarks+of+Cancer&doi=10.1016%2FS0092-8674%2800%2981683-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0liLwDNn5iNo7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520Hallmarks%2520of%2520Cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26issue%3D1%26spage%3D57%26epage%3D70%26doi%3D10.1016%2FS0092-8674%2800%2981683-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of Cancer: The Next Generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&issue=5&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+Cancer%3A+The+Next+Generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0liLwDNn5iNo7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520Cancer%253A%2520The%2520Next%2520Generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26issue%3D5%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pylayeva-Gupta, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabocka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span> <span> </span><span class="NLM_article-title">RAS Oncogenes: Weaving a Tumorigenic Web</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1038/nrc3106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnrc3106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=21993244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlSkur7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=761-774&issue=11&author=Y.+Pylayeva-Guptaauthor=E.+Grabockaauthor=D.+Bar-Sagi&title=RAS+Oncogenes%3A+Weaving+a+Tumorigenic+Web&doi=10.1038%2Fnrc3106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">RAS oncogenes: weaving a tumorigenic web</span></div><div class="casAuthors">Pylayeva-Gupta, Yuliya; Grabocka, Elda; Bar-Sagi, Dafna</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">761-774</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  RAS proteins are essential components of signalling pathways that emanate from cell surface receptors.  Oncogenic activation of these proteins owing to missense mutations is frequently detected in several types of cancer.  A wealth of biochem. and genetic studies indicates that RAS proteins control a complex mol. circuitry that consists of a wide array of interconnecting pathways.  In this Review, we describe how RAS oncogenes exploit their extensive signalling reach to affect multiple cellular processes that drive tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdHRt0jsiXtLVg90H21EOLACvtfcHk0liLwDNn5iNo7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlSkur7K&md5=d1be47023ab43a30cb81e71cb92bc0aa</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrc3106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3106%26sid%3Dliteratum%253Aachs%26aulast%3DPylayeva-Gupta%26aufirst%3DY.%26aulast%3DGrabocka%26aufirst%3DE.%26aulast%3DBar-Sagi%26aufirst%3DD.%26atitle%3DRAS%2520Oncogenes%253A%2520Weaving%2520a%2520Tumorigenic%2520Web%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26issue%3D11%26spage%3D761%26epage%3D774%26doi%3D10.1038%2Fnrc3106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomerantz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holash, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardeesy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hagan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantginis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horner, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordon-Cardo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yancopoulos, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePinho, R. A.</span></span> <span> </span><span class="NLM_article-title">Essential Role for Oncogenic Ras in Tumour Maintenance</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>400</i></span> (<span class="NLM_issue">6743</span>),  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">472</span>, <span class="refDoi"> DOI: 10.1038/22788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2F22788" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=1999&pages=468-472&issue=6743&author=L.+Chinauthor=A.+Tamauthor=J.+Pomerantzauthor=M.+Wongauthor=J.+Holashauthor=N.+Bardeesyauthor=Q.+Shenauthor=R.+O%E2%80%99Haganauthor=J.+Pantginisauthor=H.+Zhouauthor=J.+W.+Hornerauthor=C.+Cordon-Cardoauthor=G.+D.+Yancopoulosauthor=R.+A.+DePinho&title=Essential+Role+for+Oncogenic+Ras+in+Tumour+Maintenance&doi=10.1038%2F22788"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F22788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F22788%26sid%3Dliteratum%253Aachs%26aulast%3DChin%26aufirst%3DL.%26aulast%3DTam%26aufirst%3DA.%26aulast%3DPomerantz%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DBardeesy%26aufirst%3DN.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DR.%26aulast%3DPantginis%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DHorner%26aufirst%3DJ.%2BW.%26aulast%3DCordon-Cardo%26aufirst%3DC.%26aulast%3DYancopoulos%26aufirst%3DG.%2BD.%26aulast%3DDePinho%26aufirst%3DR.%2BA.%26atitle%3DEssential%2520Role%2520for%2520Oncogenic%2520Ras%2520in%2520Tumour%2520Maintenance%26jtitle%3DNature%26date%3D1999%26volume%3D400%26issue%3D6743%26spage%3D468%26epage%3D472%26doi%3D10.1038%2F22788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vigil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherfils, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossman, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Der, C. J.</span></span> <span> </span><span class="NLM_article-title">Ras Superfamily GEFs and GAPs : Validated and Tractable Targets for Cancer Therapy ?</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">857</span>, <span class="refDoi"> DOI: 10.1038/nrc2960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnrc2960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=21102635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=842-857&author=D.+Vigilauthor=J.+Cherfilsauthor=K.+L.+Rossmanauthor=C.+J.+Der&title=Ras+Superfamily+GEFs+and+GAPs%E2%80%AF%3A+Validated+and+Tractable+Targets+for+Cancer+Therapy%E2%80%AF%3F&doi=10.1038%2Fnrc2960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?</span></div><div class="casAuthors">Vigil, Dominico; Cherfils, Jacqueline; Rossman, Kent L.; Der, Channing J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">842-857</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is now considerable and increasing evidence for a causal role for aberrant activity of the Ras superfamily of small GTPases in human cancers.  These GTPases function as GDP-GTP-regulated binary switches that control many fundamental cellular processes.  A common mechanism of GTPase deregulation in cancer is the deregulated expression and/or activity of their regulatory proteins, guanine nucleotide exchange factors (GEFs) that promote formation of the active GTP-bound state and GTPase-activating proteins (GAPs) that return the GTPase to its GDP-bound inactive state.  In this Review, we assess the assocn. of GEFs and GAPs with cancer and their druggability for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwbf8B7sLmb7Vg90H21EOLACvtfcHk0lg_5xzeCpZCvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOrsbrM&md5=b7ad81f2fe0f7f7eaa5f015188f62e85</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc2960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2960%26sid%3Dliteratum%253Aachs%26aulast%3DVigil%26aufirst%3DD.%26aulast%3DCherfils%26aufirst%3DJ.%26aulast%3DRossman%26aufirst%3DK.%2BL.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26atitle%3DRas%2520Superfamily%2520GEFs%2520and%2520GAPs%25E2%2580%25AF%253A%2520Validated%2520and%2520Tractable%2520Targets%2520for%2520Cancer%2520Therapy%25E2%2580%25AF%253F%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D842%26epage%3D857%26doi%3D10.1038%2Fnrc2960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Gramont, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheithauer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smakal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kourteva, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iveson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andre, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dostalova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belly, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Ruixo, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, P. A.</span></span> <span> </span><span class="NLM_article-title">Phase III Double-Blind Placebo-Controlled Study of Farnesyl Transferase Inhibitor R115777 in Patients With Refractory Advanced Colorectal Cancer</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">3950</span>– <span class="NLM_lpage">3957</span>, <span class="refDoi"> DOI: 10.1200/JCO.2004.10.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1200%2FJCO.2004.10.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=15459217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVKitrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=3950-3957&issue=19&author=S.+Raoauthor=D.+Cunninghamauthor=A.+de+Gramontauthor=W.+Scheithauerauthor=M.+Smakalauthor=Y.+Humbletauthor=G.+Kourtevaauthor=T.+Ivesonauthor=T.+Andreauthor=J.+Dostalovaauthor=A.+Illesauthor=R.+Bellyauthor=J.+J.+Perez-Ruixoauthor=Y.+C.+Parkauthor=P.+A.+Palmer&title=Phase+III+Double-Blind+Placebo-Controlled+Study+of+Farnesyl+Transferase+Inhibitor+R115777+in+Patients+With+Refractory+Advanced+Colorectal+Cancer&doi=10.1200%2FJCO.2004.10.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer</span></div><div class="casAuthors">Rao, S.; Cunningham, D.; de Gramont, A.; Scheithauer, W.; Smakal, M.; Humblet, Y.; Kourteva, G.; Iveson, T.; Andre, T.; Dostalova, J.; Illes, A.; Belly, R.; Perez-Ruixo, J. J.; Park, Y. C.; Palmer, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3950-3957</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The aim was to det. whether R115777 improves survival in patients with refractory advanced colorectal cancer (CRC) in a multicenter, double-blind, prospective randomized study.  Three hundred sixty-eight patients were randomly assigned to R115777 (300 mg twice daily) orally for 21 days every 28 days or placebo in a 2:1 ratio.  All patients received best supportive care.  The primary end point was overall survival; secondary end points were progression free survival, tumor response, toxicity, and quality of life.  The two treatment groups were well balanced for baseline demographics, including previous chemotherapy for advanced CRC.  The median overall survival for R115777 was 174 days (95% CI, 157 to 198 days), and 185 days (95% CI, 158 to 238 days) for those patients receiving placebo (P = .376).  One patient achieved a partial response in the R115777 arm.  Stable disease (> 3 mo) was obsd. in 24.3% patients in the R115777 group compared to 12.8% in the placebo arm.  This did not translate into a statistically significant increase in progression-free survival.  Overall, treatment was well tolerated.  There was an increased incidence of reversible myelosuppression (neutropenia, thrombocytopenia), rash, and grade 1 to 2 diarrhea in the R115777 arm.  There was no statistically significant difference in quality of life between arms.  Single agent R115777, given at this dose and schedule, has an acceptable toxicity profile, but does not improve overall survival compared to best supportive care alone in refractory advanced CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2zHZh3aOg_LVg90H21EOLACvtfcHk0lg_5xzeCpZCvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVKitrk%253D&md5=ad4efce8b8dcd644afca5e7ff6842a49</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.10.037%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DS.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3Dde%2BGramont%26aufirst%3DA.%26aulast%3DScheithauer%26aufirst%3DW.%26aulast%3DSmakal%26aufirst%3DM.%26aulast%3DHumblet%26aufirst%3DY.%26aulast%3DKourteva%26aufirst%3DG.%26aulast%3DIveson%26aufirst%3DT.%26aulast%3DAndre%26aufirst%3DT.%26aulast%3DDostalova%26aufirst%3DJ.%26aulast%3DIlles%26aufirst%3DA.%26aulast%3DBelly%26aufirst%3DR.%26aulast%3DPerez-Ruixo%26aufirst%3DJ.%2BJ.%26aulast%3DPark%26aufirst%3DY.%2BC.%26aulast%3DPalmer%26aufirst%3DP.%2BA.%26atitle%3DPhase%2520III%2520Double-Blind%2520Placebo-Controlled%2520Study%2520of%2520Farnesyl%2520Transferase%2520Inhibitor%2520R115777%2520in%2520Patients%2520With%2520Refractory%2520Advanced%2520Colorectal%2520Cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26issue%3D19%26spage%3D3950%26epage%3D3957%26doi%3D10.1200%2FJCO.2004.10.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrenton, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skelton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokoe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludlam, M. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannetti, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Ligands Bind to a Distinct Pocket in Ras and Inhibit SOS-Mediated Nucleotide Exchange Activity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5299</span>– <span class="NLM_lpage">5304</span>, <span class="refDoi"> DOI: 10.1073/pnas.1116510109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1073%2Fpnas.1116510109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=22431598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslOjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=5299-5304&issue=14&author=T.+Maurerauthor=L.+S.+Garrentonauthor=A.+Ohauthor=K.+Pittsauthor=D.+J.+Andersonauthor=N.+J.+Skeltonauthor=B.+P.+Fauberauthor=B.+Panauthor=S.+Malekauthor=D.+Stokoeauthor=M.+J.+C.+Ludlamauthor=K.+K.+Bowmanauthor=J.+Wuauthor=A.+M.+Giannettiauthor=M.+A.+Starovasnikauthor=I.+Mellmanauthor=P.+K.+Jacksonauthor=J.+Rudolphauthor=W.+Wangauthor=G.+Fang&title=Small-Molecule+Ligands+Bind+to+a+Distinct+Pocket+in+Ras+and+Inhibit+SOS-Mediated+Nucleotide+Exchange+Activity&doi=10.1073%2Fpnas.1116510109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity</span></div><div class="casAuthors">Maurer, Till; Garrenton, Lindsay S.; Oh, Angela; Pitts, Keith; Anderson, Daniel J.; Skelton, Nicholas J.; Fauber, Benjamin P.; Pan, Borlan; Malek, Shiva; Stokoe, David; Ludlam, Mary J. C.; Bowman, Krista K.; Wu, Jiansheng; Giannetti, Anthony M.; Starovasnik, Melissa A.; Mellman, Ira; Jackson, Peter K.; Rudolph, Joachim; Wang, Weiru; Fang, Guowei</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5299-5304, S5299/1-S5299/13</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The Ras gene is frequently mutated in cancer, and mutant Ras drives tumorigenesis.  Although Ras is a central oncogene, small mols. that bind to Ras in a well-defined manner and exert inhibitory effects have not been uncovered to date.  Through an NMR-based fragment screen, we identified a group of small mols. that all bind to a common site on Ras.  High-resoln. cocrystal structures delineated a unique ligand-binding pocket on the Ras protein that is adjacent to the switch I/II regions and can be expanded upon compd. binding.  Structure anal. predicts that compd.-binding interferes with the Ras/SOS interactions.  Indeed, selected compds. inhibit SOS-mediated nucleotide exchange and prevent Ras activation by blocking the formation of intermediates of the exchange reaction.  The discovery of a small-mol. binding pocket on Ras with functional significance provides a new direction in the search of therapeutically effective inhibitors of the Ras oncoprotein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAXIzMe7yBqrVg90H21EOLACvtfcHk0lippgMg77UFvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslOjsrc%253D&md5=a7210cad45154c42eb2a1faeabf88c20</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1116510109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1116510109%26sid%3Dliteratum%253Aachs%26aulast%3DMaurer%26aufirst%3DT.%26aulast%3DGarrenton%26aufirst%3DL.%2BS.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DPitts%26aufirst%3DK.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DSkelton%26aufirst%3DN.%2BJ.%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DPan%26aufirst%3DB.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DLudlam%26aufirst%3DM.%2BJ.%2BC.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGiannetti%26aufirst%3DA.%2BM.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DMellman%26aufirst%3DI.%26aulast%3DJackson%26aufirst%3DP.%2BK.%26aulast%3DRudolph%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DFang%26aufirst%3DG.%26atitle%3DSmall-Molecule%2520Ligands%2520Bind%2520to%2520a%2520Distinct%2520Pocket%2520in%2520Ras%2520and%2520Inhibit%2520SOS-Mediated%2520Nucleotide%2520Exchange%2520Activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26issue%3D14%26spage%3D5299%26epage%3D5304%26doi%3D10.1073%2Fpnas.1116510109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of Small Molecules That Bind to K-Ras and Inhibit Sos-Mediated Activation</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">6140</span>– <span class="NLM_lpage">6143</span>, <span class="refDoi"> DOI: 10.1002/anie.201201358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1002%2Fanie.201201358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1entr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=6140-6143&issue=25&author=Q.+Sunauthor=J.+P.+Burkeauthor=J.+Phanauthor=M.+C.+Burnsauthor=E.+T.+Olejniczakauthor=A.+G.+Watersonauthor=T.+Leeauthor=O.+W.+Rossaneseauthor=S.+W.+Fesik&title=Discovery+of+Small+Molecules+That+Bind+to+K-Ras+and+Inhibit+Sos-Mediated+Activation&doi=10.1002%2Fanie.201201358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation</span></div><div class="casAuthors">Sun, Qi; Burke, Jason P.; Phan, Jason; Burns, Michael C.; Olejniczak, Edward T.; Waterson, Alex G.; Lee, Taekyu; Rossanese, Olivia W.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6140-6143, S6140/1-S6140/17</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">K-Ras inhibition represents an attractive therapeutic strategy for many cancers.  We report on the discovery of novel small mols. that bind directly to K-Ras between switch I and switch II and inhibit Sos-catalyzed K-Ras activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy5Cx7BSO1pLVg90H21EOLACvtfcHk0lippgMg77UFvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1entr4%253D&md5=7d579523462aaf7eac1890643f91fab3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fanie.201201358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201201358%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DBurke%26aufirst%3DJ.%2BP.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520Small%2520Molecules%2520That%2520Bind%2520to%2520K-Ras%2520and%2520Inhibit%2520Sos-Mediated%2520Activation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26issue%3D25%26spage%3D6140%26epage%3D6143%26doi%3D10.1002%2Fanie.201201358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karaguni, I.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpintero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourzoulidou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brockmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oschkinat, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, O.</span></span> <span> </span><span class="NLM_article-title">Sulindac-Derived Ras Pathway Inhibitors Target the Ras–Raf Interaction and Downstream Effectors in the Ras Pathway</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1002/anie.200353089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1002%2Fanie.200353089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=454-458&issue=4&author=H.+Waldmannauthor=I.-M.+Karaguniauthor=M.+Carpinteroauthor=E.+Gourzoulidouauthor=C.+Herrmannauthor=C.+Brockmannauthor=H.+Oschkinatauthor=O.+M%C3%BCller&title=Sulindac-Derived+Ras+Pathway+Inhibitors+Target+the+Ras%E2%80%93Raf+Interaction+and+Downstream+Effectors+in+the+Ras+Pathway&doi=10.1002%2Fanie.200353089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fanie.200353089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200353089%26sid%3Dliteratum%253Aachs%26aulast%3DWaldmann%26aufirst%3DH.%26aulast%3DKaraguni%26aufirst%3DI.-M.%26aulast%3DCarpintero%26aufirst%3DM.%26aulast%3DGourzoulidou%26aufirst%3DE.%26aulast%3DHerrmann%26aufirst%3DC.%26aulast%3DBrockmann%26aufirst%3DC.%26aulast%3DOschkinat%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DO.%26atitle%3DSulindac-Derived%2520Ras%2520Pathway%2520Inhibitors%2520Target%2520the%2520Ras%25E2%2580%2593Raf%2520Interaction%2520and%2520Downstream%2520Effectors%2520in%2520the%2520Ras%2520Pathway%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26issue%3D4%26spage%3D454%26epage%3D458%26doi%3D10.1002%2Fanie.200353089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosnizeck, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spoerner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tränkle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filchtinski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gremer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittinghofer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalbitzer, H. R.</span></span> <span> </span><span class="NLM_article-title">Stabilizing a Weak Binding State for Effectors in the Human Ras Protein by Cyclen Complexes</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">3830</span>– <span class="NLM_lpage">3833</span>, <span class="refDoi"> DOI: 10.1002/anie.200907002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1002%2Fanie.200907002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=3830-3833&issue=22&author=I.+C.+Rosnizeckauthor=T.+Grafauthor=M.+Spoernerauthor=J.+Tr%C3%A4nkleauthor=D.+Filchtinskiauthor=C.+Herrmannauthor=L.+Gremerauthor=I.+R.+Vetterauthor=A.+Wittinghoferauthor=B.+K%C3%B6nigauthor=H.+R.+Kalbitzer&title=Stabilizing+a+Weak+Binding+State+for+Effectors+in+the+Human+Ras+Protein+by+Cyclen+Complexes&doi=10.1002%2Fanie.200907002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fanie.200907002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200907002%26sid%3Dliteratum%253Aachs%26aulast%3DRosnizeck%26aufirst%3DI.%2BC.%26aulast%3DGraf%26aufirst%3DT.%26aulast%3DSpoerner%26aufirst%3DM.%26aulast%3DTr%25C3%25A4nkle%26aufirst%3DJ.%26aulast%3DFilchtinski%26aufirst%3DD.%26aulast%3DHerrmann%26aufirst%3DC.%26aulast%3DGremer%26aufirst%3DL.%26aulast%3DVetter%26aufirst%3DI.%2BR.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DK%25C3%25B6nig%26aufirst%3DB.%26aulast%3DKalbitzer%26aufirst%3DH.%2BR.%26atitle%3DStabilizing%2520a%2520Weak%2520Binding%2520State%2520for%2520Effectors%2520in%2520the%2520Human%2520Ras%2520Protein%2520by%2520Cyclen%2520Complexes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26issue%3D22%26spage%3D3830%26epage%3D3833%26doi%3D10.1002%2Fanie.200907002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, J.</span></span> <span> </span><span class="NLM_article-title">Ras Inhibition via Direct Ras Binding—is There a Path Forward?</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5766</span>– <span class="NLM_lpage">5776</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2Fj.bmcl.2012.07.082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5766-5776&issue=18&author=W.+Wangauthor=G.+Fangauthor=J.+Rudolph&title=Ras+Inhibition+via+Direct+Ras+Binding%E2%80%94is+There+a+Path+Forward%3F&doi=10.1016%2Fj.bmcl.2012.07.082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.082%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DRudolph%26aufirst%3DJ.%26atitle%3DRas%2520Inhibition%2520via%2520Direct%2520Ras%2520Binding%25E2%2580%2594is%2520There%2520a%2520Path%2520Forward%253F%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D18%26spage%3D5766%26epage%3D5776%26doi%3D10.1016%2Fj.bmcl.2012.07.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hocker, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rambahal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagineedu, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanslas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorfe, A. A.</span></span> <span> </span><span class="NLM_article-title">Andrographolide Derivatives Inhibit Guanine Nucleotide Exchange and Abrogate Oncogenic Ras Function</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">10201</span>– <span class="NLM_lpage">10206</span>, <span class="refDoi"> DOI: 10.1073/pnas.1300016110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1073%2Fpnas.1300016110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=23737504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOmsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10201-10206&issue=25&author=H.+J.+Hockerauthor=K.-J.+Choauthor=C.-Y.+K.+Chenauthor=N.+Rambahalauthor=S.+R.+Sagineeduauthor=K.+Shaariauthor=J.+Stanslasauthor=J.+F.+Hancockauthor=A.+A.+Gorfe&title=Andrographolide+Derivatives+Inhibit+Guanine+Nucleotide+Exchange+and+Abrogate+Oncogenic+Ras+Function&doi=10.1073%2Fpnas.1300016110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function</span></div><div class="casAuthors">Hocker, Harrison J.; Cho, Kwang-Jin; Chen, Chung-Ying K.; Rambahal, Nandini; Sagineedu, Sreenivasa Rao; Shaari, Khozirah; Stanslas, Johnson; Hancock, John F.; Gorfe, Alemayehu A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">10201-10206, S10201/1-S10201/12</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aberrant signaling by oncogenic mutant rat sarcoma (Ras) proteins occurs in ∼15% of all human tumors, yet direct inhibition of Ras by small mols. has remained elusive.  Recently, several small-mol. ligands have been discovered that directly bind Ras and inhibit its function by interfering with exchange factor binding.  However, it is unclear whether, or how, these ligands could lead to drugs that act against constitutively active oncogenic mutant Ras.  Using a dynamics-based pocket identification scheme, ensemble docking, and innovative cell-based assays, here we show that andrographolide (AGP) - a bicyclic diterpenoid lactone isolated from Andrographis paniculata - and its benzylidene derivs. bind to transient pockets on Kirsten-Ras (K-Ras) and inhibit GDP-GTP exchange.  As expected for inhibitors of exchange factor binding, AGP derivs. reduced GTP loading of wild-type K-Ras in response to acute EGF stimulation with a concomitant redn. in MAPK activation.  Remarkably, however, prolonged treatment with AGP derivs. also reduced GTP loading of, and signal transmission by, oncogenic mutant K-RasG12V.  In sum, the combined anal. of our computational and cell biol. results show that AGP derivs. directly bind Ras, block GDP-GTP exchange, and inhibit both wild-type and oncogenic K-Ras signaling.  Importantly, our findings not only show that nucleotide exchange factors are required for oncogenic Ras signaling but also demonstrate that inhibiting nucleotide exchange is a valid approach to abrogating the function of oncogenic mutant Ras.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCdMqypiyfGrVg90H21EOLACvtfcHk0liI0cBcGn-6ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOmsLzP&md5=7d39d426f5b107b87ad76cb8eb9a7f26</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1300016110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1300016110%26sid%3Dliteratum%253Aachs%26aulast%3DHocker%26aufirst%3DH.%2BJ.%26aulast%3DCho%26aufirst%3DK.-J.%26aulast%3DChen%26aufirst%3DC.-Y.%2BK.%26aulast%3DRambahal%26aufirst%3DN.%26aulast%3DSagineedu%26aufirst%3DS.%2BR.%26aulast%3DShaari%26aufirst%3DK.%26aulast%3DStanslas%26aufirst%3DJ.%26aulast%3DHancock%26aufirst%3DJ.%2BF.%26aulast%3DGorfe%26aufirst%3DA.%2BA.%26atitle%3DAndrographolide%2520Derivatives%2520Inhibit%2520Guanine%2520Nucleotide%2520Exchange%2520and%2520Abrogate%2520Oncogenic%2520Ras%2520Function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D25%26spage%3D10201%26epage%3D10206%26doi%3D10.1073%2Fpnas.1300016110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostrem, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sos, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">K-Ras(G12C) Inhibitors Allosterically Control GTP Affinity and Effector Interactions</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>503</i></span> (<span class="NLM_issue">7477</span>),  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1038/nature12796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnature12796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=24256730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=548-551&issue=7477&author=J.+M.+Ostremauthor=U.+Petersauthor=M.+L.+Sosauthor=J.+A.+Wellsauthor=K.+M.+Shokat&title=K-Ras%28G12C%29+Inhibitors+Allosterically+Control+GTP+Affinity+and+Effector+Interactions&doi=10.1038%2Fnature12796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions</span></div><div class="casAuthors">Ostrem, Jonathan M.; Peters, Ulf; Sos, Martin L.; Wells, James A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">7477</span>),
    <span class="NLM_cas:pages">548-551</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Somatic mutations in the small GTPase K-Ras are the most common activating lesions found in human cancer, and are generally assocd. with poor response to std. therapies.  Efforts to target this oncogene directly have faced difficulties owing to its picomolar affinity for GTP/GDP and the absence of known allosteric regulatory sites.  Oncogenic mutations result in functional activation of Ras family proteins by impairing GTP hydrolysis.  With diminished regulation by GTPase activity, the nucleotide state of Ras becomes more dependent on relative nucleotide affinity and concn.  This gives GTP an advantage over GDP and increases the proportion of active GTP-bound Ras.  Here we report the development of small mols. that irreversibly bind to a common oncogenic mutant, K-Ras(G12C).  These compds. rely on the mutant cysteine for binding and therefore do not affect the wild-type protein.  Crystallog. studies reveal the formation of a new pocket that is not apparent in previous structures of Ras, beneath the effector binding switch-II region.  Binding of these inhibitors to K-Ras(G12C) disrupts both switch-I and switch-II, subverting the native nucleotide preference to favor GDP over GTP and impairing binding to Raf.  Our data provide structure-based validation of a new allosteric regulatory site on Ras that is targetable in a mutant-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokkgcVXuBn_rVg90H21EOLACvtfcHk0liI0cBcGn-6ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqs7jO&md5=27c1e7d8ef6b7e4b2919e9f00a073923</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature12796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12796%26sid%3Dliteratum%253Aachs%26aulast%3DOstrem%26aufirst%3DJ.%2BM.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DK-Ras%2528G12C%2529%2520Inhibitors%2520Allosterically%2520Control%2520GTP%2520Affinity%2520and%2520Effector%2520Interactions%26jtitle%3DNature%26date%3D2013%26volume%3D503%26issue%3D7477%26spage%3D548%26epage%3D551%26doi%3D10.1038%2Fnature12796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shima, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijiri, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, K. -i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyakawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukunishi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumasaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, T.</span></span> <span> </span><span class="NLM_article-title">In Silico Discovery of Small-Molecule Ras Inhibitors That Display Antitumor Activity by Blocking the Ras-Effector Interaction</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8182</span>– <span class="NLM_lpage">8187</span>, <span class="refDoi"> DOI: 10.1073/pnas.1217730110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1073%2Fpnas.1217730110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=23630290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2ksL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=8182-8187&issue=20&author=F.+Shimaauthor=Y.+Yoshikawaauthor=M.+Yeauthor=M.+Arakiauthor=S.+Matsumotoauthor=J.+Liaoauthor=L.+Huauthor=T.+Sugimotoauthor=Y.+Ijiriauthor=A.+Takedaauthor=Y.+Nishiyamaauthor=C.+Satoauthor=S.+Muraokaauthor=A.+Tamuraauthor=T.+Osodaauthor=K.+-i.+Tsudaauthor=T.+Miyakawaauthor=H.+Fukunishiauthor=J.+Shimadaauthor=T.+Kumasakaauthor=M.+Yamamotoauthor=T.+Kataoka&title=In+Silico+Discovery+of+Small-Molecule+Ras+Inhibitors+That+Display+Antitumor+Activity+by+Blocking+the+Ras-Effector+Interaction&doi=10.1073%2Fpnas.1217730110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction</span></div><div class="casAuthors">Shima, Fumi; Yoshikawa, Yoko; Ye, Min; Araki, Mitsugu; Matsumoto, Shigeyuki; Liao, Jingling; Hu, Lizhi; Sugimoto, Takeshi; Ijiri, Yuichi; Takeda, Azusa; Nishiyama, Yuko; Sato, Chie; Muraoka, Shin; Tamura, Atsuo; Osoda, Tsutomu; Tsuda, Ken-ichiro; Miyakawa, Tomoya; Fukunishi, Hiroaki; Shimada, Jiro; Kumasaka, Takashi; Yamamoto, Masaki; Kataoka, Tohru</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8182-8187, S8182/1-S8182/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutational activation of the Ras oncogene products (H-Ras, K-Ras, and N-Ras) is frequently obsd. in human cancers, making them promising anticancer drug targets.  Nonetheless, no effective strategy has been available for the development of Ras inhibitors, partly owing to the absence of well-defined surface pockets suitable for drug binding.  Only recently, such pockets have been found in the crystal structures of a unique conformation of Ras·GTP.  Here we report the successful development of small-mol. Ras inhibitors by an in silico screen targeting a pocket found in the crystal structure of M-Ras·GTP carrying an H-Ras-type substitution P40D.  The selected compd. Kobe0065 and its analog Kobe2602 exhibit inhibitory activity toward H-Ras·GTP-c-Raf-1 binding both in vivo and in vitro.  They effectively inhibit both anchorage-dependent and -independent growth and induce apoptosis of H-rasG12V-transformed NIH 3T3 cells, which is accompanied by down-regulation of downstream mols. such as MEK/ERK, Akt, and RalA as well as an upstream mol., Son of sevenless.  Moreover, they exhibit antitumor activity on a xenograft of human colon carcinoma SW480 cells carrying the K-rasG12V gene by oral administration.  The NMR structure of a complex of the compd. with H-Ras·GTPT355, exclusively adopting the unique conformation, confirms its insertion into one of the surface pockets and provides a mol. basis for binding inhibition toward multiple RasGTP-interacting mols.  This study proves the effectiveness of our strategy for structure-based drug design to target Ras·GTP, and the resulting Kobe0065-family compds. may serve as a scaffold for the development of Ras inhibitors with higher potency and specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWk-yi5md5AbVg90H21EOLACvtfcHk0lg23usavaAx5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2ksL3K&md5=aa6569874162595cf17825f2528b4cd3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1217730110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1217730110%26sid%3Dliteratum%253Aachs%26aulast%3DShima%26aufirst%3DF.%26aulast%3DYoshikawa%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DAraki%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DSugimoto%26aufirst%3DT.%26aulast%3DIjiri%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DNishiyama%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DC.%26aulast%3DMuraoka%26aufirst%3DS.%26aulast%3DTamura%26aufirst%3DA.%26aulast%3DOsoda%26aufirst%3DT.%26aulast%3DTsuda%26aufirst%3DK.%2B-i.%26aulast%3DMiyakawa%26aufirst%3DT.%26aulast%3DFukunishi%26aufirst%3DH.%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DKumasaka%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKataoka%26aufirst%3DT.%26atitle%3DIn%2520Silico%2520Discovery%2520of%2520Small-Molecule%2520Ras%2520Inhibitors%2520That%2520Display%2520Antitumor%2520Activity%2520by%2520Blocking%2520the%2520Ras-Effector%2520Interaction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D20%26spage%3D8182%26epage%3D8187%26doi%3D10.1073%2Fpnas.1217730110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cromm, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Modulation of Ras Signaling</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnchembio.1560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=24929527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslGisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=613-622&issue=8&author=J.+Spiegelauthor=P.+M.+Crommauthor=G.+Zimmermannauthor=T.+N.+Grossmannauthor=H.+Waldmann&title=Small-Molecule+Modulation+of+Ras+Signaling&doi=10.1038%2Fnchembio.1560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule modulation of Ras signaling</span></div><div class="casAuthors">Spiegel, Jochen; Cromm, Philipp M.; Zimmermann, Gunther; Grossmann, Tom N.; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">613-622</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite intense efforts in pharmaceutical industry and academia, a therapeutic grip on oncogenic Ras proteins has remained elusive.  Mutated Ras is assocd. with ∼20-30% of all human cancers often not responsive to established therapies.  In particular, K-Ras, the most frequently mutated Ras isoform, is considered one of the most important but 'undruggable' targets in cancer research.  Recently, new cavities on Ras for small-mol. ligands were identified, and selective direct targeting of mutated K-RasG12C has become possible for what is to our knowledge the first time.  In addn., impairment of Ras spatial organization, in particular via targeting the prenyl-binding Ras chaperone PDEδ, has opened a fresh perspective in anticancer research.  These recent advances fuel hopes for the development of new drugs targeting Ras.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTcp4dzeVKK7Vg90H21EOLACvtfcHk0lg23usavaAx5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslGisbw%253D&md5=f8d84f054e1b392cf6bfe55d5e235c28</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1560%26sid%3Dliteratum%253Aachs%26aulast%3DSpiegel%26aufirst%3DJ.%26aulast%3DCromm%26aufirst%3DP.%2BM.%26aulast%3DZimmermann%26aufirst%3DG.%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DSmall-Molecule%2520Modulation%2520of%2520Ras%2520Signaling%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26issue%3D8%26spage%3D613%26epage%3D622%26doi%3D10.1038%2Fnchembio.1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leshchiner, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkhitko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luccarelli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellairs, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escudero, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opoku-Nsiah, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrimon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walensky, L. D.</span></span> <span> </span><span class="NLM_article-title">Direct Inhibition of Oncogenic KRAS by Hydrocarbon-Stapled SOS1 Helices</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1761</span>– <span class="NLM_lpage">1766</span>, <span class="refDoi"> DOI: 10.1073/pnas.1413185112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1073%2Fpnas.1413185112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=25624485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVehsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=1761-1766&issue=6&author=E.+S.+Leshchinerauthor=A.+Parkhitkoauthor=G.+H.+Birdauthor=J.+Luccarelliauthor=J.+A.+Bellairsauthor=S.+Escuderoauthor=K.+Opoku-Nsiahauthor=M.+Godesauthor=N.+Perrimonauthor=L.+D.+Walensky&title=Direct+Inhibition+of+Oncogenic+KRAS+by+Hydrocarbon-Stapled+SOS1+Helices&doi=10.1073%2Fpnas.1413185112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices</span></div><div class="casAuthors">Leshchiner, Elizaveta S.; Parkhitko, Andrey; Bird, Gregory H.; Luccarelli, James; Bellairs, Joseph A.; Escudero, Silvia; Opoku-Nsiah, Kwadwo; Godes, Marina; Perrimon, Norbert; Walensky, Loren D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1761-1766</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Activating mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS) underlie the pathogenesis and chemoresistance of ∼30% of all human tumors, yet the development of high-affinity inhibitors that target the broad range of KRAS mutants remains a formidable challenge.  Here, we report the development and validation of stabilized alpha helixes of son of sevenless 1 (SAH-SOS1) as prototype therapeutics that directly inhibit wild-type and mutant forms of KRAS.  SAH-SOS1 peptides bound in a sequence-specific manner to KRAS and its mutants, and dose-responsively blocked nucleotide assocn.  Importantly, this functional binding activity correlated with SAH-SOS1 cytotoxicity in cancer cells expressing wild-type or mutant forms of KRAS.  The mechanism of action of SAH-SOS1 peptides was demonstrated by sequence-specific down-regulation of the ERK-MAP kinase phosphosignaling cascade in KRAS-driven cancer cells and in a Drosophila melanogaster model of Ras85DV12 activation.  These studies provide evidence for the potential utility of SAH-SOS1 peptides in neutralizing oncogenic KRAS in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6mCxAisFrUrVg90H21EOLACvtfcHk0li4KYJngluO8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVehsL4%253D&md5=76d80d9084cd9646485986cb9277a9c0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1413185112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1413185112%26sid%3Dliteratum%253Aachs%26aulast%3DLeshchiner%26aufirst%3DE.%2BS.%26aulast%3DParkhitko%26aufirst%3DA.%26aulast%3DBird%26aufirst%3DG.%2BH.%26aulast%3DLuccarelli%26aufirst%3DJ.%26aulast%3DBellairs%26aufirst%3DJ.%2BA.%26aulast%3DEscudero%26aufirst%3DS.%26aulast%3DOpoku-Nsiah%26aufirst%3DK.%26aulast%3DGodes%26aufirst%3DM.%26aulast%3DPerrimon%26aufirst%3DN.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26atitle%3DDirect%2520Inhibition%2520of%2520Oncogenic%2520KRAS%2520by%2520Hydrocarbon-Stapled%2520SOS1%2520Helices%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26issue%3D6%26spage%3D1761%26epage%3D1766%26doi%3D10.1073%2Fpnas.1413185112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostrem, J. M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span> <span> </span><span class="NLM_article-title">Direct Small-Molecule Inhibitors of KRAS: From Structural Insights to Mechanism-Based Design</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnrd.2016.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=27469033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=771-785&issue=11&author=J.+M.+L.+Ostremauthor=K.+M.+Shokat&title=Direct+Small-Molecule+Inhibitors+of+KRAS%3A+From+Structural+Insights+to+Mechanism-Based+Design&doi=10.1038%2Fnrd.2016.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design</span></div><div class="casAuthors">Ostrem, Jonathan M. L.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">771-785</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">KRAS is the most frequently mutated oncogene in human cancer.  In addn. to holding this distinction, unsuccessful attempts to target this protein have led to the characterization of RAS as 'undruggable'.  However, recent advances in technol. and novel approaches to drug discovery have renewed hope that a direct KRAS inhibitor may be on the horizon.  In this Review, we provide an in-depth anal. of the structure, dynamics, mutational activation and inactivation, and signalling mechanisms of RAS.  From this perspective, we then consider potential mechanisms of action for effective RAS inhibitors.  Finally, we examine each of the many recent reports of direct RAS inhibitors and discuss promising avenues for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBobrhZLF3V7Vg90H21EOLACvtfcHk0li4KYJngluO8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FK&md5=b0832c7ef45cc0555e11c59baccc5abd</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.139%26sid%3Dliteratum%253Aachs%26aulast%3DOstrem%26aufirst%3DJ.%2BM.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DDirect%2520Small-Molecule%2520Inhibitors%2520of%2520KRAS%253A%2520From%2520Structural%2520Insights%2520to%2520Mechanism-Based%2520Design%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26issue%3D11%26spage%3D771%26epage%3D785%26doi%3D10.1038%2Fnrd.2016.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, F.</span></span> <span> </span><span class="NLM_article-title">The GTPase Superfamily: A Conserved Switch for Diverse Cell Functions</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>348</i></span> (<span class="NLM_issue">6297</span>),  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1038/348125a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2F348125a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=2122258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADyaK3MXhvFyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=1990&pages=125-132&issue=6297&author=H.+R.+Bourneauthor=D.+A.+Sandersauthor=F.+McCormick&title=The+GTPase+Superfamily%3A+A+Conserved+Switch+for+Diverse+Cell+Functions&doi=10.1038%2F348125a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The GTPase superfamily:  a conserved switch for diverse cell functions</span></div><div class="casAuthors">Bourne, Henry R.; Sanders, David A.; McCormick, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">6297</span>),
    <span class="NLM_cas:pages">125-32</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">A review with 129 refs., on GTPases as mol. switches whose on and off states are triggered by binding and hydrolysis of GTP.  Conserved structure and mechanism in myriad versions of the switch, in bacteria, yeast, insects, and vertebrates, suggest that all derive from a single primordial protein, repeatedly modified in the course of evolution to perform a wide variety of functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3f0MIHO0zb7Vg90H21EOLACvtfcHk0li4KYJngluO8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhvFyjtQ%253D%253D&md5=c2365e283558479acbdf5487709ceac2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2F348125a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F348125a0%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DH.%2BR.%26aulast%3DSanders%26aufirst%3DD.%2BA.%26aulast%3DMcCormick%26aufirst%3DF.%26atitle%3DThe%2520GTPase%2520Superfamily%253A%2520A%2520Conserved%2520Switch%2520for%2520Diverse%2520Cell%2520Functions%26jtitle%3DNature%26date%3D1990%26volume%3D348%26issue%3D6297%26spage%3D125%26epage%3D132%26doi%3D10.1038%2F348125a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konstantinopoulos, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karamouzis, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papavassiliou, A. G.</span></span> <span> </span><span class="NLM_article-title">Post-Translational Modifications and Regulation of the RAS Superfamily of GTPases as Anticancer Targets</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.1038/nrd2221</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnrd2221" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=541-555&issue=7&author=P.+A.+Konstantinopoulosauthor=M.+V.+Karamouzisauthor=A.+G.+Papavassiliou&title=Post-Translational+Modifications+and+Regulation+of+the+RAS+Superfamily+of+GTPases+as+Anticancer+Targets&doi=10.1038%2Fnrd2221"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrd2221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2221%26sid%3Dliteratum%253Aachs%26aulast%3DKonstantinopoulos%26aufirst%3DP.%2BA.%26aulast%3DKaramouzis%26aufirst%3DM.%2BV.%26aulast%3DPapavassiliou%26aufirst%3DA.%2BG.%26atitle%3DPost-Translational%2520Modifications%2520and%2520Regulation%2520of%2520the%2520RAS%2520Superfamily%2520of%2520GTPases%2520as%2520Anticancer%2520Targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26issue%3D7%26spage%3D541%26epage%3D555%26doi%3D10.1038%2Fnrd2221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeng, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Sagi, D.</span></span> <span> </span><span class="NLM_article-title">Sos-Mediated Cross-Activation of Wild-Type Ras by Oncogenic Ras Is Essential for Tumorigenesis</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1168</span>, <span class="refDoi"> DOI: 10.1038/ncomms2173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fncomms2173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=23132018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A280%3ADC%252BC3s7hsVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1168&author=H.-H.+Jengauthor=L.+J.+Taylorauthor=D.+Bar-Sagi&title=Sos-Mediated+Cross-Activation+of+Wild-Type+Ras+by+Oncogenic+Ras+Is+Essential+for+Tumorigenesis&doi=10.1038%2Fncomms2173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sos-mediated cross-activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis</span></div><div class="casAuthors">Jeng Hao-Hsuan; Taylor Laura J; Bar-Sagi Dafna</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1168</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Mammalian cells contain three closely related ras genes, H-ras, K-ras and N-ras.  Although in a given tumour type, oncogenic mutations are selectively observed in only one of the ras genes, the acquisition of the transformed phenotype has been shown to require the contribution of the normal products of the other ras genes.  Here we demonstrate that oncogenic K-Ras promotes the activation of wild-type H- and N-Ras.  This activation is mediated by oncogenic K-Ras-dependent allosteric stimulation of Sos and confers a growth advantage to oncogenic K-Ras harbouring cancer cells.  These findings underscore the complementary functions of oncogenic and wild-type Ras in tumour cells and identify a potential new targeting strategy for Ras-driven tumours.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxasvmDUX5qczK395ZObgVfW6udTcc2eYEcMmp2OhwErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7hsVCjsA%253D%253D&md5=6a6d220101045790cf83c770f11e78fe</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fncomms2173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms2173%26sid%3Dliteratum%253Aachs%26aulast%3DJeng%26aufirst%3DH.-H.%26aulast%3DTaylor%26aufirst%3DL.%2BJ.%26aulast%3DBar-Sagi%26aufirst%3DD.%26atitle%3DSos-Mediated%2520Cross-Activation%2520of%2520Wild-Type%2520Ras%2520by%2520Oncogenic%2520Ras%2520Is%2520Essential%2520for%2520Tumorigenesis%26jtitle%3DNat.%2520Commun.%26date%3D2012%26volume%3D3%26spage%3D1168%26doi%3D10.1038%2Fncomms2173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J. J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brassington, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breeze, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chresta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embrey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairley, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadola, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, G.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Binding Sites on the Ras:SOS Complex Can Be Exploited for Inhibition of Ras Activation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2265</span>– <span class="NLM_lpage">2274</span>, <span class="refDoi"> DOI: 10.1021/jm501660t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501660t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2265-2274&issue=5&author=J.+J.+G.+Winterauthor=M.+Andersonauthor=K.+Bladesauthor=C.+Brassingtonauthor=A.+L.+Breezeauthor=C.+Chrestaauthor=K.+Embreyauthor=G.+Fairleyauthor=P.+Faulderauthor=M.+R.+V.+Finlayauthor=J.+G.+Kettleauthor=T.+Nowakauthor=R.+Overmanauthor=S.+J.+Patelauthor=P.+Perkinsauthor=L.+Spadolaauthor=J.+Tartauthor=J.+A.+Tuckerauthor=G.+Wrigley&title=Small+Molecule+Binding+Sites+on+the+Ras%3ASOS+Complex+Can+Be+Exploited+for+Inhibition+of+Ras+Activation&doi=10.1021%2Fjm501660t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm501660t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501660t%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DJ.%2BJ.%2BG.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DBrassington%26aufirst%3DC.%26aulast%3DBreeze%26aufirst%3DA.%2BL.%26aulast%3DChresta%26aufirst%3DC.%26aulast%3DEmbrey%26aufirst%3DK.%26aulast%3DFairley%26aufirst%3DG.%26aulast%3DFaulder%26aufirst%3DP.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DKettle%26aufirst%3DJ.%2BG.%26aulast%3DNowak%26aufirst%3DT.%26aulast%3DOverman%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%2BJ.%26aulast%3DPerkins%26aufirst%3DP.%26aulast%3DSpadola%26aufirst%3DL.%26aulast%3DTart%26aufirst%3DJ.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWrigley%26aufirst%3DG.%26atitle%3DSmall%2520Molecule%2520Binding%2520Sites%2520on%2520the%2520Ras%253ASOS%2520Complex%2520Can%2520Be%2520Exploited%2520for%2520Inhibition%2520of%2520Ras%2520Activation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D5%26spage%3D2265%26epage%3D2274%26doi%3D10.1021%2Fjm501660t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Approach for Targeting Ras with Small Molecules That Activate SOS-Mediated Nucleotide Exchange</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">3401</span>– <span class="NLM_lpage">3406</span>, <span class="refDoi"> DOI: 10.1073/pnas.1315798111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1073%2Fpnas.1315798111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=24550516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtl2mtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=3401-3406&author=M.+C.+Burnsauthor=Q.+Sunauthor=R.+N.+Danielsauthor=D.+Camperauthor=J.+P.+Kennedyauthor=J.+Phanauthor=E.+T.+Olejniczakauthor=T.+Leeauthor=A.+G.+Watersonauthor=O.+W.+Rossaneseauthor=S.+W.+Fesik&title=Approach+for+Targeting+Ras+with+Small+Molecules+That+Activate+SOS-Mediated+Nucleotide+Exchange&doi=10.1073%2Fpnas.1315798111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange</span></div><div class="casAuthors">Burns, Michael C.; Sun, Qi; Daniels, R. Nathan; Camper, DeMarco; Kennedy, J. Phillip; Phan, Jason; Olejniczak, Edward T.; Lee, Taekyu; Waterson, Alex G.; Rossanese, Olivia W.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3401-3406</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aberrant activation of the small GTPase Ras by oncogenic mutation or constitutively active upstream receptor tyrosine kinases results in the deregulation of cellular signals governing growth and survival in ∼30% of all human cancers.  However, the discovery of potent inhibitors of Ras has been difficult to achieve.  Here, we report the identification of small mols. that bind to a unique pocket on the Ras:Son of Sevenless (SOS):Ras complex, increase the rate of SOS-catalyzed nucleotide exchange in vitro, and modulate Ras signaling pathways in cells.  X-ray crystallog. of Ras:SOS:Ras in complex with these mols. reveals that the compds. bind in a hydrophobic pocket in the CDC25 domain of SOS adjacent to the Switch II region of Ras.  The structure-activity relationships exhibited by these compds. can be rationalized on the basis of multiple x-ray cocrystal structures.  Mutational analyses confirmed the functional relevance of this binding site and showed it to be essential for compd. activity.  These mols. increase Ras-GTP levels and disrupt MAPK and PI3K signaling in cells at low micromolar concns.  These small mols. represent tools to study the acute activation of Ras and highlight a pocket on SOS that may be exploited to modulate Ras signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl9pTZ-cO_8rVg90H21EOLACvtfcHk0lgy5raO31B0xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtl2mtrc%253D&md5=aefb332e4acb9de6731f206383bcca6f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1315798111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1315798111%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DCamper%26aufirst%3DD.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DApproach%2520for%2520Targeting%2520Ras%2520with%2520Small%2520Molecules%2520That%2520Activate%2520SOS-Mediated%2520Nucleotide%2520Exchange%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D3401%26epage%3D3406%26doi%3D10.1073%2Fpnas.1315798111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodges, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobolik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beesetty, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of Aminopiperidine Indoles That Activate the Guanine Nucleotide Exchange Factor SOS1 and Modulate RAS Signaling</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">6002</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00360</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00360" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6002-6017&issue=14&author=J.+R.+Abbottauthor=T.+R.+Hodgesauthor=R.+N.+Danielsauthor=P.+A.+Patelauthor=J.+P.+Kennedyauthor=J.+E.+Howesauthor=D.+T.+Akanauthor=M.+C.+Burnsauthor=J.+Saiauthor=T.+Sobolikauthor=Y.+Beesettyauthor=T.+Leeauthor=O.+W.+Rossaneseauthor=J.+Phanauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Discovery+of+Aminopiperidine+Indoles+That+Activate+the+Guanine+Nucleotide+Exchange+Factor+SOS1+and+Modulate+RAS+Signaling&doi=10.1021%2Facs.jmedchem.8b00360"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00360%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DJ.%2BR.%26aulast%3DHodges%26aufirst%3DT.%2BR.%26aulast%3DDaniels%26aufirst%3DR.%2BN.%26aulast%3DPatel%26aufirst%3DP.%2BA.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DSai%26aufirst%3DJ.%26aulast%3DSobolik%26aufirst%3DT.%26aulast%3DBeesetty%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520Aminopiperidine%2520Indoles%2520That%2520Activate%2520the%2520Guanine%2520Nucleotide%2520Exchange%2520Factor%2520SOS1%2520and%2520Modulate%2520RAS%2520Signaling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D14%26spage%3D6002%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.8b00360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browning, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of Quinazolines That Activate SOS1-Mediated Nucleotide Exchange on RAS</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">941</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00296</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00296" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOjsLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=941&author=J.+R.+Abbottauthor=P.+A.+Patelauthor=J.+E.+Howesauthor=D.+T.+Akanauthor=J.+P.+Kennedyauthor=M.+C.+Burnsauthor=C.+F.+Browningauthor=Q.+Sunauthor=O.+W.+Rossaneseauthor=J.+Phanauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Discovery+of+Quinazolines+That+Activate+SOS1-Mediated+Nucleotide+Exchange+on+RAS&doi=10.1021%2Facsmedchemlett.8b00296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Quinazolines That Activate SOS1-Mediated Nucleotide Exchange on RAS</span></div><div class="casAuthors">Abbott, Jason R.; Patel, Pratiq A.; Howes, Jennifer E.; Akan, Denis T.; Kennedy, J. Phillip; Burns, Michael C.; Browning, Carrie F.; Sun, Qi; Rossanese, Olivia W.; Phan, Jason; Waterson, Alex G.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">941-946</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proteins in the RAS family are important regulators of cellular signaling and, when mutated, can drive cancer pathogenesis.  Despite considerable effort over the last 30 years, RAS proteins have proven to be recalcitrant therapeutic targets.  One approach for modulating RAS signaling is to target proteins that interact with RAS, such as the guanine nucleotide exchange factor (GEF) son of sevenless homolog 1 (SOS1).  Here, we report hit-to-lead studies on quinazoline-contg. compds. that bind to SOS1 and activate nucleotide exchange on RAS.  Using structure-based design, we refined the substituents attached to the quinazoline nucleus and built in addnl. interactions not present in the initial HTS hit.  Optimized compds. activate nucleotide exchange at single-digit micromolar concns. in vitro.  In HeLa cells, these quinazolines increase the levels of RAS-GTP and cause signaling changes in the mitogen-activated protein kinase/extracellular regulated kinase (MAPK/ERK) pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQa6QZIgWHVrVg90H21EOLACvtfcHk0lgfZNEKenHSfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOjsLzN&md5=54b395566e713f8debbc2de33cb92363</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00296%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DJ.%2BR.%26aulast%3DPatel%26aufirst%3DP.%2BA.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DBrowning%26aufirst%3DC.%2BF.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520Quinazolines%2520That%2520Activate%2520SOS1-Mediated%2520Nucleotide%2520Exchange%2520on%2520RAS%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D941%26doi%3D10.1021%2Facsmedchemlett.8b00296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">Small Molecule–Mediated Activation of RAS Elicits Biphasic Modulation of Phospho-ERK Levels That Are Regulated through Negative Feedback on SOS1</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1060</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-17-0666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1158%2F1535-7163.MCT-17-0666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=29440291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosF2qsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=1051-1060&issue=5&author=J.+E.+Howesauthor=D.+T.+Akanauthor=M.+C.+Burnsauthor=O.+W.+Rossaneseauthor=A.+G.+Watersonauthor=S.+W.+Fesik&title=Small+Molecule%E2%80%93Mediated+Activation+of+RAS+Elicits+Biphasic+Modulation+of+Phospho-ERK+Levels+That+Are+Regulated+through+Negative+Feedback+on+SOS1&doi=10.1158%2F1535-7163.MCT-17-0666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule-Mediated Activation of RAS Elicits Biphasic Modulation of Phospho-ERK Levels that Are Regulated through Negative Feedback on SOS1</span></div><div class="casAuthors">Howes, Jennifer E.; Akan, Denis T.; Burns, Michael C.; Rossanese, Olivia W.; Waterson, Alex G.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1051-1060</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Oncogenic mutation of RAS results in aberrant cellular signaling and is responsible for more than 30% of all human tumors.  Therefore, pharmacol. modulation of RAS has attracted great interest as a therapeutic strategy.  Our lab. has recently discovered small mols. that activate Son of Sevenless (SOS)-catalyzed nucleotide exchange on RAS and inhibit downstream signaling.  Here, we describe how pharmacol. targeting SOS1 induced biphasic modulation of RAS-GTP and ERK phosphorylation levels, which we obsd. in a variety of cell lines expressing different RAS-mutant isoforms.  We show that compd. treatment caused an increase in phosphorylation at ERK consensus motifs on SOS1 that was not obsd. with the expression of a non-phosphorylatable S1178A SOS1 mutant or after pretreatment with an ERK inhibitor.  Phosphorylation at S1178 on SOS1 is known to inhibit the assocn. between SOS1 and GRB2 and disrupt SOS1 membrane localization.  Consistent with this, we show that wild-type SOS1 and GRB2 dissocd. in a time-dependent fashion in response to compd. treatment, and conversely, this interaction was enhanced with the expression of an S1178A SOS1 mutant.  Furthermore, in cells expressing either S1178A SOS1 or a constitutively membrane-bound CAAX box tagged SOS1 mutant, we obsd. elevated RAS-GTP levels over time in response to compd., as compared with the biphasic changes in RAS-GTP exhibited in cells expressing wild-type SOS1.  These results suggest that small mol. targeting of SOS1 can elicit a biphasic modulation of RAS-GTP and phospho-ERK levels through neg. feedback on SOS1 that regulates the interaction between SOS1 and GRB2.  Mol Cancer Ther; 17(5); 1051-60. ©2018 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa-L8W-8tgq7Vg90H21EOLACvtfcHk0lgfZNEKenHSfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosF2qsLc%253D&md5=e9a4fedac54fd873438cde20ce28f37d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-17-0666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-17-0666%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DAkan%26aufirst%3DD.%2BT.%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DSmall%2520Molecule%25E2%2580%2593Mediated%2520Activation%2520of%2520RAS%2520Elicits%2520Biphasic%2520Modulation%2520of%2520Phospho-ERK%2520Levels%2520That%2520Are%2520Regulated%2520through%2520Negative%2520Feedback%2520on%2520SOS1%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26issue%3D5%26spage%3D1051%26epage%3D1060%26doi%3D10.1158%2F1535-7163.MCT-17-0666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitanaka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochizuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagashima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himeno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchino, Y.</span></span> <span> </span><span class="NLM_article-title">Oncogenic Ras Triggers Cell Suicide through the Activation of a Caspase-Independent Cell Death Program in Human Cancer Cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2281</span>– <span class="NLM_lpage">2290</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1202538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fsj.onc.1202538" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=2281-2290&issue=13&author=S.+Chiauthor=C.+Kitanakaauthor=K.+Noguchiauthor=T.+Mochizukiauthor=Y.+Nagashimaauthor=M.+Shirouzuauthor=H.+Fujitaauthor=M.+Yoshidaauthor=W.+Chenauthor=A.+Asaiauthor=M.+Himenoauthor=S.+Yokoyamaauthor=Y.+Kuchino&title=Oncogenic+Ras+Triggers+Cell+Suicide+through+the+Activation+of+a+Caspase-Independent+Cell+Death+Program+in+Human+Cancer+Cells&doi=10.1038%2Fsj.onc.1202538"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1202538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1202538%26sid%3Dliteratum%253Aachs%26aulast%3DChi%26aufirst%3DS.%26aulast%3DKitanaka%26aufirst%3DC.%26aulast%3DNoguchi%26aufirst%3DK.%26aulast%3DMochizuki%26aufirst%3DT.%26aulast%3DNagashima%26aufirst%3DY.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DFujita%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DAsai%26aufirst%3DA.%26aulast%3DHimeno%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DKuchino%26aufirst%3DY.%26atitle%3DOncogenic%2520Ras%2520Triggers%2520Cell%2520Suicide%2520through%2520the%2520Activation%2520of%2520a%2520Caspase-Independent%2520Cell%2520Death%2520Program%2520in%2520Human%2520Cancer%2520Cells%26jtitle%3DOncogene%26date%3D1999%26volume%3D18%26issue%3D13%26spage%3D2281%26epage%3D2290%26doi%3D10.1038%2Fsj.onc.1202538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overmeyer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltese, W. A.</span></span> <span> </span><span class="NLM_article-title">Death Pathways Triggered by Activated Ras in Cancer Cells</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1693</span>– <span class="NLM_lpage">1713</span>, <span class="refDoi"> DOI: 10.2741/3814</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.2741%2F3814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=21196257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislCksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=1693-1713&author=J.+H.+Overmeyerauthor=W.+A.+Maltese&title=Death+Pathways+Triggered+by+Activated+Ras+in+Cancer+Cells&doi=10.2741%2F3814"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Death pathways triggered by activated Ras in cancer cells</span></div><div class="casAuthors">Overmeyer, Jean H.; Maltese, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Landmark Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1693-1713</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Ras GTPases are best known for their ability to serve as mol. switches regulating cell growth, differentiation and survival.  Gene mutations that result in expression of constitutively active forms of Ras have been linked to oncogenesis in animal models and humans.  However, over the past two decades, evidence has gradually accumulated to support a paradoxical role for Ras proteins in the initiation of cell death pathways.  In this review we survey the literature pointing to the ability of activated Ras to promote cell death under conditions where cancer cells encounter apoptotic stimuli or Ras is ectopically expressed.  In some of these cases Ras acts through known effectors and well defined apoptotic death pathways.  However, in other cases it appears that Ras operates by triggering novel non-apoptotic death mechanisms that are just beginning to be characterized.  Understanding these mechanisms and the factors that go into changing the nature of Ras signaling from pro-survival to pro-death could set the stage for development of novel therapeutic approaches aimed at manipulating pro-death Ras signaling pathways in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXifIvM6EFpbVg90H21EOLACvtfcHk0lhLbh9PKVTqVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislCksLo%253D&md5=621d16070dede0ac60ac1ed4767e3c25</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2741%2F3814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3814%26sid%3Dliteratum%253Aachs%26aulast%3DOvermeyer%26aufirst%3DJ.%2BH.%26aulast%3DMaltese%26aufirst%3DW.%2BA.%26atitle%3DDeath%2520Pathways%2520Triggered%2520by%2520Activated%2520Ras%2520in%2520Cancer%2520Cells%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2011%26volume%3D16%26spage%3D1693%26epage%3D1713%26doi%3D10.2741%2F3814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, B.</span></span> <span> </span><span class="NLM_article-title">Wentilactone A as a Novel Potential Antitumor Agent Induces Apoptosis and G2/M Arrest of Human Lung Carcinoma Cells and Is Mediated by HRas-GTP Accumulation to Excessively Activate the Ras/Raf/ERK/P53-P21 Pathway</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">e952</span>, <span class="refDoi"> DOI: 10.1038/cddis.2013.484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fcddis.2013.484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=24309939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFCqt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e952&issue=12&author=C.+Lvauthor=Y.+Hongauthor=L.+Miaoauthor=C.+Liauthor=G.+Xuauthor=S.+Weiauthor=B.+Wangauthor=C.+Huangauthor=B.+Jiao&title=Wentilactone+A+as+a+Novel+Potential+Antitumor+Agent+Induces+Apoptosis+and+G2%2FM+Arrest+of+Human+Lung+Carcinoma+Cells+and+Is+Mediated+by+HRas-GTP+Accumulation+to+Excessively+Activate+the+Ras%2FRaf%2FERK%2FP53-P21+Pathway&doi=10.1038%2Fcddis.2013.484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Wentilactone A as a novel potential antitumor agent induces apoptosis and G2/M arrest of human lung carcinoma cells, and is mediated by HRas-GTP accumulation to excessively activate the Ras/Raf/ERK/p53-p21 pathway</span></div><div class="casAuthors">Lv, C.; Hong, Y.; Miao, L.; Li, C.; Xu, G.; Wei, S.; Wang, B.; Huang, C.; Jiao, B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Dec.</span>),
    <span class="NLM_cas:pages">e952</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemotherapy remains the common therapeutic for patients with lung cancer.  Novel, selective antitumor agents are pressingly needed.  This study is the first to investigate a different, however, effective antitumor drug candidate Wentilactone A (WA) for its development as a novel agent.  In NCI-H460 and NCI-H446 cell lines, WA triggered G2/M phase arrest and mitochondrial-related apoptosis, accompanying the accumulation of reactive oxygen species (ROS).  It also induced activation of mitogen-activated protein kinase and p53 and increased expression of p21.  When we pre-treated cells with ERK, JNK, p38, p53 inhibitor or NAC followed by WA treatment, only ERK and p53 inhibitors blocked WA-induced apoptosis and G2/M arrest.  We further obsd. Ras (HRas, KRas and NRas) and Raf activation, and found that WA treatment increased HRas-Raf activation.  Knockdown of HRas by using small interfering RNA (siRNA) abolished WA-induced apoptosis and G2/M arrest.  HRas siRNA also halted Raf, ERK, p53 activation and p21 accumulation.  Mol. docking anal. suggested that WA could bind to HRas-GTP, causing accumulation of Ras-GTP and excessive activation of Raf/ERK/p53-p21.  The direct binding affinity was confirmed by surface plasmon resonance (SPR).  In vivo, WA suppressed tumor growth without adverse toxicity and presented the same mechanism as that in vitro.  Taken together, these findings suggest WA as a promising novel, potent and selective antitumor drug candidate for lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLAvfEEmYMwLVg90H21EOLACvtfcHk0lhLbh9PKVTqVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFCqt7%252FL&md5=f93de635f1df60ed2b44eacd80ede458</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.484%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DC.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DJiao%26aufirst%3DB.%26atitle%3DWentilactone%2520A%2520as%2520a%2520Novel%2520Potential%2520Antitumor%2520Agent%2520Induces%2520Apoptosis%2520and%2520G2%252FM%2520Arrest%2520of%2520Human%2520Lung%2520Carcinoma%2520Cells%2520and%2520Is%2520Mediated%2520by%2520HRas-GTP%2520Accumulation%2520to%2520Excessively%2520Activate%2520the%2520Ras%252FRaf%252FERK%252FP53-P21%2520Pathway%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26issue%3D12%26spage%3De952%26doi%3D10.1038%2Fcddis.2013.484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. J.</span></span> <span> </span><span class="NLM_article-title">Oncogene-Induced Autophagy and the Goldilocks Principle</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">922</span>– <span class="NLM_lpage">923</span>, <span class="refDoi"> DOI: 10.4161/auto.7.8.15821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.4161%2Fauto.7.8.15821" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=922-923&issue=8&author=S.+J.+Martin&title=Oncogene-Induced+Autophagy+and+the+Goldilocks+Principle&doi=10.4161%2Fauto.7.8.15821"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.4161%2Fauto.7.8.15821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.7.8.15821%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DS.%2BJ.%26atitle%3DOncogene-Induced%2520Autophagy%2520and%2520the%2520Goldilocks%2520Principle%26jtitle%3DAutophagy%26date%3D2011%26volume%3D7%26issue%3D8%26spage%3D922%26epage%3D923%26doi%3D10.4161%2Fauto.7.8.15821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overmeyer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltese, W. A.</span></span> <span> </span><span class="NLM_article-title">Active Ras Triggers Death in Glioblastoma Cells through Hyperstimulation of Macropinocytosis</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">977</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-07-2036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1158%2F1541-7786.MCR-07-2036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=18567800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVKgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=965-977&issue=6&author=J.+H.+Overmeyerauthor=A.+Kaulauthor=E.+E.+Johnsonauthor=W.+A.+Maltese&title=Active+Ras+Triggers+Death+in+Glioblastoma+Cells+through+Hyperstimulation+of+Macropinocytosis&doi=10.1158%2F1541-7786.MCR-07-2036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Active Ras triggers death in glioblastoma cells through hyperstimulation of macropinocytosis</span></div><div class="casAuthors">Overmeyer, Jean H.; Kaul, Aparna; Johnson, Erin E.; Maltese, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">965-977</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Expression of activated Ras in glioblastoma cells induces accumulation of large phase-lucent cytoplasmic vacuoles, followed by cell death.  This was previously described as autophagic cell death.  However, unlike autophagosomes, the Ras-induced vacuoles are not bounded by a double membrane and do not sequester organelles or cytoplasm.  Moreover, they are not acidic and do not contain the autophagosomal membrane protein LC3-II.  Here we show that the vacuoles are enlarged macropinosomes.  They rapidly incorporate extracellular fluid-phase tracers but do not sequester transferrin or the endosomal protein EEA1.  Ultimately, the cells expressing activated Ras detach from the substratum and rupture, coincident with the displacement of cytoplasm with huge macropinosome-derived vacuoles.  These changes are accompanied by caspase activation, but the broad-spectrum caspase inhibitor carbobenzoxy-Val-Ala-Asp-fluoromethylketone does not prevent cell death.  Moreover, the majority of degenerating cells do not exhibit chromatin condensation typical of apoptosis.  These observations provide evidence for a necrosis-like form of cell death initiated by dysregulation of macropinocytosis, which we have dubbed "methuosis." An activated form of the Rac1 GTPase induces a similar form of cell death, suggesting that Ras acts through Rac-dependent signaling pathways to hyperstimulate macropinocytosis in glioblastoma.  Further study of these signaling pathways may lead to the identification of other chem. and physiol. triggers for this unusual form of cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4aZB2o658nbVg90H21EOLACvtfcHk0ljSzbRCigLfng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVKgsr8%253D&md5=21dda1b33870d9689003e95ede1c6480</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-07-2036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-07-2036%26sid%3Dliteratum%253Aachs%26aulast%3DOvermeyer%26aufirst%3DJ.%2BH.%26aulast%3DKaul%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DE.%2BE.%26aulast%3DMaltese%26aufirst%3DW.%2BA.%26atitle%3DActive%2520Ras%2520Triggers%2520Death%2520in%2520Glioblastoma%2520Cells%2520through%2520Hyperstimulation%2520of%2520Macropinocytosis%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2008%26volume%3D6%26issue%3D6%26spage%3D965%26epage%3D977%26doi%3D10.1158%2F1541-7786.MCR-07-2036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Unni, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockwood, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zejnullahu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee-Lin, S.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varmus, H.</span></span> <span> </span><span class="NLM_article-title">Evidence That Synthetic Lethality Underlies the Mutual Exclusivity of Oncogenic KRAS and EGFR Mutations in Lung Adenocarcinoma</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e06907</span>, <span class="refDoi"> DOI: 10.7554/eLife.06907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.7554%2FeLife.06907" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=e06907&author=A.+M.+Unniauthor=W.+W.+Lockwoodauthor=K.+Zejnullahuauthor=S.-Q.+Lee-Linauthor=H.+Varmus&title=Evidence+That+Synthetic+Lethality+Underlies+the+Mutual+Exclusivity+of+Oncogenic+KRAS+and+EGFR+Mutations+in+Lung+Adenocarcinoma&doi=10.7554%2FeLife.06907"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.7554%2FeLife.06907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.06907%26sid%3Dliteratum%253Aachs%26aulast%3DUnni%26aufirst%3DA.%2BM.%26aulast%3DLockwood%26aufirst%3DW.%2BW.%26aulast%3DZejnullahu%26aufirst%3DK.%26aulast%3DLee-Lin%26aufirst%3DS.-Q.%26aulast%3DVarmus%26aufirst%3DH.%26atitle%3DEvidence%2520That%2520Synthetic%2520Lethality%2520Underlies%2520the%2520Mutual%2520Exclusivity%2520of%2520Oncogenic%2520KRAS%2520and%2520EGFR%2520Mutations%2520in%2520Lung%2520Adenocarcinoma%26jtitle%3DeLife%26date%3D2015%26volume%3D4%26spage%3De06907%26doi%3D10.7554%2FeLife.06907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ambrogio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbacid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santamaría, D.</span></span> <span> </span><span class="NLM_article-title">In Vivo Oncogenic Conflict Triggered by Co-Existing KRAS and EGFR Activating Mutations in Lung Adenocarcinoma</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">2309</span>– <span class="NLM_lpage">2318</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fonc.2016.385" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=2309-2318&issue=16&author=C.+Ambrogioauthor=M.+Barbacidauthor=D.+Santamar%C3%ADa&title=In+Vivo+Oncogenic+Conflict+Triggered+by+Co-Existing+KRAS+and+EGFR+Activating+Mutations+in+Lung+Adenocarcinoma&doi=10.1038%2Fonc.2016.385"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.385%26sid%3Dliteratum%253Aachs%26aulast%3DAmbrogio%26aufirst%3DC.%26aulast%3DBarbacid%26aufirst%3DM.%26aulast%3DSantamar%25C3%25ADa%26aufirst%3DD.%26atitle%3DIn%2520Vivo%2520Oncogenic%2520Conflict%2520Triggered%2520by%2520Co-Existing%2520KRAS%2520and%2520EGFR%2520Activating%2520Mutations%2520in%2520Lung%2520Adenocarcinoma%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26issue%3D16%26spage%3D2309%26epage%3D2318%26doi%3D10.1038%2Fonc.2016.385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vegetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anichini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sensi, M.</span></span> <span> </span><span class="NLM_article-title">Coexpression of NRAS Q61R and BRAF V600E in Human Melanoma Cells Activates Senescence and Increases Susceptibility to Cell-Mediated Cytotoxicity</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">6503</span>– <span class="NLM_lpage">6511</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-4671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1158%2F0008-5472.CAN-05-4671" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=6503-6511&issue=13&author=C.+Pettiauthor=A.+Mollaauthor=C.+Vegettiauthor=S.+Ferroneauthor=A.+Anichiniauthor=M.+Sensi&title=Coexpression+of+NRAS+Q61R+and+BRAF+V600E+in+Human+Melanoma+Cells+Activates+Senescence+and+Increases+Susceptibility+to+Cell-Mediated+Cytotoxicity&doi=10.1158%2F0008-5472.CAN-05-4671"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-4671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-4671%26sid%3Dliteratum%253Aachs%26aulast%3DPetti%26aufirst%3DC.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DVegetti%26aufirst%3DC.%26aulast%3DFerrone%26aufirst%3DS.%26aulast%3DAnichini%26aufirst%3DA.%26aulast%3DSensi%26aufirst%3DM.%26atitle%3DCoexpression%2520of%2520NRAS%2520Q61R%2520and%2520BRAF%2520V600E%2520in%2520Human%2520Melanoma%2520Cells%2520Activates%2520Senescence%2520and%2520Increases%2520Susceptibility%2520to%2520Cell-Mediated%2520Cytotoxicity%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D13%26spage%3D6503%26epage%3D6511%26doi%3D10.1158%2F0008-5472.CAN-05-4671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camper, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">High-Throughput Screening Identifies Small Molecules That Bind to the RAS:SOS:RAS Complex and Perturb RAS Signaling</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>548</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2018.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2Fj.ab.2018.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=29444450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFaju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=548&publication_year=2018&pages=44-52&author=M.+C.+Burnsauthor=J.+E.+Howesauthor=Q.+Sunauthor=A.+J.+Littleauthor=D.+V.+Camperauthor=J.+R.+Abbottauthor=J.+Phanauthor=T.+Leeauthor=A.+G.+Watersonauthor=O.+W.+Rossaneseauthor=S.+W.+Fesik&title=High-Throughput+Screening+Identifies+Small+Molecules+That+Bind+to+the+RAS%3ASOS%3ARAS+Complex+and+Perturb+RAS+Signaling&doi=10.1016%2Fj.ab.2018.01.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling</span></div><div class="casAuthors">Burns, Michael C.; Howes, Jennifer E.; Sun, Qi; Little, Andrew J.; Camper, DeMarco V.; Abbott, Jason R.; Phan, Jason; Lee, Taekyu; Waterson, Alex G.; Rossanese, Olivia W.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">548</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44-52</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">K-RAS is mutated in approx. 30% of human cancers, resulting in increased RAS signaling and tumor growth.  Thus, RAS is a highly validated therapeutic target, esp. in tumors of the pancreas, lung and colon.  Although directly targeting RAS has proven to be challenging, it may be possible to target other proteins involved in RAS signaling, such as the guanine nucleotide exchange factor Son of Sevenless (SOS).  We have previously reported on the discovery of small mols. that bind to SOS1, activate SOS-mediated nucleotide exchange on RAS, and paradoxically inhibit ERK phosphorylation (Burns et al., PNAS, 2014).  Here, we describe the discovery of addnl., structurally diverse small mols. that also bind to SOS1 in the same pocket and elicit similar biol. effects.  We tested >160,000 compds. in a fluorescence-based assay to assess their effects on SOS-mediated nucleotide exchange.  X-Ray structures revealed that these small mols. bind to the CDC25 domain of SOS1.  Compds. that elicited high levels of nucleotide exchange activity in vitro increased RAS-GTP levels in cells, and inhibited phospho ERK levels at higher treatment concns.  The identification of structurally diverse SOS1 binding ligands may assist in the discovery of new mols. designed to target RAS-driven tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdp7gmEwzlMLVg90H21EOLACvtfcHk0ljSzbRCigLfng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFaju70%253D&md5=af853c79022b68839f53bfb11303b97a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2018.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2018.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DM.%2BC.%26aulast%3DHowes%26aufirst%3DJ.%2BE.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DLittle%26aufirst%3DA.%2BJ.%26aulast%3DCamper%26aufirst%3DD.%2BV.%26aulast%3DAbbott%26aufirst%3DJ.%2BR.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DWaterson%26aufirst%3DA.%2BG.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DHigh-Throughput%2520Screening%2520Identifies%2520Small%2520Molecules%2520That%2520Bind%2520to%2520the%2520RAS%253ASOS%253ARAS%2520Complex%2520and%2520Perturb%2520RAS%2520Signaling%26jtitle%3DAnal.%2520Biochem.%26date%3D2018%26volume%3D548%26spage%3D44%26epage%3D52%26doi%3D10.1016%2Fj.ab.2018.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopple, K. D.</span></span> <span> </span><span class="NLM_article-title">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2615</span>– <span class="NLM_lpage">2623</span>, <span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&issue=12&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.-Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+Properties+That+Influence+the+Oral+Bioavailability+of+Drug+Candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0ljzWb-bGgc2LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520Properties%2520That%2520Influence%2520the%2520Oral%2520Bioavailability%2520of%2520Drug%2520Candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26issue%3D12%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Souza-Fagundes, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldkamp, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorset, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chazin, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossanese, O. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span> <span> </span><span class="NLM_article-title">A High-Throughput Fluorescence Polarization Anisotropy Assay for the 70N Domain of Replication Protein A</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>421</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">749</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2011.11.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2Fj.ab.2011.11.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2012&pages=742-749&issue=2&author=E.+M.+Souza-Fagundesauthor=A.+O.+Frankauthor=M.+D.+Feldkampauthor=D.+C.+Dorsetauthor=W.+J.+Chazinauthor=O.+W.+Rossaneseauthor=E.+T.+Olejniczakauthor=S.+W.+Fesik&title=A+High-Throughput+Fluorescence+Polarization+Anisotropy+Assay+for+the+70N+Domain+of+Replication+Protein+A&doi=10.1016%2Fj.ab.2011.11.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2011.11.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2011.11.025%26sid%3Dliteratum%253Aachs%26aulast%3DSouza-Fagundes%26aufirst%3DE.%2BM.%26aulast%3DFrank%26aufirst%3DA.%2BO.%26aulast%3DFeldkamp%26aufirst%3DM.%2BD.%26aulast%3DDorset%26aufirst%3DD.%2BC.%26aulast%3DChazin%26aufirst%3DW.%2BJ.%26aulast%3DRossanese%26aufirst%3DO.%2BW.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DA%2520High-Throughput%2520Fluorescence%2520Polarization%2520Anisotropy%2520Assay%2520for%2520the%252070N%2520Domain%2520of%2520Replication%2520Protein%2520A%26jtitle%3DAnal.%2520Biochem.%26date%3D2012%26volume%3D421%26issue%3D2%26spage%3D742%26epage%3D749%26doi%3D10.1016%2Fj.ab.2011.11.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Development and Optimization of a Binding Assay for the XIAP BIR3 Domain Using Fluorescence Polarization</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>332</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2004.05.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2Fj.ab.2004.05.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=15325294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFeltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2004&pages=261-273&issue=2&author=Z.+Nikolovska-Coleskaauthor=R.+Wangauthor=X.+Fangauthor=H.+Panauthor=Y.+Tomitaauthor=P.+Liauthor=P.+P.+Rollerauthor=K.+Krajewskiauthor=N.+G.+Saitoauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Development+and+Optimization+of+a+Binding+Assay+for+the+XIAP+BIR3+Domain+Using+Fluorescence+Polarization&doi=10.1016%2Fj.ab.2004.05.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization</span></div><div class="casAuthors">Nikolovska-Coleska, Zaneta; Wang, Renxiao; Fang, Xueliang; Pan, Hongguang; Tomita, York; Li, Peng; Roller, Peter P.; Krajewski, Krzysztof; Saito, Naoyuki G.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">261-273</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The X-linked inhibitor of apoptosis protein (XIAP) is a potent cellular inhibitor of apoptosis.  Designing small-mol. inhibitors that target the BIR3 domain of XIAP, where Smac/DIABLO (second mitochondria-derived activator of caspase/direct IAP-binding protein with low pI) and caspase-9 bind, is a promising strategy for inhibiting the antiapoptotic activity of XIAP and for overcoming apoptosis resistance of cancer cells mediated by XIAP.  Herein, we report the development of a homogeneous high-throughput assay based on fluorescence polarization for measuring the binding affinities of small-mol. inhibitors to the BIR3 domain of XIAP.  Among four fluorescent probes tested, a mutated N-terminal Smac peptide (AbuRPFK-(5-Fam)-NH2) showed the highest affinity (Kd = 17.92 nM) and a large dynamic range (ΔmP=231±0.9), and was selected as the most suitable probe for the binding assay.  The binding conditions (DMSO tolerance and stability) have been investigated.  Under optimized conditions, a Z' factor of 0.88 was achieved in a 96-well format for high-throughput screening.  It was found that the popular Cheng-Prusoff equation is invalid for the calcn. of the competitive inhibition consts. (Ki values) for inhibitors in the FP-based competitive binding assay conditions, and accordingly, a new math. equation was developed, validated, and used to compute the Ki values.  An assocd. Web-based computer program was also developed for this task.  Several known Smac peptides with high and low affinities have been evaluated under the assay conditions and the results obtained indicated that the FP-based competitive binding assay performs correctly as designed: it can quant. and accurately det. the binding affinities of Smac-based peptide inhibitors with a wide range of affinities, and is suitable for high-throughput screening of inhibitors binding to the XIAP BIR3 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWjEsqtWsZRbVg90H21EOLACvtfcHk0ljzWb-bGgc2LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFeltL0%253D&md5=23cade47a4996c7ca4c01278d3e0d3a6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.05.055%26sid%3Dliteratum%253Aachs%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DN.%2BG.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDevelopment%2520and%2520Optimization%2520of%2520a%2520Binding%2520Assay%2520for%2520the%2520XIAP%2520BIR3%2520Domain%2520Using%2520Fluorescence%2520Polarization%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D332%26issue%3D2%26spage%3D261%26epage%3D273%26doi%3D10.1016%2Fj.ab.2004.05.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The Influence of Drug-like Concepts on Decision-Making in Medicinal Chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&issue=11&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+Influence+of+Drug-like+Concepts+on+Decision-Making+in+Medicinal+Chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0li34tSf6jxAcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520Influence%2520of%2520Drug-like%2520Concepts%2520on%2520Decision-Making%2520in%2520Medicinal%2520Chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26issue%3D11%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tice, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span> <span> </span><span class="NLM_article-title">The Use of Spirocyclic Scaffolds in Drug Discovery</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3673</span>– <span class="NLM_lpage">3682</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2Fj.bmcl.2014.06.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=25052427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFykt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3673-3682&issue=16&author=Y.+Zhengauthor=C.+M.+Ticeauthor=S.+B.+Singh&title=The+Use+of+Spirocyclic+Scaffolds+in+Drug+Discovery&doi=10.1016%2Fj.bmcl.2014.06.081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The use of spirocyclic scaffolds in drug discovery</span></div><div class="casAuthors">Zheng, Yajun; Tice, Colin M.; Singh, Suresh B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3673-3682</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Owing to their inherent three-dimensionality and structural novelty, spiro scaffolds have been increasingly utilized in drug discovery.  In this brief review, we highlight selected examples from the primary medicinal chem. literature during the last three years to demonstrate the versatility of spiro scaffolds.  With recent progress in synthetic methods providing access to spiro building blocks, spiro scaffolds are likely to be used more frequently in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqzTjJrsRkyLVg90H21EOLACvtfcHk0li34tSf6jxAcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFykt7bM&md5=9a2a644cf2b97edf7876b43b6457f6d5</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.081%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DTice%26aufirst%3DC.%2BM.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DThe%2520Use%2520of%2520Spirocyclic%2520Scaffolds%2520in%2520Drug%2520Discovery%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D3673%26epage%3D3682%26doi%3D10.1016%2Fj.bmcl.2014.06.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burkhard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreira, E. M.</span></span> <span> </span><span class="NLM_article-title">2,6-Diazaspiro[3.3]Heptanes: Synthesis and Application in Pd-Catalyzed Aryl Amination Reactions</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3525</span>– <span class="NLM_lpage">3526</span>, <span class="refDoi"> DOI: 10.1021/ol801293f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol801293f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=3525-3526&issue=16&author=J.+Burkhardauthor=E.+M.+Carreira&title=2%2C6-Diazaspiro%5B3.3%5DHeptanes%3A+Synthesis+and+Application+in+Pd-Catalyzed+Aryl+Amination+Reactions&doi=10.1021%2Fol801293f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fol801293f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol801293f%26sid%3Dliteratum%253Aachs%26aulast%3DBurkhard%26aufirst%3DJ.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26atitle%3D2%252C6-Diazaspiro%255B3.3%255DHeptanes%253A%2520Synthesis%2520and%2520Application%2520in%2520Pd-Catalyzed%2520Aryl%2520Amination%2520Reactions%26jtitle%3DOrg.%2520Lett.%26date%3D2008%26volume%3D10%26issue%3D16%26spage%3D3525%26epage%3D3526%26doi%3D10.1021%2Fol801293f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burkhard, J. a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreira, E. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Azaspirocycles and Their Evaluation in Drug Discovery</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">3524</span>– <span class="NLM_lpage">3527</span>, <span class="refDoi"> DOI: 10.1002/anie.200907108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1002%2Fanie.200907108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFCnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=3524-3527&issue=20&author=J.+a.+Burkhardauthor=B.+Wagnerauthor=H.+Fischerauthor=F.+Schulerauthor=K.+M%C3%BCllerauthor=E.+M.+Carreira&title=Synthesis+of+Azaspirocycles+and+Their+Evaluation+in+Drug+Discovery&doi=10.1002%2Fanie.200907108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Azaspirocycles and their Evaluation in Drug Discovery</span></div><div class="casAuthors">Burkhard, Johannes A.; Wagner, Bjoern; Fischer, Holger; Schuler, Franz; Mueller, Klaus; Carreira, Erick M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3524-3527, S3524/1-S3524/60</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Readily synthesized heteroatom-substituted spiro[3.3]heptanes generally show higher aq. soly. than their cyclohexane analogs, and show a trend towards higher metabolic stability.  The novel framework can be mounted onto scaffolds of druglike structures, such as fluoroquinolones, to afford active compds. with similar or even improved metabolic stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW-R9uvaVrXLVg90H21EOLACvtfcHk0li34tSf6jxAcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFCnsbY%253D&md5=0367b2cb751889a3df1cb1c8d2b24bc6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fanie.200907108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200907108%26sid%3Dliteratum%253Aachs%26aulast%3DBurkhard%26aufirst%3DJ.%2Ba.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26atitle%3DSynthesis%2520of%2520Azaspirocycles%2520and%2520Their%2520Evaluation%2520in%2520Drug%2520Discovery%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26issue%3D20%26spage%3D3524%26epage%3D3527%26doi%3D10.1002%2Fanie.200907108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conradi, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, N. F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, P. S.</span></span> <span> </span><span class="NLM_article-title">Physicochemical Determinants of Passive Membrane Permeability: Role of Solute Hydrogen-Bonding Potential and Volume</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">3721</span>– <span class="NLM_lpage">3729</span>, <span class="refDoi"> DOI: 10.1021/jm010253i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010253i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3721-3729&issue=22&author=J.+T.+Goodwinauthor=R.+A.+Conradiauthor=N.+F.+H.+Hoauthor=P.+S.+Burton&title=Physicochemical+Determinants+of+Passive+Membrane+Permeability%3A+Role+of+Solute+Hydrogen-Bonding+Potential+and+Volume&doi=10.1021%2Fjm010253i"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm010253i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010253i%26sid%3Dliteratum%253Aachs%26aulast%3DGoodwin%26aufirst%3DJ.%2BT.%26aulast%3DConradi%26aufirst%3DR.%2BA.%26aulast%3DHo%26aufirst%3DN.%2BF.%2BH.%26aulast%3DBurton%26aufirst%3DP.%2BS.%26atitle%3DPhysicochemical%2520Determinants%2520of%2520Passive%2520Membrane%2520Permeability%253A%2520Role%2520of%2520Solute%2520Hydrogen-Bonding%2520Potential%2520and%2520Volume%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26issue%3D22%26spage%3D3721%26epage%3D3729%26doi%3D10.1021%2Fjm010253i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hop, C. E. C. A.</span></span> <span> </span><span class="NLM_article-title">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8238</span>– <span class="NLM_lpage">8248</span>, <span class="refDoi"> DOI: 10.1021/jm5007935</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5007935" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8238-8248&issue=20&author=X.+Liuauthor=M.+Wrightauthor=C.+E.+C.+A.+Hop&title=Rational+Use+of+Plasma+Protein+and+Tissue+Binding+Data+in+Drug+Design&doi=10.1021%2Fjm5007935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Use of Plasma Protein and Tissue Binding Data in Drug Design</span></div><div class="casAuthors">Liu, Xingrong; Wright, Matthew; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8238-8248</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is a commonly accepted assumption that only unbound drug mols. are available to interact with their targets.  Therefore, one of the objectives in drug design is to optimize the compd. structure to increase in vivo unbound drug concn.  In this review, theor. analyses and exptl. observations are presented to illustrate that low plasma protein binding does not necessarily lead to high in vivo unbound plasma concn.  Similarly, low brain tissue binding does not lead to high in vivo unbound brain tissue concn.  Instead, low intrinsic clearance leads to high in vivo unbound plasma concn., and low efflux transport activity at the blood-brain barrier leads to high unbound brain concn.  Plasma protein and brain tissue binding are very important parameters in understanding pharmacokinetics, pharmacodynamics, and toxicities of drugs, but these parameters should not be targeted for optimization in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKiYUz9ljIDrVg90H21EOLACvtfcHk0lj73xVbLSa1nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Git77M&md5=53ffbdb88ddf500a90a0eee14b0e641f</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm5007935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5007935%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWright%26aufirst%3DM.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26atitle%3DRational%2520Use%2520of%2520Plasma%2520Protein%2520and%2520Tissue%2520Binding%2520Data%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D20%26spage%3D8238%26epage%3D8248%26doi%3D10.1021%2Fjm5007935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aronheim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Alawi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlessinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Membrane Targeting of the Nucleotide Exchange Factor Sos Is Sufficient for Activating the Ras Signaling Pathway</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">949</span>– <span class="NLM_lpage">961</span>, <span class="refDoi"> DOI: 10.1016/0092-8674(94)90271-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1016%2F0092-8674%2894%2990271-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1994&pages=949-961&issue=6&author=A.+Aronheimauthor=D.+Engelbergauthor=N.+Liauthor=N.+Al-Alawiauthor=J.+Schlessingerauthor=M.+Karin&title=Membrane+Targeting+of+the+Nucleotide+Exchange+Factor+Sos+Is+Sufficient+for+Activating+the+Ras+Signaling+Pathway&doi=10.1016%2F0092-8674%2894%2990271-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2894%2990271-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252894%252990271-2%26sid%3Dliteratum%253Aachs%26aulast%3DAronheim%26aufirst%3DA.%26aulast%3DEngelberg%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DAl-Alawi%26aufirst%3DN.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DMembrane%2520Targeting%2520of%2520the%2520Nucleotide%2520Exchange%2520Factor%2520Sos%2520Is%2520Sufficient%2520for%2520Activating%2520the%2520Ras%2520Signaling%2520Pathway%26jtitle%3DCell%26date%3D1994%26volume%3D78%26issue%3D6%26spage%3D949%26epage%3D961%26doi%3D10.1016%2F0092-8674%2894%2990271-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, M.</span></span> <span> </span><span class="NLM_article-title">Multiple Decisive Phosphorylation Sites for the Negative Feedback Regulation of SOS1 via ERK</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">43</span>),  <span class="NLM_fpage">33540</span>– <span class="NLM_lpage">33548</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.135517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1074%2Fjbc.M110.135517" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=33540-33548&issue=43&author=Y.+Kamiokaauthor=S.+Yasudaauthor=Y.+Fujitaauthor=K.+Aokiauthor=M.+Matsuda&title=Multiple+Decisive+Phosphorylation+Sites+for+the+Negative+Feedback+Regulation+of+SOS1+via+ERK&doi=10.1074%2Fjbc.M110.135517"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.135517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.135517%26sid%3Dliteratum%253Aachs%26aulast%3DKamioka%26aufirst%3DY.%26aulast%3DYasuda%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DY.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DM.%26atitle%3DMultiple%2520Decisive%2520Phosphorylation%2520Sites%2520for%2520the%2520Negative%2520Feedback%2520Regulation%2520of%2520SOS1%2520via%2520ERK%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D43%26spage%3D33540%26epage%3D33548%26doi%3D10.1074%2Fjbc.M110.135517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iversen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gureasko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petit, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thill, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuriyan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groves, J. T.</span></span> <span> </span><span class="NLM_article-title">Ras Activation by SOS: Allosteric Regulation by Altered Fluctuation Dynamics</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>345</i></span> (<span class="NLM_issue">6192</span>),  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1126/science.1250373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;key=10.1126%2Fscience.1250373" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2014&pages=50-54&issue=6192&author=L.+Iversenauthor=H.-L.+Tuauthor=W.-C.+Linauthor=S.+M.+Christensenauthor=S.+M.+Abelauthor=J.+Iwigauthor=H.-J.+Wuauthor=J.+Gureaskoauthor=C.+Rhodesauthor=R.+S.+Petitauthor=S.+D.+Hansenauthor=P.+Thillauthor=C.-H.+Yuauthor=D.+Stamouauthor=A.+K.+Chakrabortyauthor=J.+Kuriyanauthor=J.+T.+Groves&title=Ras+Activation+by+SOS%3A+Allosteric+Regulation+by+Altered+Fluctuation+Dynamics&doi=10.1126%2Fscience.1250373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1126%2Fscience.1250373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1250373%26sid%3Dliteratum%253Aachs%26aulast%3DIversen%26aufirst%3DL.%26aulast%3DTu%26aufirst%3DH.-L.%26aulast%3DLin%26aufirst%3DW.-C.%26aulast%3DChristensen%26aufirst%3DS.%2BM.%26aulast%3DAbel%26aufirst%3DS.%2BM.%26aulast%3DIwig%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.-J.%26aulast%3DGureasko%26aufirst%3DJ.%26aulast%3DRhodes%26aufirst%3DC.%26aulast%3DPetit%26aufirst%3DR.%2BS.%26aulast%3DHansen%26aufirst%3DS.%2BD.%26aulast%3DThill%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DC.-H.%26aulast%3DStamou%26aufirst%3DD.%26aulast%3DChakraborty%26aufirst%3DA.%2BK.%26aulast%3DKuriyan%26aufirst%3DJ.%26aulast%3DGroves%26aufirst%3DJ.%2BT.%26atitle%3DRas%2520Activation%2520by%2520SOS%253A%2520Allosteric%2520Regulation%2520by%2520Altered%2520Fluctuation%2520Dynamics%26jtitle%3DScience%26date%3D2014%26volume%3D345%26issue%3D6192%26spage%3D50%26epage%3D54%26doi%3D10.1126%2Fscience.1250373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soll, M.</span>; <span class="NLM_string-name">Le Hir De Fallois, L.</span>; <span class="NLM_string-name">Huber, S.</span>; <span class="NLM_string-name">Lee, H.</span>; <span class="NLM_string-name">Douglas, E.</span>; <span class="NLM_string-name">Jacobs, R.</span>; <span class="NLM_string-name">Beck, B.</span></span> <span> </span><span class="NLM_article-title">Preparation of Enantiomerically Enriched Aryloazol-2-Yl Cyanoethylamino Parasiticidal Compounds</span>. <span class="NLM_patent">WO 2010056999</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+Soll&author=L.+Le+Hir+De+Fallois&author=S.+Huber&author=H.+Lee&author=E.+Douglas&author=R.+Jacobs&author=B.+Beck&title=Preparation+of+Enantiomerically+Enriched+Aryloazol-2-Yl+Cyanoethylamino+Parasiticidal+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSoll%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520Enantiomerically%2520Enriched%2520Aryloazol-2-Yl%2520Cyanoethylamino%2520Parasiticidal%2520Compounds%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5V" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5V','PDB','6D5V'); return false;">PDB: 6D5V</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5M','PDB','6D5M'); return false;">PDB: 6D5M</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5L" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5L','PDB','6D5L'); return false;">PDB: 6D5L</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5J','PDB','6D5J'); return false;">PDB: 6D5J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5H" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5H','PDB','6D5H'); return false;">PDB: 6D5H</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5G" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5G','PDB','6D5G'); return false;">PDB: 6D5G</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5E','PDB','6D5E'); return false;">PDB: 6D5E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D59" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D59','PDB','6D59'); return false;">PDB: 6D59</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D56" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D56','PDB','6D56'); return false;">PDB: 6D56</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D55" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D55','PDB','6D55'); return false;">PDB: 6D55</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i96"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01108">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_88034"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01108">10.1021/acs.jmedchem.8b01108</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Biochemical and cellular assay conditions; saturation binding curves for FPA probe molecules <b>S1</b>, <b>S2</b>, and <b>S3</b>; additional biochemical data; preliminary in vitro solubility and permeability data; experimental details for the syntheses of <b>S1</b>, <b>S2</b>, and <b>S3</b>; details regarding protein expression and purification; details regarding crystallization, X-ray data collection, structure solution, and refinement; and a table containing X-ray data collection and refinement statistics (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_001.pdf">jm8b01108_si_001.pdf (3.02 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01108/suppl_file/jm8b01108_si_002.csv">jm8b01108_si_002.csv (5.62 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes: compounds <b>3</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5V">6D5V</a>), <b>10</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5M">6D5M</a>), <b>28</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5L">6D5L</a>), <b>29</b> ( <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5J">6D5J</a>), <b>38</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5H">6D5H</a>), <b>43</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5G">6D5G</a>), <b>47</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D5E">6D5E</a>), <b>58</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D59">6D59</a>), <b>64</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D55">6D55</a>), <b>65</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6D56">6D56</a>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01108&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01108%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-19%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01108" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                11MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a9998781b191d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
